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SUMMARY 
The increasingly stringent environmental regulations on hazardous wastes has 
encouraged the search for innovative solutions for the remediation of contaminated 
wastes. In this field, bioremediation is seen as an attractive solution due to its 
reputation as a low cost, environmentally friendly and publicly acceptable treatment 
technology. The aim of this research project was to explore new potential candidates 
for the bio-treatment of wastes and environments contaminated by alkylating agents. 
The study has been specifically focused on AidB, an enigmatic component of the 
response to alkylation stress in bacterium Escherichia coli. First, AidB protein was 
functionally characterized: it was showed to bind with high affinity DNA regions 
containing an upstream element and to have transcriptional activity. At this regard, it 
was intriguing to speculate that AidB might stimulate the transcription of genes 
whose products are responsible for alkylation resistance. Successively, given that the 
knowledge of the domain architecture is necessary for understanding the 
multifunctional properties of a protein, structural and functional characterization of 
domains present in AidB was performed. Specifically, its N-terminal region was 
shown to be exhibit acyl-CoA dehydrogenase activity while the short C-terminal 
domain was shown to be responsible for the DNA binding activity and for regulatory 
function. The study was then aimed at investigate the mechanism by which AidB 
directly protects E. coli cells against alkylating compounds. It was demonstrated that 
this protein prevents alkylation damage and it does so by protecting DNA and, 
presumably, by inactivating alkylators before they are able to react with their target. 
Interestingly, a recent report on the three dimensional structure of AidB bound to 
double strand DNA supported this model, revealing that the protein is well equipped 
to sterically occlude DNA from attack by damaging agents. Importantly, the unique 
chemical environment of FAD active site provided a rationale for a possible role of 
AidB in deactivation of nitrosoguanidines such as N-methyl-N′-nitro-N-
nitrosoguanidine (MNNG) and N-ethyl-N′-nitro-N-nitrosoguanidine (ENNG). Coupled 
with structural analysis, the results obtained in this work supported the hypothesis 
that AidB might act as a detoxification enzyme to destroy nitrosoguanidines: indeed, 
it was demonstrated that aidB mutant cells display decreased resistance to MNNG 
and ENNG and no change in sensitivity to other classes of alkylators; besides, AidB 
was showed to allow more efficient gene transcription in E. coli cells exposed to 
nitrosoguanidines rather than to other mutagens. Therefore, AidB represents a 
promising tool for the bio-treatment of sites contaminated by certain alkylating 
agents. On the basis of data described above, this experimental work was ultimately 
targeted at identify as well as at characterize E. coli AidB homologues in bacteria 
used for bioremediation applications. Specifically, the acyl-CoA dehydrogenase 
coded by the PP4780 gene from Pseudomonas putida KT2440 was the object of this 
investigation. The PP4780 gene was expressed in ∆aidB and wild type E. coli strains 
and its involvement in the protection against alkylating agents was tested. 
Interestingly, the complementation of the ∆aidB mutation by PP4780 restored the 
resistance phenotype to lethal and mutagenic effects of MNNG and ENNG; besides, 
recombinant cells that overexpress PP4780 were shown to possess increased 
resistance to nitrosoguanidines as compared with wild type and aidB-overexpressing 
cells. On the basis of these observations, the acyl-CoA dehydrogenase from P. 
putida has been demonstrated to be involved in the response to alkylation stress, 
presumably functioning as a detoxification enzyme. In conclusion, the data obtained 
strongly support the possibility of developing new successful strategies for the 
bioremediation of sites contaminated by alkylating compounds.  
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RIASSUNTO  
L’impiego intensivo di composti alchilanti in diversi settori dell’attività umana 
(industria farmaceutica, chimica, agricola, alimentare) pone seri problemi connessi 
all’impatto che dette sostanze, altamente inquinanti e dotate di un elevato potere 
mutagenico e citotossico, hanno sull’ambiente e sulla salute degli esseri viventi. Di 
qui nasce l’interesse verso lo sviluppo di processi di biorisanamento 
economicamente sostenibili e a ridotto impatto ambientale da applicare in alternativa 
ai convenzionali processi di smaltimento basati sul trattamento chimico-fisico. Il 
biorisanamento, nello specifico, sfrutta sistemi ossidativi -microbici ed enzimatici- per 
la rottura e successiva trasformazione (ed eventuale completa mineralizzazione) 
delle molecole inquinanti.  
In risposta all’esposizione a composti alchilanti, numerosi microrganismi, in 
particolare i batteri, hanno sviluppato sistemi deputati a riparare i danni da 
alchilazione del DNA nonché attività enzimatiche capaci di catabolizzare, 
completamente o in parte, questi substrati. Tra i suddetti meccanismi, il sistema Ada-
dipendente del batterio Gram negativo Escherichia coli riveste un interesse 
particolare. Nello specifico, la cellula batterica risponde alla condizione di stress 
ambientale inducendo la sintesi e l’accumulo di 4 proteine: Ada, AlkB, AlkA, capaci di 
riparare il DNA alchilato, e AidB, una flavoproteina non presente in batteri 
strettamente correlati ad E. coli (Vibrio, Shewanella, Klebsiella), omologa ad acil-CoA 
deidrogenasi (ACADs) e capace di legare il DNA senza specificità di sequenza 
(1,2,3). La funzione del fattore proteico AidB non è nota sebbene diversi studi 
abbiano evidenziato il suo coinvolgimento nella risposta ai danni da alchilazione. 
Cellule di E. coli sovraproducenti AidB risultano, infatti, meno sensibili all’azione di 
molecole alchilanti quali N-metil-N’-nitrosoguanidina (MNNG), ma il meccanismo 
responsabile dell’insorgenza di questa resistenza è tuttora sconosciuto (4). 
Recentemente, la risoluzione della struttura tridimensionale di AidB (5) ha fornito 
informazioni utili a delucidarne la funzione biologica. Tali studi strutturali hanno 
messo in luce che AidB è un tetramero di subunità identiche, ognuna formata da 3 
domini che nel loro insieme presentano il fold tridimensionale tipico delle ACADs, e 
da un dominio C-terminale non riscontrato tra i membri di questa famiglia enzimatica. 
Nel tetramero le regioni C-terminali, ricche di amminoacidi carichi positivamente e 
quindi potenzialmente in grado di interagire con lo scheletro del DNA carico 
negativamente, risultano situate in prossimità della superficie della molecola e quindi 
lontane dal sito catalitico legante il coenzima FAD e le molecole di substrato. Queste 
osservazioni strutturali supportano l’ipotesi che l’interazione di AidB con il DNA sia 
finalizzata alla protezione dell’acido nucleico dall’azione dannosa di agenti mutageni. 
Gli studi cristallografici hanno inoltre dimostrato che il sito catalitico della proteina 
presenta caratteristiche strutturali non riscontrate negli omologhi ACADs. Sulla base 
di queste osservazioni è stato ipotizzato che substrati quali acil-CoA tioesteri a 
catena ramificata non sono in grado di accedere alla tasca di legame del FAD, 
(giustificando la debole attività acil-CoA deidrogenasica di AidB) e che la proteina 
possa essere capace di legare alcune classi di molecole alchilanti e catalizzarne la 
degradazione. Al di là dei suddetti ruoli biologici, esperimenti di proteomica 
funzionale condotti nel corso di questo progetto di tesi, hanno indotto ad ipotizzare 
che AidB abbia proprietà di regolazione dell’espressione genica. Nello specifico, 
AidB è stata identificata come proteina di E. coli risultante in grado di legare elementi 
upstream (UP): sequenze nucleotidiche, poste a monte della box -35 di varie regioni 
promotrici, riconosciute e legate da fattori proteici il cui ruolo è quello di attivare o 
reprimere la trascrizione (6). AidB, in qualità di regolatore trascrizionale, potrebbe 
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intervenire nel meccanismo di difesa della cellula batterica, inducendo la produzione 
di attività enzimatiche con proprietà detossificanti. Le potenzialità esibite da AidB 
risultano interessanti alla luce della prospettiva di realizzare organismi ingegnerizzati 
capaci di biodegradare sostanze alchilanti.  
Questo progetto di tesi si è proposto di definire la funzione biologica della proteina 
AidB, attraverso le seguenti tappe: 
• Caratterizzazione funzionale e strutturale dei domini presenti in AidB 
• Caratterizzazione dell’attività trascrizionale  
• Analisi funzionale di AidB nella risposta a molecole alchilanti 
• Ricerca di proteine omologhe ad EcAidB in batteri impiegati nel campo del 
biorisanamento  
 
Caratterizzazione funzionale e strutturale dei domini presenti in AidB. 
Le informazioni ricavate dagli allineamenti multipli di sequenze e dalla risoluzione 
della struttura cristallografica hanno suggerito che AidB è caratterizzata da 2 domini 
strutturalmente e funzionalmente indipendenti: un dominio di interazione col DNA 
corrispondente alla breve regione carbossi-terminale della proteina e una regione 
avente attività deidrogenasica corrispondente alla porzione polipeptidica contenente i 
3 domini che nel loro insieme presentano il fold tipico delle ACADs. Al fine di 
caratterizzare i suddetti domini, è stata effettuata la produzione ricombinante della 
proteina intera e di due mutanti di delezione: AidBCt (il frammento carbossi-
terminale) e AidB∆Ct (la porzione proteica deleta della regione C-terminale). 
Caretterizzazione del dominio di legame al DNA. 
I due mutanti e la proteina AidB, espressi in fusione con una coda di istidine, sono 
stati purificati e saggiati in vitro per la capacità di legare il DNA attraverso 
esperimenti di ritardo della mobilità elettroforetica (EMSA). E’ stata confermata la 
presenza di un dominio di interazione col DNA nella regione C-terminale della 
proteina. Esperimenti di gel filtration hanno inoltre evidenziato la struttura 
monomerica di tale regione. 
Caratterizzazione del dominio catalitico.  
L’attività ossido-reduttasica delle proteine AidB∆Ct e AidBCt purificate è stata 
misurata e confrontata con quella di AidB (campione di riferimento), registrando 
spettrofotometricamente l’ossidazione del substrato isovaleril-CoA. Solo il mutante 
AidB∆Ct è risultato in grado di catalizzare la deidrogenazione dell’isovaleril-CoA 
mostrando valori di attività specifica analoghi a quelli della proteina intera. L’attività 
catalitica risiede, quindi, nella regione N-terminale di AidB. Mediante gel filtration è 
stato dimostrato che AidB∆Ct è il dominio deputato alla tetramerizzazione. 
 
Caratterizzazione dell’attività trascrizionale. 
Allo scopo di indagare l’attività trascrizionale di AidB, si è proceduto all’identificazione 
di regioni promotrici legate dalla proteina in maniera sequenza-specifica. Tra queste, 
mediante esperimenti EMSA, è stato identificato il promotore del gene aidB (PaidB) 
caratterizzato dalla presenza di un elemento upstream. Il ruolo di AidB nella 
regolazione trascrizionale del proprio gene è stato esaminato mediante esperimenti 
di fusione trascrizionale. Nello specifico, il ceppo di E. coli wild type MV1161 ed il 
ceppo ∆aidB MV5924 sono stati trasformati con un plasmide contenente il gene 
reporter lacZ sotto il controllo di PaidB. Sono state allestite colture cellulari dei due 
ceppi ricombinanti ed è stata analizzata la quantità di β-galattosidasi prodotta. Negli 
estratti del ceppo mutante è stato registrato un incremento della produzione di β-
galattosidasi di ∼10 volte rispetto allo strain selvatico. Questi risultati hanno suggerito 
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che, nella cellula batterica non esposta all’azione di molecole alchilanti, la proteina 
AidB reprime la trascrizione del proprio gene. Al fine di verificare che l’incrementata 
espressione del gene lacZ registrata nel ceppo mutante, fosse effettivamente 
imputabile all’assenza della proteina AidB, è stato effettuato un esperimento di 
complementazione: lo strain MV5924 è stato trasformato con un plasmide di 
espressione recante il gene aidB wild type. Nel ceppo complementato, i valori di 
attività β-galattosidasica sono risultati equiparabili a quelli registrati per le cellule wild 
type, dimostrando il coinvolgimento diretto di AidB nella repressione trascrizionale 
del suo stesso gene. Il ceppo mutante recante il costrutto reporter, è stato anche 
trasformato o con il plasmide esprimente la sola regione ammino-terminale di AidB o 
con quello contenente la porzione genica relativa al frammento carbossi-terminale. 
Nel ceppo complementato con il dominio C-terminale, sono stati registrati valori di 
attività β-galattosidasica analoghi a quelli determinati per le cellule wild type, 
dimostrando che questo dominio possiede attività di regolazione trascrizionale. 
Il coinvolgimento di AidB nella repressione trascrizionale del proprio gene è stato 
anche confermato mediante esperimenti di trascrizione in vitro.  
 
Analisi funzionale di AidB nella risposta a molecole alchilanti.  
Lo studio è stato poi incentrato sulla caratterizzazione del ruolo di AidB nel 
meccanismo di resistenza della cellula all’azione di substrati alchilanti. Il primo step 
ha previsto l’identificazione di composti mutageni a cui il ceppo ∆aidB MV5924 risulta 
sensibile. A tale scopo, sono state allestite crescite delle cellule wild type e ∆aidB in 
presenza di diversi agenti alchilanti: MMS (metilmetansulfonato), MNU 
(metilnitrosourea), MNNG (N-metil-N'-nitro-N-nitrosoguanidina) ed ENNG (N-etil-N'-
nitro-N-nitrosoguanidina). Il ceppo mutante è risultato sensibile alle molecole MNNG 
ed ENNG evidenziando il coinvolgimento della proteina in un meccanismo di difesa 
dall’azione delle due nitrosoammine.  
AidB, in risposta a condizioni di stress ambientale, influenza il processo 
trascrizionale.  
Esperimenti di proteomica funzionale hanno dimostrato che AidB è parte di un 
complesso proteico che si assembla in maniera specifica sulla regione upstream del 
promotore ribosomiale rrnB P1. Da studi EMSA è risultato che questa proteina lega 
con elevata affinità regioni di DNA contenenti elementi UP. Al fine di attribuire un 
significato a queste evidenze, sono stati condotti esperimenti di fusione 
trascrizionale. Nello specifico, sono stati preparati costrutti reporter contenenti il gene 
lacZ sotto il controllo di diverse regioni promotrici: 
• Il promotore ribosomiale rrnB P1 contenente e non il suo elemento UP 
• Il promotore leuA, esempio di sequenza promotrice non ribosomiale priva di 
un elemento UP 
• Il promotore ompF, esempio di sequenza promotrice non ribosomiale 
contenente un elemento UP 
Colture cellulari dei ceppi wild type e ∆aidB trasformati con i costrutti reporter sono 
state allestite in assenza e in presenza di composti alchilanti (MMS, MNU, MNNG, 
ENNG) ed è stata analizzata la quantità di β-galattosidasi presente nei corrispondenti 
estratti cellulari. Durante la normale crescita batterica, AidB non ha sortito alcun effetto 
sul processo trascrizionale; d’altro canto, sotto condizioni di stress ambientale, nello 
strain selvatico è stato registrato un incremento dell’espressione del gene lacZ rispetto 
al ceppo mutante. In particolare, è stato dimostrato che la presenza di AidB rende più 
efficiente la trascrizione a partire da regioni promotrici contenenti un elemento 
upstream. E’ stata quindi messa in luce l’attiva partecipazione della proteina nel 
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meccanismo di resistenza a molecole alchilanti. Altra osservazione interessante 
scaturita da tale studio è che l’espressione del gene reporter risulta maggiore quando il 
ceppo selvatico è esposto all’azione di MNNG o ENNG piuttosto che agli altri mutageni 
utilizzati (MMS e MNU), avvalorando l’ipotesi che AidB sia coinvolta nel processo di 
degradazione delle nitrosammine. 
 
AidB protegge il DNA dall’attacco di agenti alchilanti. 
Le informazioni ricavate dagli studi strutturali unitamente alla capacità di AidB di legare 
il DNA, hanno indotto ad ipotizzare un suo coinvolgimento in meccanismi di protezione 
dell’acido nucleico dall’attacco di molecole alchilanti. Il progetto si è dunque proposto 
di indagare, in vivo e in vitro, tale funzione. Nell’ambito degli esperimenti in vivo, 
crescite del ceppo di E. coli wild type e del ceppo mutante ∆aidB, trasformati con un 
vettore plasmidico, sono state allestite in assenza e in presenza di molecole alchilanti 
(MMS, MNU, MNNG, ENNG). Il DNA plasmidico è stato isolato dalle suddette colture e 
trattato con due enzimi, la DNA glicosilasi AlkA e la endonucleasi IV da E. coli. 
L’enzima AlkA riconosce e catalizza la scissione di purine e pirimidine alchilate (7), la 
endonucleasi IV genera rotture di singolo filamento accanto al sito abasico (8). Il 
trattamento con i due enzimi converte, dunque, il plasmide super-avvolto (supercoiled), 
contenente basi alchilate in una forma rilassata. Tali forme topologiche mostrano una 
differente velocità di migrazione se sottoposte a separazione elettroforetica, 
consentendo quindi di determinare l’esistenza e l’entità del danno subito dalle 
molecole di DNA in presenza e in assenza di AidB. Le analisi condotte sul DNA isolato 
dalle colture esposte ad agenti mutageni hanno rivelato che, nelle cellule wild type, il 
plasmide è presente principalmente nella forma supercoiled; in assenza di AidB, 
invece, è stato osservato un incremento della forma rilassata, indice dell’avvenuta 
alchilazione del DNA.  
Relativamente agli esperimenti in vitro, due tipi di reazioni sono state allestite:  
1) la proteina AidB è stata incubata con il DNA plasmidico; il complesso proteina-DNA 
è stato alchilato con l’agente chimico MMS e poi trattato con gli enzimi AlkA ed 
endonucleasi IV. Dalle analisi condotte su gel di agarosio, il plasmide è risultato 
presente nella forma supercoiled. 
2) Il DNA plasmidico è stato dapprima alchilato con MMS e poi incubato con AidB; la 
miscela di reazione è stata trattata con gli enzimi AlkA ed endonucleasi IV e 
sottoposta ad elettroforesi su gel di agarosio. E’ stato rivelato l’incremento 
dell’intensità del segnale corrispondente alla forma rilassata e la conseguente 
scomparsa della forma supercoiled.  
Complessivamente, questi esperimenti hanno dimostrato che l’interazione di AidB col 
DNA è finalizzata alla protezione dell’acido nucleico dall’attacco delle molecole 
alchilanti e non al riparo dei danni da alchilazione. 
I risultati conseguiti dagli studi EMSA e dagli esperimenti di fusione trascrizionale 
hanno indotto ad ipotizzare che la proteina AidB possa proteggere in maniera 
preferenziale regioni geniche contenenti un elemento UP. Al fine di investigare questa 
ipotesi, l’analisi di protezione è stata ristretta ad una specifica porzione: il frammento 
lacZ posto sotto il controllo di sequenze promotrici con e senza elemento UP. Colture 
dei ceppi wild type e ∆aidB, trasformati con i costrutti reporter precedentemente 
descritti, sono state allestite in presenza di substrati alchilanti. Il DNA plasmidico è 
stato isolato dalle suddette colture ed idrolizzato al fine di rilasciare il gene lacZ. Tale 
frammento è stato dapprima trattato con gli enzimi AlkA ed endonucleasi IV e 
successivamente sottoposto ad elettroforesi su gel di agarosio in condizioni 
denaturanti, separando i due filamenti di DNA. Questo trattamento ha permesso di 
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evidenziare l’avvenuta alchilazione del gene lacZ correlandola alla comparsa di 
frammenti tronchi a singolo filamento. Le analisi condotte sui campioni isolati dalle 
cellule mutanti hanno rivelato la completa degradazione del gene lacZ; nei campioni 
isolati dalle cellule wild type, invece, è stata osservata la presenza di frammenti di DNA 
full lenght nel caso in cui l’espressione del gene lacZ è guidata da un promotore 
contenente una regione UP e la presenza di alcuni frammenti tronchi nel caso in cui il 
gene in esame è sotto il controllo di un promotore senza elemento UP. 
I risultati ottenuti hanno dimostrato che l’azione protettiva di AidB si esplica in generale 
sul DNA e preferenzialmente sulle regioni contenenti elementi upstream. 
 
Ricerca di proteine omologhe ad EcAidB in batteri impiegati nel campo del 
biorisanamento.   
Gli studi cristallografici supportano l’ipotesi che la proteina AidB sia capace di legare 
specifiche classi di molecole alchilanti (le alchil-nitrosammine) ed esserne coinvolta nel 
processo di degradazione. Tale ipotesi è stata avvalorata dai risultati conseguiti nel 
corso di questo progetto di tesi: 1) la dimostrazione che il ceppo di E. coli ∆aidB è 
particolarmente sensibile alle alchil-nitrosammine MNNG ed ENNG; 2) l’osservazione 
che nelle cellule trattate con agenti alchilanti, in particolare con alchil-nitrosammine, la 
presenza di AidB esercita un’influenza positiva sul processo trascrizionale. La 
caratterizzazione delle proprietà detossificanti di AidB risulta particolarmente 
suggestiva alla luce della prospettiva di realizzare microrganismi ingegnerizzati capaci 
di biodegradare molecole alchilanti. In virtù di questa interessante potenzialità, tale 
progetto si è proposto di ricercare proteine omologhe ad EcAidB in sistemi microbici 
impiegati nel campo del biorisanamento e caratterizzarne il coinvolgimento nella 
risposta della cellula a substrati alchilanti. Nello specifico, da studi di allineamento di 
sequenza è emerso che EcAidB presenta un’elevata similarità con una putativa acil-
CoA deidrogenasi (codificata dal gene PP4780) da Pseudomonas putida KT2440, un 
batterio Gram negativo ampiamente utilizzato nel biorisanamento (9). Alla luce di 
queste premesse, si è proceduto all’espressione ricombinante di PP4780 in E. coli e 
alla successiva analisi del coinvolgimento del corrispondente prodotto proteico nel 
meccanismo di resistenza ad agenti alchilanti. A tale scopo, sono state allestite colture 
del ceppo selvatico e delle cellule ricombinanti esprimenti PP4780 o aidB, in assenza e 
in presenza di MNNG o ENNG. Dall’analisi comparativa dei profili di crescita è emerso 
che le cellule esprimenti PP4780 risultano più resistenti, rispetto agli altri ceppi 
esaminati, alla condizione di stress ambientale. Ulteriore evidenza del ruolo esercito 
dal prodotto del gene PP4780 nella risposta a substrati alchilanti è stata ottenuta 
attraverso la complementazione del ceppo ∆aidB con questa molecola proteica. 
Dall’analisi comparativa dei profili di crescita è emerso che la putativa acil-CoA 
deidrogenasi da P. putida, analogamente ad AidB, è in grado di ripristinare la 
resistenza del batterio alla condizione di stress in atto. Tali evidenze sperimentali 
hanno suggerito l’attiva partecipazione di questo fattore proteico nel meccanismo di 
difesa della cellula batterica dall’azione di molecole alchilanti.  
Questo progetto, quindi, attraverso la caratterizzazione del ruolo biologico della 
proteina AidB e attraverso le prime indagini condotte su PP4780, ha contribuito ad 
acquisire informazioni utili per la realizzazione di un sistema di biorisanamento 
ambientale.  
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1. Biotechnology and bioremediation: a new challenge for pollution 
management 
Environmental pollutants are compounds that are released into the environment at 
high concentrations, usually as a consequence of human activities; they cause 
instability, disorder, harm to the ecosystem. Contaminants are either compounds of 
industrial origin that present chemical structures alien to the biosphere (xenobiotics), 
e.g. polychlorobiphenyls (PCBs), polichlorodioxins, trinitrotoluene (TNT) and azo 
dyes, or natural compounds that have been mobilized to a bioavailable form toxic to 
living organisms, e.g. hydrocarbons present in fossil fuels and heavy metals present 
in minerals (Fig.1). Major sources of pollution are: (i) chemical and pharmaceutical 
industries that produce a wide array of xenobiotics and synthetic polymers; (ii) pulp 
and paper bleaching, which are the main sources of chlorinated organic compounds 
in the environment; (iii) mining, which releases heavy metals into biogeochemical 
cycles; (iv) fossil fuels (coal and petroleum), which may be accidentally released in 
large amounts into the ecosystem (oil spills) and whose combustion increases 
significantly CO2 atmospheric levels (green-house effect) and causes deposition of 
nitric and sulfuric acids (acid rain and smog); and (v) intensive agriculture, which 
releases massive amounts of fertilizers, pesticides, and herbicides (Dua, M. et al., 
2002; Rieger, P.G. et al., 2002).  
The removal of pollutants from the environment via natural physico-chemical and 
biological processes (natural attenuation) is, in general, a slow and unpredictable 
way of counteracting anthropogenic pollution and irreversible damage to the 
biosphere. The urgent need of rehabilitating areas 
fouled by pollutants has encouraged the search for 
innovative solutions. In this field, bioremediation is 
seen as an attractive strategy due to its reputation 
as a low cost, environmentally friendly and publicly 
acceptable treatment technology. The term 
“bioremediation” has been used to describe the 
process of using and manipulating detoxification 
abilities of living organisms to transform hazardous 
organic contaminants into harmless metabolites or 
mineralize the pollutants into carbon dioxide and 
water (Fig.1) (Lovley, D.R. 2003; Wackett, L.P. 
2003; Wackett, L.P. et al., 2000). Although most 
organisms are endowed with detoxification 
abilities, microorganisms, particularly bacteria, 
have been the most well-studied and the most 
frequently used for bioremediation strategies. 
Bacteria, which evolved more than three billion 
years ago, have developed strategies to obtain 
energy from virtually every compound, playing 
development of the biosphere and in biogeochemi
microorganisms, together with their great ability for ho
high growth rates, allows them to evolve quickly an
changing conditions, even to extreme environments t
other living organisms. The huge genetic diversity o
their great metabolic versatility (De Lorenzo, V. 200
K.N. et al., 1999). 
 Fig.1: Main sources of pollution 
in the ecosystem and the factors 
that influence bioremediation 
processes. a crucial role in sustainable 
cal cycles. The abundance of 
rizontal gene transfer and their 
d to adapt to environmentally 
hat do not allow proliferation of 
f microorganisms accounts for 
1; Lovley, D.R. 2003; Timmis, 
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A large number of microorganisms have been isolated and applied to both in situ and 
ex-situ bioremediation processes in recent years, and the identification of new 
microbes with novel metabolic potential offers an attractive route to solve 
environmental problems (Dua, M. et al., 2002). On the other hand, advances in 
genetic and protein engineering techniques have opened up new avenues towards 
the design of genetically engineered microorganisms (GEMs) and enzymes with the 
desired biodegradation properties (Debarati, P. et al., 2005). The relative cheapness 
of the processes, the wide degradation potential offered by the different types of 
microorganisms which can be employed, and the new frontiers opened by genetic 
engineering, render bioremediation one of the most promising alternatives for 
efficient cleanup of pollutants.  
 
2. Alkylating agents as environmental contaminants  
Alkylating agents comprise a broad class of highly reactive chemical compounds that 
introduce alkyl groups into biologically active molecules and prevent normal 
functioning. Living organisms are continuously exposed to alkylating molecules 
released into the ecosystem at high concentrations, usually as a consequence of 
human activities (Vaughan, P. et al., 1991; Taverna, P. and Sedgwick, B. 1996). 
Alkylating compounds such as 1,2-dichloroethane, 1-chloro-2,3-epoxypropane and 
methyl isothiocyanate have a widespread use in the industry as solvents, 
intermediates in chemical synthesis and fumigant pesticides. Food (cured meats and 
different fish products), beverages and tobacco smoke can be a source of exposure 
to alkylating N-nitroso compounds (Jagerstad, M. and Skog, K. 2005), a class of 
agents highly reactive. Alkylating compounds found in the environment are also 
produced by microorganisms or may be formed by chemical reactions. Some 
Streptomyces sp. release alkylating antibiotics, such as streptozotocin and 
azaserine, into the soil creating an urgent need for an adaptive response in other 
microorganisms. Furthermore, certain algae and fungi, growing in saline 
environments generate methyl chloride (MeCl) as a product of chloride detoxification 
(Sedgwick, B. and Vaughan, P. 1991). Alkylating agents may be chemically formed 
by nitrosations, in slightly acidic conditions, of amides, amines, amino acids and 
peptides (Sedgwick, B. 1997; Sedgwick, B. and Vaughan, P. 1991). These reactions 
could occur in decaying matter, in acidic soils or in putrid water.  
Numerous alkylating agents found in the environment are known to be extremely 
cytotoxic. These chemicals react deleteriously with cellular macromolecules (DNA, 
RNA and proteins) either directly or following metabolic activation (Taverna, P. and 
Sedgwick, B. 1996;  Vaughan, P. et al., 1991).  Arguably, the most important cellular 
target is the DNA molecule. The alkylating agents can introduce methyl or larger alkyl 
groups into all the available nitrogen 
and oxygen atoms in DNA bases 
(Fig.2) in addition at the anionic 
oxygen of the phosphodiester 
backbone (Sedgwick, B. and Lindahl, 
T. 2002;  Sedgwick, B. 2004). Alkyl 
base lesions can arrest replication, 
interrupt transcription, or signal the 
activation of cell-cycle checkpoints or 
apoptosis. In mammals they could be 
involved in carcinogenesis, 
neurodegenerative disease and aging. 
 
Fig.2: Sites of alkylation on the DNA bases. Thick 
arrows indicate sites alkylated by most of the 
agents. The curly arrow indicates an additional site 
alkylated by alkyl radicals. 
10 
 
The majority of evidence indicates that among the 11 identified base modifications, 3-
methyladenine and O6-methylguanine are mainly responsible for the biological effects 
of alkylation agents (Singer, B. 1976). The alkylating agent-DNA interaction can also 
result in cross-linking or strand-breaking reactions. Depending on their processing by 
the cell, these lesions can give rise either to mutation or to cell death. The relative 
proportions of the different base lesions depend on the nature of the alkylating agent, 
its reaction mechanism and the 
secondary structure of the DNA 
target (Table 1). 
Based on the reaction 
mechanism used, alkylating 
agents fall into two chemical 
categories: SN1 reagents, which 
typically react  through a 
monomolecular mechanism 
(meaning spontaneous 
departure of the leaving group), 
and SN2 agents, that act through 
a bimolecular reaction (leaving 
group departure occurs only 
upon reaction with another 
species). The SN1 type agents 
such as N-methylnitrosourea 
(MNU), and N-methyl-N’-nitro-N-
nitrosoguanidine (MNNG) 
introduce alkyl adducts at ring 
nitrogenes, exocyclic oxygens of 
the bases, and at oxygens of the 
sugar-phosphate backbone; SN2 
agents, such as methyl methanesulfonate (MMS) and methyl iodide (MeI) target 
mainly ring nitrogenes. These lesions are less readily formed in duplex DNA because 
the modification sites are involved in base pairing, and are therefore shielded from 
alkylation. Additionally, alkylated lesions can arise through the reaction of DNA with 
alkyl radicals. These modified base lesions are both toxic and mutagenic (Delaney, 
J.C. and Essigmann, J.M. 2004; Delaney, J.C. and Essigmann, J.M. 1999) and their 
repair facilitates cellular survival. Environmental mutagens such as 1,2-
dimethylhydrazine, tert-butylhydroperoxide and diazo-quinones generate methyl 
radicals that react with guanine residues in DNA to form miscoding 8-methylguanine 
adducts (Hix et al., 1995). 
One implication of the mutagenic property of alkylating agents is their carcinogenic 
potential. Cytotoxic alkylating agents are commonly used as drugs in cancer 
chemotherapy (Hurley, L.H. 2002; Chaney, S.G. and Sancar, A. 1996). DNA damage 
seems to be a critical component of the efficacy of these drugs, and increased DNA 
repair is a common cause of developed resistance (Gerson, S.L. and Willson, J.K. 
1995). Both mono-and bi-functional alkylators are used as chemotherapeutic agents 
and these drugs function by creating a range of adducts from alkyl lesions to 
interstrand cross-links (Margison, G.P. et al., 2002; Ludlum, D.B. 1990).  
Table 1: Relative proportions of reaction at each base 
position by common alkylating agents. nd= not detected. 
SN2 SN1 Position of 
alkylation 
RNA
ssDNA
dsDNA 
RNA
ssDNA  dsDNA 
Adenine      
N1 18 3.8 2.8 1.3 
N3 1.4 10.4 2.6 9 
N7 3.8 1.8 1.8 1.7 
Guanine     
N3 ~1 0.6 0.4 0.8 
O6 - 0.3 3 6.3 
N7 68 83 69 67 
Uracil/Thymine     
O2 nd nd nd 0.11 
N3 nd nd nd 0.3 
O4 nd nd nd 0.4 
Cytosine     
O2 nd nd nd 0.1 
N3 10 <1 2.3 0.6 
Diester 2 0.8 ~10 17 
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Fig.3: Structural formulas of some alkylating agents.  seful chemotherapeutic alkylating agents include alkyl sulfonates, nitrosoureas, 
itrogen mustards, ethylenimines derivatives, and triazines (Fig.3).  
herefore, the release of alkylating molecules in the ecosystem is a remarkable 
ource of pollution and perturbation of life since many of these compounds are toxic, 
elatively new, stable, recalcitrant and less easy to degrade than many other organic 
ompounds. These concerns have led to new and/or stricter regulations regarding 
lkylating wastewater discharges. Various methods of alkylating agents removal from 
 contaminated site have been proposed and used but bioremediation mediated by 
icroorganisms has emerged as friendly and cost-competitive alternative. 
. Microbial utilization of alkylating compounds 
icroorganisms excel at using organic substances, natural or synthetic, as sources 
f nutrients and energy. The explanation for their remarkable range of degradative 
bilities is that, by the time human beings came on the scene, microorganisms had 
lready coexisted for billions of years with an immense variety of organic 
ompounds. The vast diversity of potential substrates for growth led to the evolution 
f enzymes capable of transforming many unrelated natural organic compounds by 
any different catalytic mechanisms. The resulting giant “library” of microbial 
nzymes serves as raw material for further evolution whenever a new chemical 
ecomes available (Butler, C.S. and Mason, J.R. 1997; Ellis, B.M.L. 2000).  
icroorganisms can use a wide array of pollutants through aerobic or anaerobic 
rocesses. In aerobic environments, oxygen is the most common final electron 
cceptor. However, many polluted environments are often anoxic, e.g., aquifers, 
quatic sediments and submerged soils. In such environments, biodegradation is 
arried out by either strict anaerobes or facultative microorganisms using alternative 
lectron acceptors, such as nitrate (denitrifying organisms), sulphate (sulfate 
educers), Fe(III) (ferric-ion reducers), CO2 (methanogens), or other acceptors 
chlorate, Mn, Cr, U, etc.) (Gibson, J. et al., 2002; Lovley, D.R. 2003; Widdel, F. et 
l., 2001).   
tructurally diverse alkylating molecules such as the fumigant pesticides methyl 
romide (MeBr), trichloronitromethane, methyl isothiocyanate (MITC) and the 
lkylating N-nitroso compounds are among the most prevalent pollutants released 
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into the ecosystem (Zhang, Y. et al., 2005). Bioremediation is seen as an attractive 
route to reduce the concentration and toxicity of these contaminants.   
A wide diversity of microorganisms with the capacity to biotransform alkylating 
compounds have been identified. Methanotrophs, pseudomonads and nitrifiers are 
the attractive models for such bioremediation processes. In the case of MeBr, 
methanotrophic and nitrifying bacteria are able of co-oxidizing MeBr to CO2 during the 
oxidation of methane and ammonia, respectively (Oremland, R.S. et al., 1994; 
Rasche, M.E. et al., 1990). The degradation of MeBr is catalyzed by methane and 
ammonia monooxygenase enzyme, respectively. Trichloronitromethane can be 
dehalogenated by Pseudomonas species, with the major metabolic pathway 
occurring through three successive reductive dehalogenations to nitromethane 
(Castro, C.E. et al., 1983). Microorganisms responsible for degradation of MITC 
specifically target the isothiocyanate functional group. Recently, several bacteria 
expressing monooxygenase enzymes have been reported to degrade N-
nitrosodimethylamine (NDMA), a potent alkylating agent that has been detected in 
discharges of industries as rubber manufacturing, leather tanning and, in addition, 
sewage treatment plant effluent (Fournier, D. et al., 2009). NDMA is a potent 
carcinogen, so the metabolism of NDMA and other nitrosamines by mammals has 
been widely studied (Mitch, W.A. and Sedlack, D.L. 2004). Metabolic conversion of 
NDMA is initiated by the cytochrome P450-dependent mixed function oxidase system 
(P-450) (Haggerty, H.G. and Holsapple, M.P. 1990; Lee, V.M. et al., 1996) and 
follows either the α-hydroxylation or a denitrosation pathway of the nitrosamine. The 
α-hydroxylation pathway results in the formation of the strongly methylating 
methyldiazonium ion (CH3N+≡N), which alkylates biological macromolecules such as 
DNA, RNA, and proteins. In this manner NDMA can exert its genotoxic effects (Sohn, 
S.O. et al., 2001). Alternately, NDMA can be oxidized via a denitrosation route, which 
leads to the formation of methylamine (CH3NH2) and formaldehyde as metabolites. 
Interestingly, various bacteria expressing broad-specificity monooxygenase enzymes 
have been observed to degrade NDMA, including Pseudomonas mendocina KR1 
(toluene-4-monooxygenase; Sharp, J.O. et al., 2005), Rhodococcus ruber ENV425 
(propane monooxygenase; Fournier, D. et al., 2009) and Methylosinus trichosporium 
OB3b (soluble methane monooxygenase; Yoshinari, T. and Shafer, D. 1990). 
However, few data exist concerning the pathways of NDMA and other nitrosamines 
metabolism in bacteria. Studying the biochemistry and genetics of the microbial 
pathways is crucial to develop efficient bioremediation strategies. Indeed, although 
microorganisms have acquired the ability to use pollutants as carbon and energy 
sources, their efficiency at removing such molecules might not be optimal for 
cleaning up present-day pollution. Microorganisms have evolved towards ecological 
fitness rather than biotechnological efficiency; thus, it would take a long time for 
bacteria capable of cleaning up anthropogenic pollution to evolve by natural 
selection. Hence, developing an understanding of microbial communities and their 
response to the natural environment and pollutants, becomes crucial to recreate and 
accelerate natural processes in the test tube as well as to accomplish their rational 
manipulation to design more efficient biocatalysts for different biotechnological 
applications. These include: (i) bioremediation of polluted sites, (ii) biotransformation 
of toxic compounds into fine chemicals and other high added-value products (green 
chemistry), and (iii) development of in situ biomonitoring devices and biosensors to 
monitor pollutant bioavailability (De Lorenzo, V. 2001; Timmis, K.N. et al, 1999). 
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4. The Escherichia coli adaptive response to alkylating agents 
Alkylating agents potentially cytotoxic and mutagenic occur in the environment and 
also in the living cells, as byproducts of normal metabolism. Since these molecules 
are ubiquitous and hence unavoidable, all organisms (eubacteria, archaebacteria, 
and eukaryotes) possess several defense systems to overcome their effects. The 
repair of alkylation damage to DNA involves at least four different mechanisms: (i) 
direct repair mediated by methyltransferases or oxidative demethylases; (ii) base 
excision repair initiated by DNA glycosylases; (iii) mismatch repair system; and (iv) 
nucleotide excision repair (Pegg, A.E. 2000). Among the systems protecting cells 
against the action of alkylating agents, there is the adaptive response to DNA 
damage. To defend against fluctuating levels of environmental alkylating compounds, 
many bacteria (Bacillus subtilis, Gloetrichia ghosei, Micrococcus luteus, 
Pseudomonas aeruginosa, Shigella sonnei, and Xanthomonas maltophilia) mount an 
inducible response that enhances cellular resistance to alkylation damage. The 
adaptive response to alkylating agents has been most extensively studied in model 
organism Escherichia coli. Decades ago, it was discovered that the relationship 
between mutation frequency in chemically-treated E. coli and the length of exposure 
to the alkylating agent was not linear, but rather increased initially and then reached 
a plateau (Cerda-Olmedo, E. and Hanawalt, P. C. 1968; Neale, S. 1972). 
Interestingly, the height of that plateau was related to the dose of alkylating molecule 
to which the bacteria were exposed (Jimenez-Sanchez, A. and Cerda-Olmedo, E. 
1975). These observations, combined with the subsequent discovery that exposure 
of E. coli cells to sub-lethal doses of alkylating agents renders them resistant to 
higher concentrations of drug, led to the discovery of the so-called "adaptive 
response" (Jeggo, P. et al., 1977; Samson, L. and Cairns, J. 1977). The inducible 
protective effect required active protein synthesis (Samson, L. and Cairns, J. 1977), 
suggesting that it was due to the production of proteins that could defend against the 
toxic and mutagenic effects of alkylating agents. Later studies demonstrated that the 
phenomenon involved increasing expression of four genes, (ada, alkA, alkB, and 
aidB) (Schendel, P. F. and Robins, P. E. 1978; Evensen, G. and Seeberg, E. 1982), 
three of which produce proteins of established function. The first protein product of 
the adaptive response to be identified was Ada. The characterization of this factor 
revealed its bifunctional nature: Ada repairs alkylated bases and also regulates the 
adaptive response (Fig.4). 
 
Ada as a multi-substrate repair protein.  
Ada is the key enzyme of the adaptive response; this protein is composed of two 
major domains, a 19 kDa C-terminal (C-Ada19) and a 20 kDa N-terminal (N-Ada20), 
linked by a hinge region. These domains are capable of carrying out two types of 
DNA repair reaction: C-Ada19 directly dealkylates the mutagenic bases O6-
methylguanine and O4-methylthymine, and transfers the methyl groups on to its Cys-
321 residue (Demple, B. et al., 1985). N-Ada20 demethylates Sp-diastereo-isomers of 
the apparently innocuous methylphosphotriester lesion by methyl transfer on to the 
Cys-38 residue (Kondo, H. et al., 1986; Lindahl, T. et al., 1988). This methylation 
reaction alleviates the normal repulsion that exists between the negatively charged 
cysteine center and the DNA backbone (He, C. et al., 2005), increasing the affinity of 
Ada for DNA and converting the protein into a transcription factor regulated by post-
translational modification. Cys-38 of Ada can be directly methylated by SN2 agents, 
such as methyl iodide (Mel), which may be an alternative of Ada activation as a 
positive gene regulator (Takahashi, K. et al., 1988). Ethylating agents, despite 
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produce more triesters in the DNA backbone than 
their corresponding methylating counterparts (Singer, 
B. and Kusmierek, J.T. 1982), are weaker at inducing 
the adaptive response. This effect is not due to an 
inability of the protein to remove ethyl groups, 
however, as the ethylphosphotriesters are repaired 
by Ada (Margison, G. P. et al., 1985) indicating that 
ethylation of the Cys-38 residue is less efficient at 
activating transcriptional activity than methylation.  
Both DNA repair actions of Ada are suicidal, resulting 
in loss of the repair function of the Ada protein in a 
stoichiometric manner, and requiring the activity to be 
replenished through new protein synthesis. 
Interestingly, when repair occurs via the Ada 
pathway, the restoration of a single alkylated base 
consumes an entire protein molecule. Although this 
repair method seems energetically expensive, it 
allows reversal of damage in a single step, without 
compromising the integrity of the DNA backbone or 
the coding content of the DNA strand. For these 
reasons, direct reversal of base damage, such as that 
exhibited by the suicidal Ada protein, can be  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4: Representation of the E. 
coli Ada response. Ada is 
activated as a positive regulator 
by methylation of its Cys-38 in the 
N-terminal domain. This 
activation occurs by repair of 
methylphosphotriesters (PTE) in 
DNA or by direct protein 
methylation. Activated Ada 
induces expression of several 
genes. advantageous. The question concerning the 
mechanism of the Ada response termination remains open. It has been postulated 
that the activated Ada protein is simply diluted by cell division after withdrawal of 
alkylating agents (Lindahl, T. et al., 1988). A second hypothesis is that unmethylated 
Ada, when all repairable methylphosphotriesters have been repaired, shuts off the 
adaptive response by accumulation in the cell and competition with the methylated 
protein for binding to the regulated genes (Saget, B.M. and Walker, G.C. 1994). This 
negative feedback loop to some extent mitigates the energetic burden of a suicidal 
protein repair system. 
 
Ada as a transcriptional regulator. 
The Ada protein is activated as a transcriptional factor by methylation of its Cys-38 
residue in the amino-terminal half of the protein. N-methylated Ada acquires the 
ability to bind to specific DNA sequences in the promoter region of the ada-alkB 
operon and the alkA and aidB genes (Landini, P. and Volkert, M.R. 2000) (Fig.4). 
Binding of N-methylated Ada makes the promoters accessible to RNA polymerase 
and therefore activates their transcription (Nakabeppu, Y. and Sekiguchi, M. 1986). 
The mechanisms by which Ada interacts with the promoters of the Ada regulon and 
RNA polymerase have been reviewed in detail (Landini, P. and Volkert, M.R. 2000). 
The activation of ada, alkB, alkA and aidB genes confers increased cellular 
resistance to the mutagenic and cytotoxic effects of alkylating agents. Three of the 
four  genes are known to be involved in the repair of DNA lesions and each employs 
a different mechanism.  
 
AlkB, a DNA dioxygenase.  
AlkB was shown to be an α-ketoglutarate-Fe(II)-dependent dioxygenase that  
hydroxylates the aberrant methyl or larger alkyl group of a range of DNA adducts (1-
methyladenine, 3-methylcytosine, 3-ethylcytosine, 1-ethyladenine, hydroxyethyl, 
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propyl, hydroxypropyl lesions) creating an unstable intermediate that will decompose 
spontaneously to release formaldehyde and the repaired base (Trewick, S.C. et al., 
2002; Choi, J. Y. et al., 2006). 
 
AlkA, a DNA glycosylase with broad substrate specificity. 
The E. coli alkA gene encodes a 3-methyladenine-DNA glycosylase, which is 
responsible for excising a broad spectrum of lethal adducts from the genome, 
initiating the process of base excision repair (BER). AlkA removes the abundant 
lesion 3-methyladenine and it also can excise the minor products 3-methylguanine, 
7-methylguanine, O2-alkylpyrimidines (Thomas, L., et al., 1982; Lindahl, T. 1976; 
Choi, J. Y. and Guengerich, F.P. 2004).  
E. coli has a second 3-methyladenine-DNA glycosylase (Tag) and a second O6-
methylguanine-DNA methyltransferase (Ogt) that are expressed constitutively, and 
will repair some 3-methyladenine and O6-methylguanine lesions in DNA during the 
vulnerable period in which the adaptive response is being induced (Samson, L. 
1992). Ingeniously, methylphosphotriesters, a relatively innocuous type of DNA 
damage, that are not repaired by Ogt or any other known constitutive activity, are 
used as the inducing signal for the adaptive response. Repair of one of the two 
stereo-isomers of methylphosphotriesters therefore serves solely as a sensor for 
changing levels of DNA alkylation damage in bacteria (Lindahl, T. et al., 1988). 
 
AidB, the most enigmatic protein involved in the Ada-response. 
Despite years of effort, the function of the fourth adaptive response protein, AidB, is 
still unclear. In an attempt to elucidate the possible function of this protein, the 
deduced amino sequence of the 60.5 kDa AidB was used in homology searches in 
Swiss Protein and GenBank-EMBL databases. While no homology was found with 
any known DNA repair protein, significant homology was detected with several 
mammalian acyl-coenzyme A dehydrogenases (ACADs), a family of enzymes which 
use a flavin adenine dinucleotide (FAD) to catalyze the α,β,-dehydrogenation of acyl-
coenzyme A (acyl-CoA) conjugates (Landini, P. et al., 1994; Rohankhedkar, M.S. et 
al., 2006). Multiple sequence alignments have showed that numerous residues of 
ACADs are conserved in AidB sequence; in particular, the conservation of Glu425, 
that corresponds to the catalytic glutamate in most of the short- and medium-chain 
acyl-CoA dehydrogenases, suggests that a dehydrogenase or oxidase activity is 
essential to the physiological function of the protein.   
It has been determined that AidB shows 24.6% identity with human isovaleryl-CoA 
dehydrogenase (IVD) precursor (Landini, P. et al., 1994), an enzyme involved in 
leucine metabolism in mammalian cells. AidB has been shown recently to bind 
stoichiometric amounts of redox active FAD, and IVD activity has been detected from 
both crude cell extracts overexpressing AidB and purified preparations (Landini, P. et 
al., 1994; Rohankhedkar, M.S. et al., 2006). However, the level of IVD activity 
observed in AidB is quite low compared to other ACADs. Probably the IVD activity in 
AidB is a side reaction that is distinct from its functional role (Rohankhedkar, M.S. et 
al., 2006).  
The Ada-dependent upregulation of AidB in vivo, in response to the presence of 
alkylating agents is one of two ways in which synthesis of the protein can be 
triggered. Expression of the aidB gene is also induced by anaerobiosis or by addition 
of sodium acetate to growth medium, at a slightly acidic pH (ranging 6.0 to 6.8), in an 
Ada-independent fashion (Volkert, M. R. et al., 1989). This second pathway of 
expression is mediated by rpoS (Volkert, M. R. et al., 1994), a gene which encodes 
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an alternative sigma factor of RNA polymerase, mainly active in late-logarithmic and 
stationary phases of E. coli growth. Discovery of the IVD activity of AidB led to the 
hypothesis that the protein, like other acyl-CoA dehydrogenases plays a role in 
energy production during fermentation and anaerobic metabolism (Brockman, H. L, 
and Wood, W.A. 1975). This hypothesis could explain the observed induction of AidB 
in response to anaerobiosis, but does not provide a explanation for its Ada-
dependent induction. 
In an attempt to define the function of AidB in the adaptive response,  the effect of its 
overexpression in E. coli cells exposed to methylating agent MNNG, was tested. 
Overexpression of AidB reduced the mutagenic effect of MNNG (Landini, P. et al., 
1994) prompting the hypothesis that the protein may act as a detoxification enzyme 
to destroy nitrosoguanidines or their reactive intermediates. Paradoxically, strains 
with insertionally inactivated aidB showed two different phenotypes: those with 
alkylation sensitivity identical to wild-type and those that display increased resistance 
to both lethal and mutagenic effects of MNNG, but no alteration in sensitivity to other 
alkylating compounds (Volkert, M. R. et al., 1986). The finding that the same 
phenotype can be produced both by insertional mutation and by overexpression of 
the aidB gene is apparently paradoxical. It has been observed that insertion mutants 
studied all affected only the terminal third of the gene. It is therefore possible that 
these mutants produce a functional fragment of AidB protein. The observed 
phenotypes could be explained if expression of the first two-thirds of the gene 
produced a functional protein that is either more stable or more active in the resistant 
strains and similar to wild-type AidB in the non-resistant strains. Since sensitivity to 
only MNNG is affected in the insertional mutants, it has been suggested that AidB 
may be involved either in repair of MNNG specific DNA lesions or in an MNNG 
detoxification pathway. MNNG, in fact, must be metabolically activated to exert its 
mutagenic and lethal activity (Lawley, P. D. 1974). In E. coli such a pathway involves 
glutathione; interestingly, it has been detected that a nonprotein thiol: glutathione-
deficient mutants are generally more resistant to MNNG (Sedgwick, B. and Robins, 
P. 1980). AidB might be involved in this or in an alternative detoxification pathway, 
either by acting directly on MNNG or by synthesis or modification of some MNNG-
reactive compound. It is noteworthy that when E. coli is exposed to sodium acetate in 
a medium with a final pH of 6.5 (inducing conditions for aidB), it becomes more 
resistant to the mutagenic effect of MNNG (Oktyabrsky, O. N. et al., 1993).  
More recent studies have shown that the AidB protein is able to bind to dsDNA 
(Rohankhedkar, M.S. et al., 2006). 
AidB was suspected to have this ability 
on the basis of its coregulation with 
DNA repair enzymes and because a 
short region of its C terminus is 
homologous to a DNA-binding domain 
of human topoisomerase I. No 
sequence specificity was observed, 
but further studies are warranted to 
characterize this in greater detail. The 
presence of an enzymatically active 
flavin and the protein's demonstrated 
DNA-binding capability led to the 
suggestion that AidB might catalyze 
the repair of alkylated DNA by a 
 
 
   
 
Fig.5: Hypothesis that AidB is a methylated-base 
dehydrogenase. The Schiff's base product would 
hydrolyze to release the free base plus 
formaldehyde, and the reduced flavin could either 
react with oxygen to produce hydrogen peroxide or 
transfer electrons to another suitable electron 
acceptor. 
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dehydrogenase mechanism, such as that shown in Fig.5 (Rohankhedkar, M.S. et al., 
2006).  
Whether AidB acts to reduce mutagenicity by a DNA repair or a detoxification 
mechanism is currently a matter of speculation. However, It has been observed that, 
whereas ada and alkB genes form a transcriptional unit, alkA and aidB are well 
separated from this operon and from each other. These observations raise the 
possibility that AidB may be of secondary importance for repair of alkylation damage 
to DNA. To help resolve this issue, recently the crystal structure of the AidB protein 
has been determined (Bowles, T. et al., 2008). The structural analysis revealed that 
AidB is well equipped to sterically occlude dsDNA from chemical attack. Importantly, 
the structure is not consistent with a DNA repair function. Alternatively, the unique 
chemical environment of AidB’s putative FAD active site provides a rationale for a 
possible role in deactivation of alkylating agents.  
 
5. Structural properties and potential cellular function of AidB 
As predicted (Landini, P. et al., 1994; Rohankhedkar, M.S. et al., 2006), the structure 
of E. coli AidB is representative of the ACAD family of flavoproteins. ACADs form 
tightly bound homodimers or homotetramers and typically have three domains: an N-
terminal α-helical domain, a middle β-sheet domain, and a C-terminal helical bundle 
(Kim, J.J. and Miura, R. 2004). However, AidB contains unique features that 
distinguish it functionally from the ACAD enzymes. One AidB subunit (Fig.6A) 
consists of an N-terminal α-helical domain (domain I, residues 1–179), a seven-
stranded β-barrel (domain II, residues 180–285), a central α-helical region (domain 
III, residues 286–444), and an α-helical domain at its C terminus (domain IV, 
residues 445–540). Domains I–III collectively constitute the ACAD core fold. Domain 
IV, however, is not present in the ACAD family (Fig.7). In the crystal structure, AidB 
forms a tetramer (Fig.6B). Sedimentation velocity ultracentrifugation showed that 
AidB (60,590 Da 
per subunit) 
sediments as a 
234-kDa protein, 
and gel filtration 
analysis was 
consistent with a 
tetramer in 
solutions. The  
AidB tetramer is 
a dimer-of-
dimers. As in 
ACAD structures, 
AB and CD 
dimers are each 
formed from 
extensive 
contacts 
between 
domains II and 
III. Two FAD 
molecules (one 
per subunit) are A B 
 
Fig.6: The structure of E. coli AidB. (A) Stereo image of one subunit colored 
according to domains. The FAD is shown as ball and stick. (B) 
Representation  of the AidB tetramer. Four subunits A, B, C, and D associate 
with dihedral symmetry as a dimer of dimers. The FAD cofactors at each of 
the A/B and C/D dimer interfaces are shown as black CPK spheres. N-
terminal extensions and L1'2' loops that form the AB/CD interface unique to 
AidB are labeled with the letter N and orange stars, respectively. 18 
 
Fig.7: Structure-based sequence alignment of AidB, medium-chain acyl-CoA dehydrogenase 
(MCAD, PDB ID code 3MDE) (Kim, J.J. et al., 1993), isovaleryl acyl-CoA dehydrogenase (IVD, 
PDB ID code 1IVH) (Tiffany, K.A. et al. 1997), acyl-CoA oxidase II (ACO, PDB ID code 1IS2) 
(Nakajima, Y. et al., 2002), and nitroalkane oxidase (NAO, PDB ID code 2C0U) (Nagpal, A. et al., 
2006). AidB residues important for tetramerization and DNA binding are highlighted gray and 
black, respectively, and those predicted to contact DNA are marked with black triangles. ACAD 
substrate binding and catalytic residues are highlighted blue and yellow, respectively. Black circles 
denote FAD binding residues, and AidB Trp-424 is marked with a red star. 
 
bound at each of these A/B and C/D dimer interfaces (Fig.6B).  
Unlike the ACADs, however, AidB has a unique quaternary architecture formed by an 
extended random coil at the extreme N terminus and a β-hairpin loop (L1'2') inserted 
between helices αB and αC that project outward to interlock AB and CD dimers 
together (Fig.6B and Fig.7). Therefore AidB, as result of the novel N-terminal 
interface and the additional C-terminal domain IV, adopts an homotetrameric 
architecture different from the ACAD tetramer. In addition, several unique features 
distinguish AidB’s FAD cavity from the ACAD active sites despite the conservation of 
their general properties. 
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The FAD active-site cavity as a sink for reactive alkylating agents. 
Proteins within the ACAD superfamily share conserved features inside their FAD 
active sites (Kim, J.J. and Miura, R. 2004). The FAD binds in an extended 
conformation at the A/B subunit interface, with the 
isoalloxazine ring buried within a central cavity that 
contains catalytic residues. Immediately adjacent to 
the FAD binding site is a substrate access channel 
that leads from the protein exterior into the flavin 
active site. A conserved phenylalanine/tyrosine 
residue (e.g., MCAD Tyr-375) helps position the 
substrate for catalysis (Fig.8). The α,β-
dehydrogenation/oxidation reactions in ACAD 
enzymes are typically catalyzed by a conserved 
glutamate carboxylate (e.g., MCAD Glu-376) and 
the isoalloxazine N5 nitrogen, which are positioned 
adjacent to the acyl chain Cα and Cβ carbons, 
respectively (Ghisla, S. and Thorpe, C. 2004). The 
FAD–protein interactions within domains II and III 
are largely conserved among AidB and ACADs 
(Fig.7). In addition, the substrate access channel in 
AidB is similar in size and shape to that of ACADs. 
However, the unique features of the FAD pocket 
provide a structural rationale for AidB’s weak 
isovaleryl dehydrogenase activity and for the absence
in the presence of isovaleryl-CoA (Landini, P. et al., 19
2006). Specifically, AidB differs significantly from the A
important for positioning the substrates in close pro
channel is blocked at the flavin ring by Trp-424, which
primary sequence as MCAD Tyr-375 (Figs.7 and 8).
chain sterically blocks access to the back half of the c
to the isoalloxazine N5 nitrogen involved in the α,β-d
significantly restructures the environment of the 
AidB putative substrate cavity. It has been 
proposed that the glycine in this position in IVD 
allows for binding branched acyl chains (Kim, J.J. 
and Miura, R. 2004, Tiffany, K.A. et al. 1997). In 
addition to the Trp-424 steric block, the 5-Å 
displacement of the Glu-425 carboxylate from its 
normal position in ACADs would render the 
carboxylate ineffective at abstracting the Cα-H 
hydrogen from the acyl-CoA substrate. Although 
the FAD cavity is spacious enough for Trp-424 
and Glu-425 side chains to shift position, such a 
large conformational change to accommodate an 
extended acyl chain is not likely to occur in light of 
the small active-site changes observed upon acyl-
CoA binding in MCAD and isobutyryl-CoA 
dehydrogenase (Kim, J.J. et al., 1993, Battaile, 
K.P. et al., 2004). Thus, it appears that the 
elongated FAD cavity in AidB is an evolutionary 
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Fig.8: Superposition of AidB 
(green) and MCAD (gray) 
structures. The AidB flavin is 
yellow, and the MCAD octanoyl-
CoA substrate is pink. The black 
arrows highlight the shift in Glu-
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remnant and not a bona fide active site for fatty or amino acid acyl-CoA thioesters. 
The volume of the FAD binding pocket (∼290 Å2) is large enough to accommodate a 
small molecule. AidB has been proposed to detoxify MNNG or one of its reactive 
metabolites (Landini, P. et al., 1994). Unlike MMS or MNU, MNNG is activated by 
thiols, including glutathione, to produce highly reactive methylation agents (e.g., 
methyldiazonium ion) (Lawley, P. D. 1974). Interestingly, AidB’s FAD cavity is rich in 
thiol and methylsulfide groups (Fig.9), a characteristic distinctly different from other 
structural homologues. In fact, four of 13 solvent-accessible residues lining the AidB 
pocket are cysteine or methionine, whereas there are no such residues in contact 
with substrates in MCAD, IVD, ACO, or NAO (Fig.7). It is therefore intriguing to 
speculate that Cys-133, Met-137, Met-182, and Cys-302 may alter the redox 
potential of AidB’s pocket relative to those of other, functionally unrelated enzymes. 
In particular, Cys-133 and Met-137 sulfur atoms are positioned 5.8 and 4.3 Å from 
the flavin, respectively, and are oriented toward the mouth of the substrate channel 
(Fig.9). Thus, it appears that AidB’s putative active site may act as a sink for reactive 
MNNG derivatives.  
Structural studies also suggested that the C-terminal domain of AidB, highly 
electropositive, is responsible for DNA binding. Therefore AidB does not engage 
DNA at the acyl-CoA substrate binding cavity, the only entry point into the FAD active 
site. These observations argue against the notion that AidB repairs DNA by an FAD-
dependent mechanism. AidB’s tetrameric assembly exposes DNA binding surfaces 
at each end of the tetramer. Nonspecific DNA binding at the ends of the tetramer 
suggests that the protein might function to protect naked DNA from attack by 
alkylating agents. A similar role has been observed in the Dps protein, which protects 
DNA in starved E. coli against oxidative damage (Almiron, M. et al., 1992; Martinez, 
A. and Kolter, R. 1997). Both AidB and Dps are up-regulated during stationary phase 
and are rpoS dependent (Volkert, M.R. et al., 1994; Altuvia, S. et al., 1994). 
Interestingly, endogenous methylating agents such as nitrosamines are formed as 
by-products of stationary-phase metabolism (Taverna, P. and Sedgwick, B. 1996). 
This leads to an accumulation of alkylation damage to DNA during stationary phase, 
as demonstrated by an increase in spontaneous mutation in methyltransferase (ada 
ogt)-deficient E. coli in nondividing cells (Rebeck, G.W. and Samson, L. 1991). 
Induction of AidB expression, therefore, could serve to prevent endogenous 
stationary-phase alkylation damage in a manner similar to Dps protection of oxidative 
damage. Dps protection of DNA is believed to occur by binding DNA duplexes within 
the pores of hexagonally packed Dps dodecamers (Grant, R.A. et. al, 1998). 
Interestingly, crystal form of AidB displays that the putative DNA binding faces are 
clustered symmetrically around 25-Å pore that is perfectly sized to accommodate 
DNA. Thus, it appears that AidB tetramers cluster around DNA to restrict access by 
damaging agents. Coupled with unique features of FAD site, these observations 
suggest that AidB may be the cell’s line of defense to prevent alkylation damage by 
protecting DNA and by detoxifying the alkylating compounds before they are able to 
react with DNA. 
 
6. Potential role for AidB as a detoxification enzyme: a new challenge for 
pollution cleanup 
Despite detailed understanding of Ada, AlkA, and AlkB, the mechanism by which 
AidB protects against DNA damage in the adaptive response is less well understood. 
Although the specific function remains to be determined, the structural features of 
AidB’s unique DNA binding domain, subunit organization, and FAD chemical 
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environment help to support the involvement of the protein in a detoxification 
pathway of certain alkylators.  
The possibility that AidB might degrade alkylating molecules, among the most 
prevalent pollutants released into the environment, makes this protein a promising 
tool for bioremediation applications. Besides, interestingly, full-length AidB 
homologues are not present in many bacteria closely related to E. coli (Klebsiella, 
Vibrio, Shewanella, and Photorhabdus), but the closest hits are from some γ-
proteobacteria such as Pseudomonas, Azotobacter, and Acinetobacter. This 
observation is intriguing because Pseudomonas species and closely related 
organisms are the most extensively studied and the most frequently used for 
bioremediation applications, owing to their ability to degrade numerous different 
contaminants (Wackett, L.P. 2003). The huge potential of the pseudomonads does 
not solely depend on a high proportion of genes responsible for the metabolism, 
transport and efflux of organic compounds (Nelson, K.E. et al., 2002), but also on 
broad capability of metabolic regulation: indeed, the control of gene expression is the 
key determinant of their flexibility and, in this respect, a variety of highly integrated 
regulatory mechanisms have been identified.  
Taken together, these observations suggest that the characterization of the potential 
ability of AidB protein and its homologues to degrade alkylators, could allow the 
development of new successful strategies for the bioremediation of environments and 
industrial effluents contaminated by alkylating compounds. 
 
7. Aim of the thesis 
The aim of this research project was to explore new potential candidates for the bio-
treatment of wastes and environments contaminated by alkylating agents. The study 
has been specifically focused on AidB protein due its potential ability to degrade 
certain alkylators.  
Initially, the work has been aimed at investigate the role of AidB in the bacterial cell; 
given that the knowledge of the domain architecture is necessary for understanding 
the multifunctional properties of a protein, structural and functional characterization of 
domains present in AidB was performed. Successively, the mechanism by which this 
protein directly protects E. coli cells against alkylating compounds has been 
determined. Finally, taking into account the potential role played by AidB in the 
detoxification of alkylating molecules, this experimental work was targeted at identify 
as well as at characterize E. coli AidB homologues in bacteria used for 
bioremediation applications. Specifically, the study has been focused on the acyl-
CoA dehydrogenase coded by the PP4780 gene from Pseudomonas putida KT2440. 
The involvement of this protein in the response to alkylation stress has been 
investigated in order to enrich the knowledge of this enzyme, thus improving its 
potential application in bioremediation strategies. In conclusion, the data obtained in 
this research project support the possibility of developing new successful strategies 
for the bioremediation of environments and wastes contaminated by alkylating 
compounds.  
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ABSTRACT 
The transcriptional machinery at the 
ribosomal RNA rrnB P1 promoter of 
Escherichia coli was investigated by 
functional proteomics. Synthetic 
oligonucleotides encompassing the -35 
sequence of the rrnB P1 promoter and 
its associated element upstream 
(“UP35”) were incubated with the total 
protein extract. Proteins found to bind 
exclusively to the “UP35” 
oligonucleotide were identified by mass 
spectrometry and specific protein-
protein interactions were confirmed by 
co-immunoprecipitation. Proteins 
specifically binding to the rrnB P1 
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promoter region belong to different 
functional groups: in addition to 
components of the transcription 
machinery, we also found proteins 
involved in translation, DNA repair and 
protection mechanisms and in cell 
metabolic processes. Presence of 
several ribosomal proteins strongly 
suggests that the ribosome can 
establish direct interaction with 
bacterial RNA polymerase. 
Interestingly, we found that non-
specific DNA binding proteins, i.e. Dps 
and AidB, are recruited into the 
transcriptional complex. Functional 
hypotheses on the possible biological 
significance of the different functional 
groups were suggested. 
 
Keywords: rRNA transcription, 
proteomics, cellular network, alkylation, 
fishing for partners, mass 
spectrometry. 
 
Running title: Complex transcription 
machinery at E. coli rrnB P1 promoter. 
 
INTRODUCTION 
The availability of complete genome 
sequences for a constantly growing 
number of organisms has opened the 
door for novel proteomic approaches 
aimed at identifying components of 
complex protein machineries and thus 
to elucidate their function. Moreover, 
microarray technologies (1) providing 
information on global mRNA 
expression, clearly demonstrated that 
in many cases mRNA transcripts do 
not directly correlate with protein 
expression (2,3). Therefore, the field of 
proteomics is challenged with the task 
of providing both quantitative and 
functional data to further complement 
genomics (4).  
In particular, functional proteomics has 
emerged as a new area of study aimed 
at isolating and identifying molecular 
components belonging to multi-protein 
complexes (5). It is now clear, in fact, 
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that fundamental biological 
mechanisms are carried out by a 
multitude of proteins that assemble to 
form large functional complexes (6) or 
specific cell pathways (7). A 
comprehensive description of cellular 
processes at the molecular level is 
then strictly dependent on the clear 
definition of the individual protein 
components involved in these 
functional entities. A key contribution to 
the disclosure of biological 
mechanisms can then be provided by 
functional proteomic strategies. 
Isolation of the entire multiprotein 
complexes can be essentially 
accomplished by either affinity based 
techniques (including “pull down” and 
“tap tag” experiments) (8-10) or 
immunoprecipitation procedures (11). 
Both methodologies take advantage 
from the availability of different 
(immuno)-affinity ligands endowed with 
high binding efficiency. The success of 
an affinity-based approach strictly 
depends on the absence of excessive 
nonspecific interactions that in turn is 
related to the specificity of the bait-
partners recognition. When this binding 
specificity is extremely high, as in the 
case of DNA/RNA-binding proteins, a 
low level of false positives is expected.  
Ribosomal RNA (rRNA) transcription 
constitutes a fundamental biological 
process in all living cells. Several 
studies demonstrated that transcription 
of rRNA is the rate-limiting step in 
ribosome synthesis (12-14). Consistent 
with this crucial role in ribosome 
biogenesis, the control of rRNA 
transcription initiation, the efficient 
elongation of RNA polymerase as well 
as all the other steps involved in the 
transcription machinery are tightly 
regulated by a complex network of 
protein components (14 and 
references therein). Ribosomal RNA 
accounts for >90% of total RNA 
present in the bacterial cell. Operons 
encoding ribosomal RNA are present 
in multiple copies in the genome, an 
unusual feature for bacterial genes; for 
instance, in Escherichia coli rRNA is 
encoded by 7 different operons. 
Ribosomal proteins are subject to 
various forms of regulation: proteins 
such as Fis or H-NS (15), as well as 
direct interaction between RNA 
polymerase and the ppGpp signal 
molecule (16,17) can modulate the 
activity of rRNA promoters. An 
important feature of ribosomal 
promoters is the presence of the so-
called UP element, an A/T rich 
sequence located at 40 to 80 
nucleotides upstream of the 
transcription start site that can 
stimulate transcription from the rrnB P1 
promoter through direct interaction with 
the C-terminal domain of the RNA 
polymerase α subunit (18,19). 
In this report, we have investigated the 
functional protein complex that gathers 
at the upstream elements of the 
ribosomal rrnB P1 promoter of E. coli. 
We find that several ribosomal proteins 
assemble at the rrnB P1 promoter, 
thus suggesting direct interaction 
between RNA polymerase and the 
ribosome. In addition, proteins involved 
in DNA repair/protection mechanisms 
are also found in the promoter-binding 
protein complex. Altogether, our 
findings strongly suggest that proteins 
with functions not directly related to 
transcription associate with RNA 
polymerase to form multiprotein 
complexes.  
 
MATERIALS AND METHODS  
Proteomic grade trypsin, dithiothreitol 
(DTT), HEPES, KCl, MgCl2, glycerol, 
ammonium bicarbonate and triton were 
purchased from Sigma. Cyanogen 
bromide-activated agarose matrices 
were obtained from Pharmacia 
Biotech. All used solvents were of the 
highest purity available from Romil. 
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Escherichia coli K12 strain growth 
conditions and protein extract 
preparation. 
E. coli K12 strain was grown in aerobic 
conditions at 37°C in LB medium (20). 
After 16 h, bacteria were harvested by 
centrifugation and resuspended in 
Buffer Z (25 mM HEPES pH 7.6, 50 
mM KCl, 12.5 mM MgCl2, 1 mM DTT, 
20% glycerol, 0.1% triton) containing 1 
µM phenyl methyl sulfonyl fluoride. 
Cells were disrupted by sonication. 
The suspension was centrifuged at 
90,000 x g for 30 min at 4°C. After 
centrifugation the protein concentration 
of the extract was determined with 
Bradford assay (21).  
 
Preparation of the oligonucleotide bait 
and coupling to Sepharose. 
A 28-mer deoxynucleotide 
encompassing the upstream and the    
-35 sequence of the ribosomal 
promoter rrnB P1 and a randomised 
version of the same sequence  were 
chemically synthesized (Table 1). The 
complementary oligonucleotides (500 
µg) were annealed, 5’-phosphorylated 
and ligated as follows. Gel purified 
oligodeoxynucleotides were combined 
in 10 mM Tris pH 7.5, 50 mM NaCl, 1 
mM EDTA pH 8. The total mixture was 
incubated at 90°C for 5 min, 65°C for 
10 min, 37°C for 10 min and RT for 5 
min. ATP (20 mM) and T4 
polynucleotide kinase (200 units) were 
then added and the resulting solution 
was incubated at 37°C for 2 hours. The 
DNA was phenol extracted and then 
ethanol precipitated and the pellet was 
resuspended in H2O and the ligation 
reaction was initiated by the addition of  
20 mM ATP and T4 DNA ligase (15 
units). The mixture was incubated at 
16°C and the desired multimerization 
grade was monitored by agarose gel. 
The final DNA product was phenol 
extracted and ethanol precipitated. The 
polymerised oligonucleotides were 
covalently linked to cyanogen bromide-
activated agarose beads following the 
procedure recommended by 
Amersham. 
 
Electrophoretic shift mobility assays. 
Annealed DNA oligonucleotides 
(fragments UP, UP35 and Neg) were 
32P labelled at 5’ positions by using T4 
polynucleotide kinase (20 units). 
Electromobility shift assays were 
performed in 20 µl reaction volume. 
Total protein extract (10 µg) or each 
individual recombinant protein (1 µg) 
were incubated with the 32P-labelled 
DNA (2 ng, 50,000-100,000 cpm) in 
buffer Z, for 20 min at RT. Mixtures 
were then analysed by electrophoresis 
on 8% native polyacrylamide gel (29:1 
cross-linking ratio) in 45 mM Tris pH 
8.0, 45 mM boric acid, 1 mM EDTA. 
Electrophoreses were performed at 
room temperature at 200 V (20 V/cm). 
The gels were dried and analysed by 
autoradiography.  
 
DNA affinity chromatography. 
A 4 ml affinity chromatography column 
was prepared with the agarose 
derivatizated beads. The column was 
equilibrated with 30 ml of buffer Z. The 
entire cell extract (300 mg) was 
incubated with the bait overnight at 
4°C. The column was washed with 50 
ml of buffer Z and the proteins 
selectively retained from the DNA 
probe were eluted with the same buffer 
containing 1 M KCl. The fractions 
containing the proteins of interest 
eluted from the affinity chromatography 
were pooled and dialyzed in H2O. The 
same affinity chromatography 
procedure was applied to the Neg 
oligonucleotide. Both the eluted and 
dialyzed fractions were loaded onto 
SDS-PAGE gel and visualized by 
colloidal Coomassie staining. 
 
In situ digestion and MALDI analysis. 
Protein bands stained with Coomassie 
brilliant blue were excised from the gel 
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and destained by repetitive washes 
with 0.1 M NH4HCO3 pH 7.5 and 
acetonitrile. Samples were reduced by 
incubation with 50 µl of 10 mM DTT in 
0.1 M NH4HCO3 buffer pH 7.5 and 
carboxyamidomethylated with 50 µl of 
55 mM iodoacetamide in the same 
buffer. Enzymatic digestion was carried 
out with trypsin (12.5 ng/µl) in 10 mM 
ammonium bicarbonate pH 7.8. Gel 
pieces were incubated at 4°C for 2 
hours. Trypsin solution was then 
removed and a new aliquot of the 
digestion solution was added; samples 
were incubated for 18 hr at 37°C. A 
minimum reaction volume was used as 
to obtain the complete rehydratation of 
the gel. Peptides were then extracted 
by washing the gel particles with 10 
mM ammonium bicarbonate and 1% 
formic acid in 50% acetonitrile at room 
temperature. The resulting peptide 
mixtures were desalted using ZipTip 
pipettes from Millipore, following the 
recommended purification procedure.  
 
MALDI Analyses. 
MALDI-TOF mass spectra were 
recorded using an Applied Biosystem 
Voyager DE-STR instrument. A 
mixture of analyte and matrix solution 
(alfa-cyano-hydroxycinnamic acid 10 
mg/ml in 70% ACN, 0.1% citric acid, in 
MilliQ water) was applied to the 
metallic sample plate and dried at 
room temperature. Mass calibration 
was performed using external peptide 
standards. Raw data were analysed 
using the computer software provided 
with the instrument and reported as 
monoisotopic masses. Peptide masses 
of each digested protein were used to 
search for protein databases using the 
Mascot mass fingerprinting software 
(Matrix Science). 
 
Liquid Chromatography Tandem Mass 
Spectrometry (LC/ MS/MS) analyses. 
Tryptic peptide mixtures obtained from 
in situ digestions were also analysed 
by LC/MS/MS “on-line” using a 4000Q-
Trap linear trap ion mass spectrometer 
(Applied Biosystems) coupled to an 
1100 nano HPLC system (Agilent 
Technologies). The mixture was 
loaded on an Agilent reverse-phase 
pre-column cartridge (Zorbax 300 SB-
C18, 5x0.3 mm, solvent 0.1% formic 
acid, loading time 5 min). Peptides 
were separated on a Agilent reverse-
phase column (Zorbax 300 SB-C18, 
150 mm), at flow rate of 0.3 µl/min with 
a 5 to 65% linear gradient in 60 min (A 
solvent 0.1% formic acid, 2% ACN in 
water; B solvent 0.1% formic acid, 2% 
water in ACN). Nanospray source was 
used at 2.5 kV with liquid coupling, with 
a declustering potential of 50 V, using 
an uncoated silica tip from 
NewObjectives (Ringoes, NJ) (O.D. 
150 µm, I.D. 50 µm, Tip.Diameter. 15 
µm). Spectra acquisition was based on 
a survey scan (EMS) using Linear Ion 
Trap scanned from m/z 400 to m/z 
1600 at 4000 amu/sec. This scan 
mode was followed by an enhanced 
resolution experiment (ER) for the five 
most intense ions of interest and then 
by MS2 acquisitions of the five most 
intense ions for peptide charge, from 
+2 to +3. MS2 spectra were acquired 
using the best collision energy 
calculated on the bases of m/z values 
and charge state (rolling collision 
energy). 
The acquired MS/MS spectra were 
transformed in Mascot generic file 
format and used for peptides 
identification with a licensed version of 
MASCOT, in a local database. 
 
Comparison with IntAct data. 
Validation of the proteomic results was 
performed by comparing our data with 
those provided by IntAct database 
(htpp://www.ebi.ac.uk/intact/search/do/
search?search String={0}) linked in the 
corresponding Swiss-Prot entries 
(htpp://www.expasy.org/sprot/). Each 
protein candidate was submitted to the 
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IntAct databank obtaining a list of all 
proteins involved in interaction with the 
query protein. 
 
Construction of expression vectors. 
The bacterial strains and plasmids 
used in this work are all reported in 
Table 1. The rluC, fabZ, tufA, srmB, 
aidB and hns genes of E. coli K12 
were amplified from host DNA by 
polymerase chain reaction (PCR) using 
the forward and reverse primers listed 
in Table 1. To obtain RluC, FabZ, EF-
Tu and H-NS tagged with c-myc 
epitope, the corresponding 
amplification products were digested 
with BamHI and XhoI and cloned into 
the pET22b-c-myc vector, respectively. 
To obtain pET22b-c-myc, a 
NdeI/BamHI digested fragment 
corresponding to the c-myc epitope 
was inserted into the pET22b (+) 
expression plasmid (Novagen) 
linearized with NdeI and BamHI. 
RluC, SrmB and H-NS tagged with T7 
epitope were made by insertion of the 
corresponding amplified fragments into 
the BamHI and XhoI sites of pET28a 
(+) expression vector (Novagen). The 
plasmid pET28a-aidB was constructed 
by cloning aidB coding sequence into 
pET28a (+) digested with BamHI and 
HindIII. 
All plasmids (Table 1) contain the 
coding sequence for the corresponding 
recombinant protein fused to a 6X 
histidine tag to facilitate protein 
purification by Ni2+ affinity 
chromatography. Plasmids 
construction was verified by automated 
DNA sequencing. 
 
Production and purification of 
recombinant proteins. 
The recombinant genes were 
separately expressed into the E. coli 
strain C41 (DE3) (22). For RluC, FabZ 
and SrmB production, the recombinant 
cells were grown in LB medium at 
37°C without induction until the OD600 
reached 3.0. The aidB, tufA and hns 
genes were expressed as follows: 
recombinant cells were grown at 37°C 
to an optical density at 600 nm of        
~0.5, at which time 0.05 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG) 
was added and the cultures were 
shifted down to 25°C for AidB 
production and to 28°C for EF-Tu and 
H-NS expression until the OD600 
reached 3.0. 
Selective antibiotics were used at the 
following concentrations: 100 µg/ml 
ampicillin; 50µg/ml kanamicin. After 
incubation, cells were harvested by 
centrifugation at 5000 x g for 15 min at 
4°C, resuspended in 50 mM Na2HPO4, 
pH 7.4, disrupted by passage through 
a French Press and centrifuged at 
14000 x g for 30 min at 4°C.  
Recombinant proteins were purified by 
affinity chromatography on His-Select 
Nickel Affinity Gel fv (Sigma). The 
lysate was loaded onto His-Select 
Nickel Affinity Gel equilibrated with 
equilibration buffer (50 mM Na2HPO4, 
pH 7.4, 0.3 M NaCl, 10 mM imidazole). 
After 1 min of incubation at 4°C, the 
matrix was collected by centrifugation 
at 11000 x g for 1 min and washed 3 
times with same equilibration buffer.  
The recombinant proteins were eluted 
with buffer containing 250 mM 
imidazole in 50 mM Na2HPO4, pH 7.4, 
0.3 M NaCl. 
Protein concentration was estimated 
with Bradford reagent (Bio-Rad protein 
assay) and protein content was 
checked by SDS-polyacrilamide gel 
electrophoresis (SDS-PAGE).  
 
Co-immunoprecipitation and Western 
blotting. 
For co-immunoprecipitations, E. coli 
strain C41 (DE3) was co-transformed 
with the following constructs:  
pET28a-aidB/pET22b-c-myc-fabZ, 
pET28a-srmB/pET22b-c-myc-tufA, 
pET28a-srmB/pET22b-c-myc-rluC, 
pET28a-rluC/pET22b-c-myc-tufA, 
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Table 1: Bacterial strains, plasmids and oligonucleotides 
Strains/plasmids Description 
Reference 
or 
Source 
Strains   
C41 (DE3)     Strain that derives from BL21 [F-ompT hsdSB (rB- mB-) gal 
dcm (DE3)]. This strain has at least one uncharacterized 
mutation that prevents cell death associated with expression 
of many toxic recombinant proteins     
ref. 22 
Plasmids   
pET22b(+)  carries an N-terminal pelB signal sequence for potential 
periplasmic localization, plus an optional C-terminal His-tag 
sequence 
Novagen 
pET28a(+)  carries an N-terminal His•Tag®/thrombin/T7•Tag® 
configuration plus an optional C-terminal His•Tag sequence 
Novagen 
pET22b-c-myc pET22b∆(NdeI-BamHI)Ω(c-myc) This work 
pET22b-c-myc-rluC     pET22b-c-myc∆(BamHI-XhoI)Ω(rluC gene)     This work 
pET22b-c-myc-fabZ pET22b-c-myc∆(BamHI-XhoI)Ω(fabZ gene) This work 
pET22b-c-myc-tufA     pET22b-c-myc∆(BamHI-XhoI)Ω(tufA gene)     This work 
pET22b-c-myc-hns pET22b-c-myc∆(BamHI-XhoI)Ω(hns gene)     This work 
pET28a-aidB pET28a∆(BamHI-HindIII)Ω(aidB gene)   This work 
pET28a-rluC pET28a∆(BamHI-XhoI)Ω(rluC gene)   This work 
pET28a-srmB pET28a∆(BamHI-XhoI)Ω(srmB gene)   This work 
pET28a-hns pET28a∆(BamHI-XhoI)Ω(hns gene)   This work 
Oligonucleotides  
UP Fw         5'-AGAAAATTATTTTAAATTTC-3' 
UP Rv 5'-GAAATTTAAAATAATTTTCT-3' 
UP35 Fw 5'-GAAAATTATTTTAAATTTCCTCTTGTCA-3' 
UP35 Rv         5'-TGACAAGAGGAAATTTAAAATAATTTTC-3' 
Neg Fw 5'-CAACTATAGTATAAGATATTCTTTCTTT-3' 
Neg Rv 5'-AAAGAAAGAATATCTTATACTATAGTTG-3' 
c-myc Fw 5'TTCATATGGAACAAAAACTCATCTCAGAAGAGGATCTGAATGGGGCC
GCAGGATCCTAT3’ 
c-myc Rv 5'ATAGGATCCTGCGGCCCCATTCAGATCCTCTTCTGAGATGAGTTTTT
GTTCCATATGAAT3’ 
rluC Fw 5'-ATAGGATCCATGAAAACAGAGACTCC-3'  
rluC-pET22b Rv         5'-ATACTCGAGTAAGCGCGCGTTACG-3'  
rluC-pET28a Rv         5'-ATACTCGAGTTAGCGCGCGTTACG-3'  
fabZ Fw 5'-ATAGGATCCTTGACTACTAACACTC-3'  
fabZ Rv 5'-TAACTCGAGTTAGGCCTCCCGGC-3'  
tufA Fw 5'-TATGGATCCGTGTCTAAAGAAAAATTTG-3'  
tufA Rv         5'-TATCTCGAGTAAGCCCAGAACTTTAGC-3'  
hns Fw 5'-TAAGGATCCATGAGCGAAGCACTTA-3'  
hns-pET22b Rv 5'-ATACTCGAGTAATTGCTTGATCAGG-3'  
hns-pET28a Rv 5'-ATACTCGAGTTATTGCTTGATCAGG-3'  
aidB Fw 5'-ATAGGATCCGTGCACTGGCAAACTCACACCG-3'  
aidB Rv 5'-CGCGAGCTCCGTAAGCTTTTACACACACACTC-3'  
srmB Fw 5'-ATAGGATCCATGACTGTAACGACTTTT-3'  
srmB Rv 5'-ATACTCGAGTTACTCTTCTGTCGTTTG-3'  
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pET28a-aidB/pET22b-c-myc-hns, 
pET28a-hns/pET22b-c-myc-fabZ, 
pET28a-hns/pET22b-c-myc-rluC, 
pET28a-aidB/pET22b-c-myc-rluC. 
After expression of the recombinant 
genes without induction, cells were 
harvested, suspended in 50 mM 
Na2HPO4 (pH 7.4), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C. The supernatants were used for 
the co-immunoprecipitation 
experiments.  
Cell lysates (0.5 mg) were incubated 
with agarose-linked T7 antibody 
(Bethyl) and with agarose beads only 
(control of the experiment) at 4°C 
overnight. The beads were then 
collected by centrifugation. Precipitates 
were washed several times, the bound 
proteins were eluted with 1×SDS–
PAGE sample buffer and subjected to 
SDS-PAGE followed by Western blot 
analysis that was performed by using 
anti-T7 mouse antibody (Novagen) and 
anti-c-myc mouse antibody 
(Calbiochem) as first antibodies and 
anti-mouse IgG conjugated to 
peroxidase as a secondary antibody 
(Calbiochem).  
 
RESULTS 
Interaction of Escherichia coli proteins 
with the rrnB P1 promoter upstream 
elements. 
Escherichia coli cell extracts were 
tested for their ability to bind to the 
upstream element of the rrnB P1 
promoter in electrophoresis mobility 
shift assays (EMSA). EMSA 
experiments were carried out using 
three different DNA oligonucleotides as 
probes. The first oligonucleotide (20 
nucleotides, oligo “UP”, Table 1) 
corresponds to the UP element alone, 
i.e. the DNA sequence directly involved 
in interaction with the α subunit of RNA 
polymerase and located immediately 
upstream of the -35 promoter element 
(23,24). The second oligonucleotide 
(28 nt, “UP35”, Table 1) includes both 
the UP element and an additional 8 
base pairs containing the TTGTCA 
sequence of the rrnB P1 -35 box. 
Finally, a third 28-nt oligonucleotide 
with the same nucleotide content as 
“UP35”, but lacking any known 
promoter or regulatory elements 
(“Neg”, Table 1) was also used as 
negative control in EMSA experiments 
(Table 1). Each probe was incubated 
with 10 µg of protein extracts from E. 
coli cells. At this protein concentration, 
a clear gel mobility shift band could 
only be detected with the “UP35” 
oligonucleotide, i.e. with the DNA 
fragment containing the upstream 
element and the -35 box (Fig. 1, lane 
2). In contrast, no interaction was 
observed with either the “UP” DNA 
fragment containing only the upstream 
element or with the “Neg” 
oligonucleotide, suggesting that the 
presence of the -35 box is necessary 
for efficient protein binding at the 
concentration used (Fig. 1, lanes 1 and 
3). The specific nature of protein 
binding to UP35 detected in EMSA 
was further confirmed by competition 
experiments: the radiolabelled “UP35” 
probe was incubated with the protein 
extract from E. coli cells and increasing 
quantities (100-500 fold) of either 
unlabelled “UP35” or “Neg” were 
added. Binding to the radiolabelled 
“UP35” by cell extract was reversed by 
an excess of unlabelled “UP35”, while 
it was not affected by competition with 
identical concentrations of the “Neg” 
probe (Fig. 1, lanes 4-7). 
These results demonstrated that the 
UP35 region could be recognised by 
specific protein factors and that binding 
to the upstream element was specific 
and dependent on the presence of the 
-35 box.  
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Figure 1. Electrophoresis mobility shift assays (EMSA) performed using either the UP or the 
UP35 elements and total protein extract from E. coli cells. Lane 1: E. coli protein extract 
incubated with UP; lane 2: E. coli protein extract incubated with UP35; lane 3: E. coli protein 
extract incubated with Neg; lane 4 - 5: Competition assay with UP35 (100x-500x); lane 6 - 7: 
Competition assay with Neg (100x-500x). 
 UP35 Neg 
Probe UP35: 
UPSTREAM -35 
Probe UP: 
UPSTREAM 
 
Identification of proteins specifically 
interacting with the oligonucleotide 
bait. 
In order to identify which proteins are 
involved in binding to the rrnB P1 
promoter upstream elements (UP 
element and -35 box), we performed 
functional proteomic assays using the 
“UP35” synthetic oligonucleotide linked 
to agarose beads (“baits”), as 
described in Materials and Methods. 
The total protein extract from E. coli 
K12 cells was first incubated with 
agarose beads to remove proteins that 
could bind the agarose matrix, then 
split in two fractions that were 
incubated with the agarose-linked DNA 
baits, i.e. the “UP35” and the “Neg” 
oligonucleotides, respectively. After 
extensive washing, the proteins 
specifically retained by the native and 
the random oligonucleotides were 
eluted with a strong ionic buffer 
containing 1 M KCl and visualized on 
SDS-PAGE. Figure 2 shows the 
corresponding Coomassie Blue stained  
 
gel displaying a number of discrete 
protein bands both in the sample 
incubated with “UP35” (lane A) and in 
the negative control (sample incubated 
with the “Neg” oligonucleotide, lane B). 
Proteins specifically interacting with the 
native double-strand DNA probe were 
selected by comparing the two 
electrophoretic patterns: bands solely 
occurring in the sample and absent in 
the control (samples 1 to 13 in Fig. 2) 
were selected for identification. In 
addition, we excised gel slices from 
lane B in the positions corresponding 
to the bands selected for identification 
(samples C1 to C13 in Fig. 2), and 
identified the proteins as well. 
Common proteins identified in both the 
sample and the control gel slices were 
eliminated, thus greatly decreasing the 
number of false positives.  
Protein identification was carried out by 
MALDI-MS on peptides obtained by in-
gel trypsin proteolytic digestion; 
peptides were assigned to specific 
proteins using the Mascot software. 
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Figure 2. SDS PAGE 
fractionation of the protein 
complexes isolated by 
affinity chromatography 
using the UP35 bait. 
Coomassie Blue stained 
protein bands solely 
occurring in the sample 
(lane A) and absent in the 
control were submitted to 
mass spectral analyses 
(samples 1 to 13). 
Corresponding gel slices 
from the control lane B 
(samples C1 to C13) were 
also submitted to the 
identification procedure. 
Common proteins 
identified in both the 
sample and the control gel 
slices were eliminated.  
 
 
henever the peptide mass 
ngerprinting procedure was unable to 
rovide unambiguous identification of 
e proteins, the peptide mixtures were 
nalysed by LC-MS/MS techniques 
enerating sequence information on  
dividual peptides leading to the 
entification of the protein 
omponents. The results obtained by 
e proteomic approach are 
ummarised in Table 2. Proteomic 
nalysis of the excised bands identified 
 total of 27 proteins solely present in 
e complex binding to the “UP35” 
ligonucleotide. In many cases, the 
eptides found in the mass spectral 
nalyses led to a sequence coverage 
f about 50% or greater as for the 
longation factor Tu or for 
yptophanase. As expected, the α, β 
nd β’ subunits of the RNA polymerase 
ere all found to be part of the “UP35”-
omplex. To our surprise, we could not 
factors, which are 
RNA polymerase 
subunits responsible 
for binding to core 
promoter elements 
such as the -35 
sequence. Thus, it  
appears that, despite 
the need for the -35 
sequence for specific 
binding (Fig. 1, lanes 
1 and 2), RNA 
polymerase 
interaction with the 
“UP35” 
oligonucleotide mostly 
takes place via 
binding of the α 
subunit to the UP 
element. However, we 
cannot exclude that 
σ70 was not identified 
simply due to 
technical reasons. In 
addition to RNA 
polymerase, our 
results suggest that a large number of 
proteins can bind specifically to the 
rrnB P1 promoter region (Table 2). Not 
surprisingly, some of these additional 
proteins are either transcription 
regulators or known DNA-binding 
proteins (e.g. H-NS, Dps). However, a 
significant fraction of these additional 
proteins are part of the translation 
machinery: ribosomal proteins, 
proteins involved in RNA binding and 
modification (e.g. SrmB, DeaD) and in 
nascent polypeptides modifications 
(DnaJ), possibly suggesting that the 
protein synthesis machinery might 
assemble with RNA polymerase at the 
rrnB P1 promoter. Finally, some 
proteins are involved in cell energetic 
and catabolic metabolism (e.g. LpdA, 
TnaA), and their role as part of a 
transcription complex is less 
straightforward.  
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Table 2: Putative protein interactors identified by functional proteomic analysis 
Gene 
name Protein name 
SwissProt 
protein 
identification 
number 
Number 
of 
peptides 
found by 
MALDI-
MS 
analysis 
Number of 
peptides 
found by 
LC/MS/MS 
analysis 
rpoB RNA polymerase subunit beta 
(RNAP β) 
P0A8V2  8 
rpoC RNA polymerase subunit beta' 
(RNAP β’) 
P0A8T7 22  
lon ATP-dependent protease La P0A9M0 21  
rnr Ribonuclease R P21499 22 12 
deaD Cold-shock DEAD box protein A (CsdA) 
(ATP-dependent RNA helicase DeaD) 
P0A9P6  3 
lpdA Dihydrolipoyl dehydrogenase P0A9P0 13 4 
aidB AidB P33224 18 5 
srmB ATP-dependent RNA helicase SrmB P21507  5 
pssA CDP-diacylglycerol--serine O-
phosphatidyltransferase 
(Phosphatidylserine synthase) 
P23830 17  
tnaA Tryptophanase P0A853 6 2 
tufA Elongation factor Tu (EF-Tu) P0A6N1 17 3 
rluC Ribosomal large subunit pseudouridine 
synthase C (RluC) 
P0AA39 33 781 
ydbC Putative oxidoreductase YdbC P25906 9 185 
rpoA RNA polymerase subunit alpha P0A7Z4 13 3 
dnaJ Chaperone protein DnaJ P08622  3 
fabZ (3R)-hydroxymyristoyl-[acyl-carrier-
protein] dehydratase (FabZ) 
P0A6Q6 15 9 
rplI 50 S ribosomal protein L9 P0A7R1  6 
rplQ 50 S ribosomal protein L17 P0AG44  4 
rpsI 30 S ribosomal protein S9 P0A7X3  4 
rplP 50 S ribosomal protein L16 P0ADY7  3 
dps DNA protection during starvation protein P0ABT2  4 
rpsF 30 S ribosomal protein S6 P02358  3 
rpsL 30 S ribosomal protein S12 P0A7S3  2 
rpsC 30 S ribosomal protein S3 P0A7V4  2 
rpsG 30 S ribosomal protein S7 P02359  2 
rpsE 30 S ribosomal protein S5 P0A7W1  2 
hns DNA-binding protein H-NS P0ACF8  2 
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DNA binding properties of proteins part 
of the “UP35” binding complex. 
In addition to recruitment by protein-
protein interaction, proteins may be 
present in the complex by binding to 
the upstream elements of the rrnB P1 
promoter through direct DNA binding. 
We tested some of the proteins 
identified by proteomic approach for 
their DNA binding ability, i.e. AidB, 
known to be a DNA-binding protein, 
two RNA-binding protein (EF-Tu and 
RluC) and FabZ, which is not known to 
bind any nucleic acid. To this aim, the 
corresponding genes, aidB, tufA, rluC 
and fabZ were cloned into a 
commercial expression vector of the 
pET series and the recombinant 
proteins were expressed as chimeric 
proteins bearing a 6 His tag. 
The expressed proteins were then 
purified by affinity chromatography on 
Ni
2+
-agarose beads and their 
homogeneity was tested by SDS-
PAGE and mass fingerprinting 
analyses. EMSA experiments were 
carried out by incubating each 
individual protein with the radioactive 
“UP35” oligonucleotide probe, and the 
randomised version of the probe used 
as control (data not shown). As 
expected, addition of AidB retarded the 
migration of both the “UP35” DNA 
fragment and the “Neg” probe, thus 
confirming the ability of AidB to bind 
double stranded DNA in a non-specific 
fashion (25). In contrast, neither RluC 
nor FabZ and nor EF-Tu were able to 
bind the rrnB P1 promoter upstream 
region. This result is not surprising. It is 
conceivable that regulation of the rrnB 
operon is accomplished by a multi 
protein complex gathered at the 
promoter region in which only few 
proteins can effectively directly bind 
the DNA sequence whereas the 
complex is mainly stabilised by protein-
protein interactions. 
 
Validation of protein-protein 
interactions by database search. 
In order to understand their role in the 
protein complexes formed at the 
“UP35” oligonucleotide, we verified 
protein-protein interactions by 
database search and by co-
immunoprecipitation experiments. We 
searched each protein identified as 
part of the complex gathered at the 
upstream elements of the rrnB P1 
promoter in the Swiss Prot databank 
(http://au.expasy.org/) and in related 
databases such as IntAct 
(http://www.ebi.ac.uk/intact/site/index.j
sf). In addition to interactions among 
ribosomal proteins or RNA polymerase 
subunits, many examples of protein-
protein interaction between 
transcription and translation machinery 
have already been reported; for 
instance, the β’ subunit of RNA 
polymerase has been shown to interact 
with ribosomal proteins S5, S7, L17 (all 
found in our experiments) as well as 
with S4, S13, L2, L3, L4, L13 and L15. 
Even proteins involved in cell 
metabolism, such as FabZ (a β-
hydroxyacyl-ACP dehydratase involved 
in fatty acid biosynthesis) are known to 
interact with ribosomal proteins (S3, 
S5, S7 and L9) as well as with 
Elongation factor Tu, another factor 
involved in protein synthesis. With the 
sole exceptions of tryptophanase 
(TnaA) and of the YdbC putative 
alcohol dehydrogenase, all other 
proteins were found to be involved in 
protein-protein interactions with one or 
more components of the “UP35” 
binding complex.  
 
Validation of protein-protein 
interactions by co-immunoprecipitation 
experiments. 
Databases screening provided initial 
support to our experimental results, 
suggesting that the proteins identified 
in the functional proteomic approach 
might indeed be involved in a complex 
network of interactions. However, in 
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order to validate the observed protein-
protein interactions, we performed co-
immunoprecipitation experiments, 
using the data obtained by database 
search to select which proteins to test 
in co-immunoprecipitation experiments.  
Initially, we focused on interactions 
between proteins belonging to the 
same functional groups; thus, we  
tested potential interactions between 
SrmB (an RNA helicase) with either 
EF-Tu or RluC (23S rRNA 
pseudouridine synthase), both RNA-
binding proteins involved in either 
protein synthesis or ribosome 
biogenesis. T7-tagged SrmB was 
expressed in E. coli cells together with 
either c-myc tagged EF-Tu or RluC 
and the protein extract was 
immunoprecipitated by anti-T7 
agarose-conjugated antibody, as 
described in Materials and Methods. 
The immunoprecipitate was run on 
SDS-PAGE and the SrmB protein was 
detected by Western blot using anti-T7 
antibody (Fig. 3A, 3B, left panels). c-
myc-labelled proteins that co-
immunoprecipitate with T7-tagged 
SrmB could be detected by 
immunodetection using antibodies 
directed against the c-myc peptides 
(Fig. 3A, 3B, right panels). We could 
not detect any band when antibodies 
directed against either T7 or c-myc  
were used in Western Blot experiments 
using samples incubated with agarose 
beads alone (lane 3). The bands 
detected by Western blot in co-
immunoprecipitates perfectly match c-
myc tagged EF-Tu and RluC 
respectively used as control (lane 2). 
Analogous co-immunoprecipitation 
experiments showed interaction 
between RluC and EF-Tu (Fig. 3C). 
Thus, our findings strongly suggest 
that RluC, SrmB and EF-Tu can 
interact and might indeed be part of the 
same protein complex in vivo. Co-
immunoprecipitation experiments were 
then performed to determine whether 
proteins identified as part of the 
“UP35”-binding protein complex, but 
belonging to different functional 
classes, could interact among each 
other. Indeed, we found that the 
transcription regulator H-NS was not 
only able to interact with AidB, a DNA-
binding protein (Fig. 3D), but also with 
FabZ (involved in fatty acid 
metabolism, Fig. 3E) and with RluC 
(23S rRNA pseudouridine synthase, 
Fig. 3F). Likewise, AidB can establish 
protein-protein interactions with both 
FabZ (Fig. 3G) and RluC (Fig. 3H). 
These experimental results clearly 
indicated that the proteins identified in 
the functional proteomic experiments 
are involved in a complex network of 
interactions. 
 
DISCUSSION 
The ability of any organism to survive 
depends, in part, on mechanisms that 
enable it to modify its patterns of gene 
expression in response to extra- and 
intracellular signals. In the past, 
bacterial signalling was thought to 
function as a set of isolated, linear 
pathways. More recent studies, 
however, have demonstrated that 
many signalling pathways interact, thus 
forming an intricate network, which 
integrates both extracellular and 
intracellular signals, to ensure that the 
correct amount of the appropriate 
subset of genes is expressed at the 
proper time. Complete description of 
this complex signal transcription and 
transduction network and use of the 
network to predict the full range of 
cellular behaviours are major goals of 
system biology. One of the key issues 
in the contemporary genomic biology is 
to understand the structure and 
function of these cellular networks at 
different molecular levels. Among 
them, the transcriptional regulatory 
network (TRN) plays a crucial function, 
regulating cell physiology and 
metabolism through gene expression. 
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Figure 3. Co-immunoprecipitations experiments. Total protein extracts from E. coli strain C41 co-
transformed with T7 and c-myc tagged version of individual proteins were subjected to 
immunoprecipitation with agarose-linked T7 antibody or with agarose beads only as control, 
followed by immunoblotting with anti-T7 and anti c-myc antibodies. In all cases, the left panel 
shows the control of the immunoprecipitation procedures (IP: anti-T7, Blot: anti-T7) whereas the 
right panel reports the interaction between the two proteins (IP: anti-T7, Blot: anti-c-myc). 
In all the experiments, lane 1 corresponds to the fraction eluted from anti-T7 antibody beads, lane 
3 shows the corresponding fraction eluted from agarose beads as negative control while lane 2 
contains the purified T7 and/or c-myc tagged form of the individual proteins. 
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In bacterial cells, regulation of 
ribosomal RNA (rRNA), which 
accounts to more than 90% of total 
RNA, is crucial for metabolic and 
energetic balance. Consistent with 
such an important role, ribosomal RNA 
gene transcription is tightly regulated. 
However, it is likely that not all the 
factors controlling rRNA transcription 
initiation, processing and modification 
have been identified to date.  
In the last decade, a considerable 
amount of attention has been given to 
an A+T-rich promoter sequence, the 
so-called UP element, located 
upstream of the core promoter region. 
In the E. coli ribosomal rrnB P1 
promoter, the UP element is located in 
a region spanning the -40 and -60 
positions, and is able to increase 
transcription from 30 to 70 fold by 
acting as a binding site for the α 
subunit of RNA polymerase (18). This 
element is a potential target for 
regulation of rRNA transcription by 
binding other putative factors able to 
modulate RNA polymerase activity. 
Indeed, a large number of promoters 
subjected to complex regulation 
possess strong α−binding sites (26-
28).  
In this work, we used a double 
stranded DNA oligonucleotide carrying 
the UP element and the -35 sequence 
of the rrnB P1 promoter as a bait to 
isolate the transcription complexes that 
gather at this promoter and to identify 
its components. Altogether, we were 
able to identify 27 different proteins by 
mass spectrometry methodologies. 
Interestingly, several of the identified 
proteins were already known to 
interact, either from data obtained from 
the literature, or from databases such 
as IntAct 
(http://www.ebi.ac.uk/intact/site/index.j
sf), thus suggesting that they might be 
indeed involved in functional networks. 
According to their reported biological 
activities, the various promoter 
interactors can be grouped into three 
functional categories: DNA binding 
proteins and transcription factors, 
RNA-binding and translation factors, 
and cell metabolism-related proteins. 
As expected, we found the 
components of E. coli RNA 
polymerase, with the exception of σ70, 
suggesting that, despite the presence 
of the -35 sequence, binding to the 
“UP35” oligonucleotide is mediated by 
core RNA polymerase, probably via 
interaction between the α subunit and 
the UP element. Despite the “UP35” 
oligonucleotide being an artifactual 
system, reports of RNA polymerase 
binding to promoter independent of σ70 
interaction with core promoter 
elements would support this model 
(26,29 and unpublished data). 
However, it should be considered that 
σ70 might have also escaped 
identification in the proteomic 
experiment simply because of 
technical reasons. 
An important component of the protein 
complex isolated at the upstream 
elements of the rrnB P1 promoter is 
represented by ribosomal proteins, 
which would suggest that the ribosome 
assembles with RNA polymerase at 
bacterial promoters. This model would 
be in agreement with various 
observations on direct protein-protein 
interaction between RNA polymerase 
subunits and ribosomal proteins 
(30,31), and with reports on 
multifunctional roles of protein 
synthesis factors (32). In addition, our 
results provide biochemical evidence 
that are consistent with known 
mechanisms of cross-talk between the 
ribosome and RNA polymerase, such 
as attenuation and stringent response. 
Indeed, direct interaction between 
transcription and translation 
machineries would greatly facilitate this 
genetic processes: for instance, ppGpp 
synthesis by ribosomal proteins RelA 
and SpoT would be relayed more 
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efficiently to RNA polymerase if both a 
ribosome and RNA polymerase are 
part of the same protein complex.  
Enzymes active in cell metabolism 
(e.g. FabZ, LpdA), as well as proteins 
involved in RNA modification (e.g. 
RluC) or post-translational maturation 
of nascent peptides (e.g. DnaJ, La) 
might be recruited to the transcription 
complex either by transcription factors 
or by ribosomal proteins, as suggested 
by our co-immunoprecipitation 
experiments (Fig. 3).  
Another interesting scenario is based 
on the nature of the DNA-binding 
proteins found in the “UP35”-binding 
complex. The H-NS protein is the only 
bona fide transcription regulator and it 
binds curved DNA regions with a 
strong preference for A/T rich 
stretches. The H-NS protein is a trans-
acting regulatory factor that negatively 
modulates the transcription of several 
ribosomal RNA genes by binding to the 
upstream sequence of their respective 
promoters. This protein is 
overexpressed during the stationary 
phase when the synthesis of rRNAs 
has to be decreased (33). In contrast 
to H-NS, both AidB and Dps are non-
specific DNA binding proteins (25,34) 
involved in the response to alkylation 
and oxidative damage, respectively. In 
this work, we suggest potential roles 
for the AidB protein in transcription 
complexes. AidB belongs to the 
adaptive response to alkylating agents 
(35,36 and references therein), which 
is defined by the Ada regulon including 
ada itself, alkA, alkB and aidB genes. 
The repair mechanism is governed by 
the Ada protein, that can repair O6-
methylated guanidine residues and 
acts upon self-methylation as a 
transcription activator of the ada-alkB 
operon and the alkA and aidB 
promoters (reviewed in 37). In contrast 
to the situation for DNA repair proteins 
Ada, AlkA, and AlkB, the role of AidB in 
the adaptive response is still 
uncharacterized. AidB has been 
proposed to repair alkylated DNA or 
detoxify alkylating reagents (25,38,39). 
Findings reported here demonstrated 
that AidB can establish direct protein-
protein interaction with other 
components of the rrnB P1 promoter 
binding complex, including H-NS. 
Interaction with H-NS might re-direct 
AidB binding towards curved DNA or 
A/T rich regions, thus recruiting AidB to 
transcription initiation complexes. The 
role of AidB might be related to repair 
of single strand DNA: indeed, single 
strand DNA has been demonstrated to 
undergo alkylation processes much 
quicker than double strand molecules 
even in the absence of oxidative stress 
(40). During transcription, the 
transcriptional fork generates single 
strand DNA molecules that might be a 
target for endogenous alkylating 
agents. In this respect, the recruitment 
of AidB and its related enzymes 
activities directly onto the promoter 
might prevent alkylation to damage the 
transcription process. Another 
intriguing, but perhaps more unlikely 
possibility could be that AidB might be 
recruited to this specific promoter to 
counteract alkylation of the nascent 
rRNA molecule. Both hypotheses are 
currently being investigated. 
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ABSTRACT  
Upon exposure to alkylating agents, 
Escherichia coli increases expression 
of aidB along with three genes (ada, 
alkB, and alkA) that encode DNA 
repair proteins. Despite extensive 
efforts, the molecular mechanism by 
which AidB protects against the 
mutagenic effects of DNA alkylators 
remains elusive. In this study, we 
assigned a biological role to AidB 
protein in the cell not exposed to 
alkylating agents. AidB was shown to 
possess a high affinity for ada/alkB, 
alkA and aidB promoters containing an 
upstream element, an AT rich 
transcriptional enhancer sequence. 
The physiological significance of this 
specific binding was investigated by in 
                                                 
*Corresponding Author:  
Angela Duilio 
Dipartimento di Chimica Organica e 
Biochimica, 
Complesso Universitario di Monte 
Sant’Angelo  
Via Cinthia 4 
80126 Napoli (Italy). 
Tel +39-081674314 
Fax +39081674313; 
email: anduilio@unina.it
 
vivo transcription assays. The results 
clearly demonstrated that AidB 
represses its own synthesis during 
normal cell growth. Another objective 
of this study was to define and 
characterize the domain architecture of 
AidB. The N-terminal region consisting 
of the first 439 residues was shown to 
exhibit isovaleryl-CoA dehydrogenase 
activity and to purify as a tetramer; the 
C-terminal region corresponding to 
residues 440-541 was determined to 
possess DNA binding activity, to purify 
as a monomer and to function as a 
transcriptional repressor in vivo. Thus, 
we demonstrated that the AidB protein 
is a modular transcription factor which 
requires the short C-terminal region for 
its regulatory function. 
 
Keywords: AidB protein, adaptive 
response genes, upstream element, 
transcription regulation. 
 
Running title: Transcriptional role of 
AidB protein in Escherichia coli. 
 
INTRODUCTION 
Transcription regulation is one of the 
principal strategies used by bacteria to 
respond to external stimuli and to 
adapt to a changing environment. 
Exposure of Escherichia coli to 
sublethal concentrations of alkylating 
agents such as methyl 
methanesulfonate (MMS) stimulates 
the expression of four genes, ada, 
alkB, alkA, and aidB. The activation of 
these genes confers increased cellular 
resistance to the mutagenic and 
cytotoxic effects of alkylating agents 
and is known as the adaptive response 
(Karran, P. et al., 1982; Kataoka, H. et 
al.,1983; Nakabeppu, Y. et al., 1984; 
Volkert, M.R. and Nguyen, D.C. 1984). 
The Ada protein is the key enzyme of 
this process; Ada acts both as a 
methyltransferase able to remove 
methyl groups from damaged DNA and 
as a transcriptional activator for the 
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adaptive response genes (Teo, I. et al., 
1986; Nakabeppu, Y. et al., 1984; 
Landini, P. and Volkert, M.R. 1995). 
AlkA is a DNA glycosylase that 
catalyzes the base excision repair of 
alkylpurines (Nakabeppu, Y. et al., 
1984). AlkB is an α-ketoglutarate-
Fe(II)-dependent DNA dioxygenase 
that repairs 1-methyladenine and 3-
methylcytosine lesions by oxidative 
demethylation (Trewick, S.C. et al., 
2002). Despite detailed understanding 
of Ada, AlkA, and AlkB, the mechanism 
by which AidB protects against DNA 
damage in the adaptive response 
remains elusive. It has been suggested 
that AidB may act as a detoxification 
enzyme to destroy certain alkylating 
reagents or as a DNA repair enzyme 
(Landini, P. et al., 1994; Landini, P. 
and Volkert, M.R. 1995).  
AidB is a protein of 541 amino acids 
that is related in sequence to acyl-CoA 
dehydrogenases (ACADs), a family of 
enzymes which use a flavin adenine 
dinucleotide (FAD) to catalyze the α,β-
dehydrogenation of acyl-CoA 
conjugates (Landini, P. et al., 1994; 
Rohankhedkar, M.S., et al., 2006). 
Recently, AidB has been shown to bind 
stoichiometric amounts of redox active 
FAD and to exhibit weak isovaleryl-
CoA dehydrogenase (IVD) activity 
(Landini, P. et al., 1994; 
Rohankhedkar, M.S., et al., 2006). 
Subsequent structural studies revealed 
a distinctive FAD active site that 
provides a rationale for AidB’s limited 
acyl-CoA dehydrogenase activity. AidB 
was also shown to bind double strand 
DNA independently of its sequence 
(Rohankhedkar, M.S., et al., 2006). 
However, recently we demonstrated 
that AidB is part of the protein complex 
that binds to the -35 and upstream 
elements of the ribosomal rrnB P1 
promoter but not to sequences lacking 
the UP element  (Amoresano et al., 
submitted for publication), an AT rich 
transcriptional enhancer sequence. 
This result suggested that AidB might 
possess sequence-specific binding. 
Since the -60 to -40 regions of 
ada/alkB, alkA and aidB promoters 
resemble the rrnB P1 UP element in 
A/T content and location relative to the 
core promoter (Landini, P. et al., 1998), 
we supposed that AidB protein might 
specifically interact with the promoters 
of the Ada-regulated adaptive 
response.  
In this work, we show that AidB 
displays a high affinity for UP regions 
of Pada/alkB, PalkA and PaidB. The 
functional significance of this specific 
binding was investigated by in vivo 
transcription assays using lacZ as 
reporter gene. AidB was shown to 
repress its own synthesis during 
normal cell growth.  
Another objective of this study was to 
define and characterize the domain 
architecture of AidB. The N-terminal 
region consisting of the first 439 
residues was shown to exhibit 
isovaleryl-CoA dehydrogenase activity; 
the C-terminal region corresponding to 
residues 440-541 was determined to 
possess DNA binding activity and to 
function as a transcriptional repressor 
in vivo. Thus, the results reported here 
showed that the AidB protein is a 
modular transcription factor which 
requires the short C-terminal region for 
its regulatory function. 
 
MATERIALS AND METHODS 
Bacterial strains and plasmids. 
The bacterial strains, the plasmids and 
the oligonucleotides used in this work 
are listed in Table 1. Plasmids 
pMV132H, pSL101 and pSL112 were a 
kind gift from P. Landini (University of 
Milan, Italy). MV1161, MV5924, 
MV1601, MV6608 MV1571 and 
MV6607 E. coli strains were a kind gift 
from M. Volkert (University of 
Massachusetts, Worcester, MA). 
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 edia and chemicals. 
uria-Bertani or nutrient broths (for 
acterial cultures and plating) and 
uspension medium (for bacterial 
ilutions) were used as described by 
iller (Miller, J.H. 1972). Ampicillin and 
anamycin (Sigma) were used at 100 
nd 50 µg/ml, respectively. 
onstruction of the expression 
lasmids. 
he aidB, aidB∆Ct and Ct-aidB genes 
ere amplified from DNA genomic of 
. coli K12 by polymerase chain 
eaction (PCR) using the forward and 
everse primers listed in Table 1. The 
mplified fragments were digested with 
he restriction enzymes underlined in 
able 1 and cloned into the expression 
ector pET28a (Novagen) which was 
inearized with the same restriction 
nzymes. The resulting plasmids, 
esignated as listed in Table 1, were 
erified by automated DNA 
equencing. 
or the complementation experiments, 
he aidB, aidB∆Ct and Ct-aidB genes 
ere cloned into the expression vector 
ET28a-Plac. The lac promoter was 
mplified from DNA genomic of E. coli  
by PCR using the primers listed in 
Table 1. The amplification product was 
digested with SphI and BamHI and 
cloned into the pET28a (+) plasmid. 
Then the aidB, aidB∆Ct and Ct-aidB 
genes were positioned downstream of 
the lac promoter. Plasmid construction 
was verified by automated DNA 
sequencing.  
 
Production and purification of  
recombinant proteins. 
The constructs pET28a-aidB, pET28a-
aidB∆Ct, pET28a-Ct-aidB (Table 1) 
were individually transformed into the 
E. coli strain C41 (DE3). The 
recombinant cells were grown at 25°C 
to an optical density at 600 nm of        
~0.5, at which time 0.05 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG) 
was added and the cultures were 
allowed to grow until the OD600 
reached 3.0. Cells were harvested by 
centrifugation at 5000 x g for 15 min at 
4°C, resuspended in buffer A (50 mM 
Na2HPO4, pH 7.4, 0.3 M NaCl, 10 mM 
imidazole, 1 mM PMSF), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C.Table 1: Bacterial strains, plasmids and oligonucleotides
Strains/plasmids 
 
Description                                                                                
 
 Reference or 
source  
E. coli strains 
C41 (DE3)     
 
Strain that derives from BL21 [F-ompT hsdSB (rB- mB-) gal dcm 
(DE3)]. This strain has at least one uncharacterized mutation 
that prevents cell death associated with expression of many 
toxic recombinant proteins     
  
Miroux and  
Walker, 1996 
MV1161 rfa-550 derivative of AB1157 that carries the following 
additional markers: argE3 hisG4 leu-6 proA2 thr-1 ara-14 
galK2 lacY1 mtl-1 xyl-5 rpsL31 supE44 tsx-6 rfa-550 
 Volkert 
MV5924 Strain derivative of MG1655 in which the aidB gene had been 
inactivated by a tetracycline resistance cassette 
 Volkert 
MV1601 Strain carrying a lacZ transcriptional insertion within the 
chromosomal alkB gene 
 Volkert 
MV6608 Strain harboring the aidB mutation in the alkB::lacZ 
background 
 Volkert 
MV1571 Strain harboring lacZ fragment in the chromosomal alkA gene  Volkert 
MV6607 Strain harboring the aidB mutation in the alkA::lacZ 
background 
 Volkert 
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The recombinant proteins were purified 
by affinity chromatography on His-
Select Nickel Affinity Gel (Sigma). The 
lysate was loaded onto His-Select 
Nickel Affinity Gel equilibrated with 
equilibration buffer (50 mM Na2HPO4, 
pH 7.4, 0.3 M NaCl, 10 mM imidazole). 
After 1 min of incubation at 4°C, the 
matrix was collected by centrifugation 
at 11000 x g for 1 min and washed 3 
times with same equilibration buffer. 
The recombinant proteins were eluted 
with buffer containing 250 mM 
imidazole in 50 mM Na2HPO4, pH 7.4, 
pET28a(+) Plasmid carrying an N-terminal His•Tag®/thrombin/T7•Tag® 
configuration plus an optional C-terminal His•Tag sequence  
 Novagen
pET28a-aidB pET28a∆(BamHI-HindIII)Ω(aidB gene)  This work
pET28a-aidB∆Ct  pET28a∆(BamHI-HindIII)Ω(aidB∆Ct gene)  This work
pET28a-Ct-aidB pET28a∆(BamHI-XhoI)Ω(Ct-aidB gene)  This work
pET28a-Plac pET28a∆(SphI-BamHI)Ω(lac promoter)  This work
pET28a-Plac-aidB pET28a-Plac∆(BamHI-HindIII )Ω(aidB gene)  This work
pET28a-Plac-aidB∆Ct  pET28a-Plac∆(BamHI-HindIII )Ω(aidB∆Ct gene)  This work
pET28a-Plac-Ct-aidB pET28a-Plac∆(BamHI-XhoI)Ω(Ct-aidB gene)  This work
pMV132H Plasmid carrying lacZ fusion under the control of the wild type 
PaidB 
 Landini 
pSL101 Plasmid derivative of  pJCD01 carrying a 242 bp fragment of 
the wild type PaidB  
 Landini 
pSL112  Plasmid derivative of  pJCD01 carrying a 238 bp  fragment of 
the mutant PaidB in which -12C has been substituted with the 
residue T 
 Landini 
 
Oligonucleotides 
 
UP35 PaidB Fw 5'-GATAAGAATGTTTTAGCAATCTCTTTCTGTCA-3' 
UP35 PaidB Rv 5'-TGACAGAAAGAGATTGCTAAAACATTCTTATC-3' 
UP35 Pada Fw 5'-GCGAAAAAAATTAAAGCGCAAGATTGTTGGTT-3' 
UP35 Pada Rv 5'-AACCAACAATCTTGCGCTTTAATTTTTTTCGC-3' 
UP35 PalkA Fw 5'-TTGCCGTCGCGACAACCGGAATATGAAAGCAA-3' 
UP35 PalkA Rv 5'-TTGCTTTCATATTCCGGTTGTCGCGACGGCAA-3' 
Neg PaidB Fw 5’-ATGAATGTACTGTATCTAGTCTACTAGTATCT-3’ 
Neg PaidB Rv 5’-AGATACTAGTAGACTAGATACAGTACATTCAT-3’ 
Neg Pada Fw 5'-TAGACTTGATCAGATGAGATGAAGTACAGATA-3' 
Neg Pada Rv 5'-TATCTGTACTTCATCTCATCTGATCAAGTCTA-3' 
Neg PalkA Fw 5'-AGTCACTGTCAGTCACAGTACAGACGACGAGA-3' 
Neg PalkA Rv 5'-TCTCGTCGTCTGTACTGTGACTGACAGTGACT-3' 
PleuA Fw 5’-GGGTTGACATCCGTTTTTGTATCCAGTAACTC-3’ 
PleuA Rv 5’-GAGTTACTGGATACAAAAACGGATGTCAACCC-3’ 
aidB Fw 5'-ATAGGATCCGTGCACTGGCAAACTCACACCG-3' 
aidB Rv 5'-CGCGAGCTCCGTAAGCTTTTACACACACACTC-3' 
aidB∆Ct Fw 5'-ATAGGATCCGTGCACTGGCAAACTC-3' 
aidB∆Ct Rv 5'-AATAAGCTTTTAGAGAACGCGCAACACATC-3' 
Ct-aidB Fw 5'-ATAGGATCCAATAAGCAAGCGGGCG-3' 
Ct-aidB Rv 5'-TTACTCGAGTTACACACACACTCCCC-3' 
Plac Fw 5’-TAAAGCATGCTTTACACTTTATGCTTCCGGTCGTATGTTGTGTGGAAAGCTTTTA-3’ 
Plac Rv 5’-TAAAAGCTTTCCACACAACATACGACCGGAAGCATAAAGTGTAAAGCATGCTTTA-3’ 
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0.3 M NaCl. Protein concentration was 
estimated with Bradford reagent (Bio-
Rad protein assay) and protein content 
was checked by SDS-polyacrilamide 
gel electrophoresis (SDS-PAGE).  
 
In vivo transcription assays. 
MV1161 (wild type) and MV5924 
(∆aidB) E. coli strains were 
transformed with reporter plasmid 
pMV132H carrying the lacZ gene 
under the control of PaidB. The 
complementation experiments were 
performed by transforming MV5924 
containing pMV132H with the following 
constructs: pET28a-Plac-aidB, 
pET28a-Plac-aidB∆Ct, pET28a-Plac-
Ct-aidB. These bacterial cultures 
grown overnight in LB medium at 37°C, 
were diluted 1:100 in fresh medium. At 
an A600 nm of 0.4, the cultures were 
divided in two aliquots, and one was 
supplemented with 0.04% MMS to 
activate the adaptive response. 
Cellular pellets were collected during 
the exponential growth phase. The 
cells were resuspended in 50 mM 
Na2HPO4 (pH 7.4), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C. The supernatant was collected 
and protein concentration was 
determined with the Bio-Rad protein 
assay (Bradford, M.M. 1976), using 
bovine serum albumine as standard. β-
galactosidase activity was determined 
by measuring ONPG-hydrolysis, as 
described by Miller (Miller, J.H., 1972). 
In vivo transcription from the ada 
promoter region was measured using 
both MV1601 and MV6608 strains; to 
measure in vivo transcription from the 
alkA promoter we used both MV1571 
and MV6607 strains. 
 
In vitro transcription assays. 
Transcription experiments were 
performed on two different DNA 
templates: plasmid pSL101 containing 
wild type PaidB and plasmid pSL112 
carrying mutant PaidB with a C-T 
substitution at position -12. Plasmids (5 
nM) and RNA polymerase holoenzyme 
(120 nM) (Epicentre Technology) were 
incubated for 20 min at 37°C, in a 
solution of 40 mM Hepes pH 8.0, 10 
mM magnesium chloride, 200 mM 
potassium glutamate, 4 mM 
dithiothreitol  and 100 µg/ml bovine 
serum albumin in the absence and in 
the presence of  increasing quantities 
of the AidB protein (0.1-0.4 µg). 
Elongation step was started by the 
addition of a pre-warmed mixture 
containing nucleotides and heparin 
(final concentrations were 500 µM 
ATP, GTP and CTP, 30 µM UTP, 1 µCi 
of [α32P]UTP and 500 µg/ml heparin) to 
the template-polymerase mix  and 
allowed to proceed for 10 min at 37°C. 
The reactions were stopped by the 
addition of stop solution (10 mM EDTA, 
0.5% bromophenol blue, 0.025% 
xylene cyanol). After heating to 65°C, 
samples were subjected to 
electrophoresis on a 7% denaturing 
polyacrilamide gel in 0.5 X Tris borate-
EDTA. Transcripts were detected by 
exposure to X-ray film overnight at       
-80°C.  
 
Native molecular mass of AidB∆Ct and 
Ct-AidB. 
Size exclusion chromatography was 
performed by using a Superdex 200 
PC 3.2/30 (for AidB∆Ct) and a 
Superdex 75 PC 3.2/30 (for Ct-AidB) 
column (GE Healthcare) equilibrated in 
buffer containing 50 mM Tris-HCl, 150 
mM NaCl, pH8. The molecular mass of 
the native proteins was estimated by 
comparing their retention time to those 
of molecular mass standards 
(thyroglobulin, 670,000 Da; bovine γ-
globulin, 158,000 Da; chicken 
ovalbumin, 44,000 Da; equine 
myoglobin, 17,000 Da; vitamin B12, 
1,350 Da; Bio-Rad). 
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Isovaleryl-CoA dehydrogenase activity 
assay.
Isovaleryl-CoA dehydrogenase activity 
assays were carried out at room 
temperature in 200 mM phosphate 
buffer, pH 8.0, and using purified 
recombinant proteins that had been 
dialyzed to remove imidazole. For 
routine assays, 2 mM isovaleryl-CoA 
(Sigma) was used as the substrate and 
0.1 mM 2,6-dichlorophenolindophenol 
(DCPIP) was used as the terminal 
electron acceptor in a final volume of 
300 µl. The change in absorbance at 
600 nm was monitored by using a 
Beckman DU 7500 spectrophotometer, 
and the enzyme activity was calculated 
by assuming an extinction coefficient of 
20.6 mM−1 cm−1 for DCPIP (Engel, 
P.C., 1981). 
 
Electrophoretic shift mobility assays. 
Annealed DNA oligonucleotides 
(fragments UP35 PaidB, UP35 Pada, 
UP35 PalkA, Neg PaidB, Neg Pada, 
Neg PalkA) were 32P labelled at 5’ 
positions by using T4 polynucleotide 
kinase (20 units). Electromobility shift 
assays were performed in 20 µl 
reaction volume. AidB protein (2 pmol) 
was incubated with the 32P-labelled 
DNA (2 ng, 50,000-100,000 cpm) in 
buffer Z (25 mM HEPES pH 7.6, 50 
mM KCl, 12.5 mM MgCl2, 1 mM DTT, 
20% glycerol, 0.1% triton), for 20 min 
at RT. Mixtures were then analysed by 
electrophoresis on 8% native 
polyacrylamide gel (29:1 cross-linking 
ratio) in 45 mM Tris pH 8.0, 45 mM 
boric acid, 1 mM EDTA. 
Electrophoreses were performed at 
room temperature at 200 V (20 V/cm). 
The gels were dried and analysed by 
autoradiography.  
For EMSA performed by using 
biotinylated UP35 PaidB, protein-DNA 
complexes were separated on 8% 
nondenaturing polyacrylamide gels. 
After electrophoresis, gels were 
transferred to nylon membranes and 
transferred DNA was immobilized by 
UV crosslinking for 3 min. For 
detection of bound DNA, membranes 
were blocked using blocking buffer 
followed by the addition of 
Streptavidin-HRPO and blots were 
developed according to the 
manufacturer’s instructions 
(Amersham, Arlington Heights, IL, 
U.S.A.).  
 
RESULTS 
AidB shows a high affinity for upstream 
regulatory regions.  
In a previous report (Rohankhedkar et 
al., 2006), it was shown that AidB 
binds double strand DNA 
independently of its sequence. 
However, our recent work 
demonstrated that AidB is part of the 
protein complex that gathers at the -35 
and UP elements of the rrnB P1 
promoter but not at identical 
sequences lacking the UP element 
(Amoresano et al., submitted for 
publication). This result suggested that 
AidB might possess sequence-specific 
binding. Since the -60 to -40 regions of 
ada/alkB, alkA and aidB promoters 
resemble the rrnB P1 UP element in 
A/T content and location relative to the 
core promoter (Landini et al., 1998), 
we supposed that AidB protein might 
specifically interact with the promoters 
of the Ada-regulated adaptive 
response. This hypothesis was 
investigated by electrophoresis mobility 
shift gel assays (EMSA). To this aim, 
the aidB gene was cloned into a 
commercial expression vector of the 
pET series and the recombinant 
protein was expressed as chimeric 
protein bearing a 6 His tag at the C-
terminus. The expressed protein was 
then purified by affinity 
chromatography on Ni2+-agarose 
beads and its homogeneity was tested 
by SDS-PAGE and mass fingerprinting 
analyses. EMSA experiments were 
carried out using three different 
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Competitor 
 
UP35 PaidB      -      100    500     -        -  
PleuA               -        -         -     100    500 
   1     2   3   4   5
 
Fig. 1. Gel retardation experiments performed incubating the AidB protein with the UP35 PaidB; 
competitors were included as indicated. Lane 1: AidB protein incubated with UP35 PaidB. Lane 2-
3: Competition assay with UP35 PaidB (100x-500x) as a specific competitor. Lane 4-5: 
Competition assay with PleuA as a non specific competitor (100x-500x). 
radiolabelled DNA fragments 
corresponding to the UP region and 
the -35 box of the aidB, ada/alkB and 
alkA promoters (“UP35 PaidB”, “UP35 
Pada”, “UP35 PalkA”, Table 1). The 
randomised version of each UP35 
probe, i.e. an oligonucleotide with the 
same nucleotide content as UP35, but 
lacking any known promoter or 
regulatory elements (“Neg PaidB”, 
“Neg Pada”, “Neg PalkA”, Table 1), 
was also used in EMSA experiments. 
As expected, addition of AidB retarded 
the migration of both the UP35 DNA 
fragments and the “Neg” probes (data 
not shown). The specificity of AidB 
binding to the three UP35 probes was 
tested by competition experiments: the 
radiolabelled “UP35” probes were 
incubated with the AidB protein and 
increasing quantities (100-500 fold) of 
either unlabelled “UP35” (used as a 
specific competitor) or PleuA (a 
promoter lacking the UP element used 
as a non specific competitor), were 
added to the reaction mixture. The  
Fig. 1 shows that the binding to the 
radiolabelled “UP35 PaidB” by AidB 
was reversed by an excess of 
unlabelled “UP35” (Lanes 2-3), while it 
was not affected by competition with 
identical concentrations of PleuA 
(Lanes 4-5). Analogous experiments 
showed the specific interaction of AidB 
with “UP35 Pada” and “UP35 PalkA” 
(data not shown). Altogether, these 
results demonstrated that AidB 
possesses high binding affinity for the 
upstream regions of the adaptive 
response genes. 
 
AidB acts as a transcriptional repressor 
in vivo.  
In order to determine whether the 
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Fig. 2. In vivo transcription from the aidB promoter. Vector pMV132H was introduced into MV1161 
(wild type) and MV5924 (∆aidB) E. coli strains and the β-galactosidase specific activity was 
determined in the absence (A) and in the presence (B) of 0.04% MMS as alkylating agent. MV5924 
strain was also transformed with plasmid pET28a-Plac-aidB producing functional AidB protein and 
the corresponding β-galactosidase activity was evaluated. Means and standard deviations have 
been calculated from four independent assays. 
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specific binding of AidB to PaidB, Pada 
and PalkA might be of biological 
significance, we tested its effect on 
transcription from these promoters by 
in vivo β-galactosidase reporter 
assays. The putative AidB activity on 
its promoter was investigated by 
transforming both MV1161 (wild type) 
and MV5924 (∆aidB) E. coli strains 
with plasmid pMV132H carrying the 
gene coding for the β-galactosidase 
under the control of the aidB promoter. 
These strains were grown in LB 
medium, in the absence and in the 
presence of sub-inhibitory 
concentrations of the alkylating agent 
methyl methane sulfonate (MMS) and 
the β-galactosidase activity was 
monitored during the exponential 
growth phase. As shown in Fig. 2A, 
during the growth in LB medium, the 
∆aidB strain exhibited levels of β-
galactosidase activity 13-fold higher 
than that observed in the wild type 
cells, suggesting that transcription from 
the aidB promoter is repressed by AidB 
during normal cell growth. The 
complementation of the ∆aidB mutation 
by pET28a-Plac-aidB restored 
transcription levels from the aidB 
promoter to wild type levels. These 
data clearly demonstrated that in the 
absence of DNA alkylation damage, 
the AidB protein is required for 
repression of its own expression. 
Exposure to sub-inhibitory 
concentrations of MMS, as expected, 
resulted in an increase of aidB 
promoter activity (comparison between 
Figs. 2A and 2B). Interestingly, the 
transcription levels in the ∆aidB strain 
were slightly higher (by almost 2.5-fold) 
than that observed for the wild type 
cells suggesting that the activator 
methylated Ada, in the absence of 
AidB, is more efficient in activating 
transcription of the aidB gene. This 
effect could be due to the competition 
between AidB and methylated Ada for 
binding to same site on the aidB 
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promoter. In fact, gel retardation 
experiments performed in this work 
have demonstrated that AidB is able to 
bind to a region of PaidB extending 
from the upstream element to the -35 
box and previous studies (Landini, P. 
and Volkert, M.R. 1995) have found 
that methylated  Ada protects the 
residues from -62 to -38 in the aidB 
promoter. 
Successively, we evaluated the AidB 
activity on the ada promoter (which 
controls expression of the ada and 
alkB genes) and the alkA promoter. In 
vivo transcription from the ada 
promoter region was measured using 
both MV1601 strain carrying a lacZ 
transcriptional insertion within the 
chromosomal alkB gene and MV6608 
strain harboring the aidB mutation in 
the alkB::lacZ background. To 
measure in vivo transcription from the 
alkA promoter we used MV1571 strain 
which has a chromosomal lacZ operon 
fused to the alkA promoter and its aidB 
mutant derivative MV6607. We did not 
observe any effect of the aidB deletion 
on lacZ expression driven by the ada 
and alkA promoters: during normal cell 
growth, the β-galactosidase catalytic 
activities determined in the ∆aidB 
strains were low and similar to that 
resulting from the wild type strains 
(data not shown). Thus, we could not 
assign any role to AidB protein in 
transcription regulation of ada, alkB 
and alkA genes, although gel 
retardation assays have shown specific 
interaction between AidB and 
promoters under study.  
 
In vitro regulatory activity of AidB. 
The transcriptional activity of the AidB 
protein on its promoter was further 
investigated through in vitro 
transcription assays using E. coli RNA 
polymerase holoenzyme. Although 
RNA polymerase σ70 (Eσ70) is able to 
bind to the aidB promoter region in the 
absence of additional factors, it can 
initiate transcription efficiently only in 
the presence of the activator protein 
Ada (Landini, P. and Volkert, M.R. 
1995). Studies performed by Lacour et 
al., (2002) have shown that Eσ70, in the 
absence of others factors, is able to 
activate transcription from a mutant 
form of the aidB promoter in which the 
residue C at position -12 has been 
substituted with the nucleotide T. For 
this reason, in vitro transcription 
assays were carried out by using two 
different DNA templates: plasmid 
pSL101 containing wild type PaidB and 
vector pSL112 carrying mutant PaidB 
with a C-T substitution at position -12. 
The results of these experiments are 
shown in Fig. 3. Two distinct gel bands 
were detected when the RNA 
polymerase σ70 was incubated with the 
plasmid pSL112 containing mutant 
PaidB (Fig. 3, Lane 2). The upper band 
is relative to the aidB transcript while 
the lower band corresponds to the 
transcript of the RNA I promoter used 
as an internal control. The upper band 
is rather weak when the RNA 
polymerase σ70 was incubated with the 
plasmid pSL101 (Fig. 3, Lane 1) 
because, as described above, Eσ70 
requires the activator Ada protein to 
initiate transcription efficiently from the 
wild type aidB promoter. When 
increasing quantities (0.1-0.4 µg) of the 
AidB protein were added to the 
transcription reaction containing vector 
pSL112, the band corresponding to the 
aidB transcript clearly disappeared 
(Fig. 3, Lanes 3-6) while the transcript 
of the RNA I promoter was not affected 
by the presence of AidB. In agreement 
with the results of the in vivo 
transcription experiments, AidB was 
shown to be involved in negative 
regulation of  its own gene. 
 
Characterization of the functional 
domains in AidB. 
Knowledge of the domain architecture 
of the AidB flavoprotein is necessary 
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Fig. 3. In vitro transcription experiments with RNA polymerase at the aidB promoter.  
RNA polymerase σ70 was incubated with the plasmid pSL101 containing wild type PaidB or with the 
plasmid pSL112 containing mutant PaidB, in the absence and in the presence of AidB. Lane 1: 
pSL101. Lane 2: pSL112. Lanes 3-6: pSL112 incubated with 0.1, 0.2, 0.3 and 0.4 µg of AidB. The 
filled arrow head shows the position of the transcript from the aidB promoter. The open arrow head 
indicates the position for the transcript of the RNA I promoter used as an internal control. 
for understanding its potential 
multifunctional properties. Sequence 
analysis showed that the N-terminal 
439 residues of AidB are homologous 
to the acyl-CoA dehydrogenases 
(ACADs) (Ghisla, S. and Thorpe, C. 
2004) and that the C-terminal region 
involving residues 440-541 exhibits 
similarity to a DNA binding domain of 
human topoisomerase I. This region of 
AidB has been defined by the x-ray 
crystal structure as its putative DNA 
binding site. On the basis of these 
observations, we focused our study on 
the identification of the catalytic and 
DNA-binding domains that are required 
for AidB function in vivo. To this aim, 
we synthesized two deletion 
derivatives of the AidB protein: 
AidB∆Ct consisting of the first 439 
residues and Ct-AidB corresponding to 
residues 440-541. The PCR products 
corresponding to two deletion mutants 
were cloned into a commercial 
expression vector of the pET series 
and the recombinant products were 
expressed as chimeric proteins bearing 
a 6 His tag at the C-terminus. The 
expressed proteins were then purified 
by affinity chromatography on Ni2+-
agarose beads and their homogeneity 
was tested by SDS-PAGE and mass 
fingerprinting analyses. The two 
mutant proteins were then 
characterized by size-exclusion 
chromatography. On the basis of its 
retention time and comparison to 
standard proteins, AidB∆Ct was 
estimated to possess a molecular 
mass of 196 KDa: given that the 
predicted molecular mass is around 50 
kDa (including the C-terminal 
hexahistidine tag), AidB∆Ct was 
determined to be a tetramer. In 
contrast, Ct-AidB was shown to purify 
as a monomer.  
Successively, the functional 
characterization of these deletion 
mutants was performed examining 
their DNA binding and enzymatic 
properties. To identify the catalytic 
domain, the isovaleryl-CoA 
dehydrogenase (IVD) activity of 
AidB∆Ct and Ct-AidB was examined 
55 
 
Table 2: Isovaleryl-CoA dehydrogenase activity of the full length and mutant AidB proteins was 
assayed as described in Materials and Methods following the isovaleryl-CoA-dependent reduction of 
he electron acceptor DCPIP. The data shown are averages of 10 measurements. Nd=not detected. t
 
    AidB protein Isovaleryl-CoA dehydrogenase activity 
  µmol min-1 [mg protein]-1
full lenght  0.12 ± 0 
AidB∆Ct  0.12 ± 0 
Ct-AidB  Nd 
 
             1       2         3          4 
 
and compared with that of the full 
length AidB. AidB∆Ct mutant displayed 
low levels of isovaleryl-CoA catalytic 
activity that are identical to that 
exhibited by the full-length AidB protein 
(Table 2) whereas Ct-AidB mutant had 
no detectable enzymatic activity.  
Therefore, as predicted by the 
structural analysis, we have shown that 
the N-terminal region of AidB is 
responsible for catalytic activity.  
To gain insight into the domain that 
interacts with DNA, AidB∆Ct and Ct-
AidB were assayed in vitro for DNA 
binding activity by gel retardation 
assays. These experiments were 
performed using the biotin-labelled 
DNA fragment corresponding to the UP 
region and the -35 box of the aidB 
promoter (“UP35 PaidB”, Table 1). As 
shown in Fig. 4, Ct-AidB exhibited DNA 
binding activity (Lane 4) while AidB∆Ct 
was not able to bind to DNA (Lane 2). 
These experiments clearly 
demonstrated that the C-terminal 
domain alone is sufficient for DNA 
binding activity.  
Finally, the ability of the two mutant 
proteins to repress the transcription of 
the aidB gene  was tested by in vivo β-
galactosidase reporter assays. The 
∆aidB strain was transformed with 
reporter plasmid pMV132H together 
with either pET28a-Plac-aidB∆Ct or 
pET28a-Plac-Ct-aidB.  
E. coli cells were grown in LB medium 
and the β-galactosidase activity was 
monitored and compared with that 
detected in the ∆aidB strain as well as 
in the ∆aidB strain carrying aidB gene 
on the plasmid pET28a. As shown in 
Table 3, Ct-AidB repressed lacZ 
expression with levels of β-
galactosidase activity decreased to 7% 
compared with control cells that lacked 
AidB protein. In contrast, AidB∆Ct was 
not able to repress the PaidB-lacZ 
transcription. These reporter assays 
clearly demonstrated that Ct-AidB acts 
as a transcriptional repressor of the 
aidB gene in vivo.  
 
 
Fig. 4. Gel retardation experiments 
carried out by incubating the full length 
and mutant AidB proteins with the “UP35 
PaidB” probe. Lane 1: UP35 PaidB 
probe. Lanes 2-4: UP35 PaidB fragment 
incubated with AidB∆Ct, AidB and Ct-
AidB proteins, respectively. 
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Table 3: β-galactosidase activity from E. coli strain MV5924 harbouring the lacZ reporter construct 
pMV132H and various aidB gene constructs. Means and standard deviations have been calculated 
rom four independent assays. f 
AidB protein                                 β-galactosidase activity 
  Miller units % 
None    3150 ± 46 100 
AidB      222 ± 32    7 
AidB∆Ct    3162 ± 48 100 
Ct-AidB      225 ± 31    7 
DISCUSSION 
Understanding protein functions as 
well as unravelling cellular 
mechanisms at the molecular level 
constitutes a major challenge in 
modern biology. In this paper, we 
report a new biological role for AidB, a 
component of the E. coli adaptive 
response to alkylating agents. While 
many questions about its function in 
the Ada-regulated response remain, 
we assigned a role to AidB in the cell 
not exposed to alkylating agents. In 
this study, we provided evidence that 
AidB shows a high affinity for the 
upstream regions of Pada/alkB, PalkA 
and PaidB. This observation lead us to 
a line of inquiry concerning its possible 
role in the transcription mechanism. 
This hypothesis was investigated in 
vivo by performing β-galactosidase 
reporter assays in both wild type and 
∆aidB E. coli strains. In the absence of 
alkylation damage, a large increase in 
the lacZ expression driven by aidB 
promoter was observed in the E. coli 
cells lacking AidB as compared to the 
wild type control. In addition, the 
complementation of the ∆aidB mutation 
restored lacZ transcription to wild type 
levels. Taken together, these results 
clearly demonstrated that AidB 
represses its own synthesis during 
normal cell growth. In vitro transcription 
experiments performed by using a 
DNA template containing the aidB 
promoter and in the presence and 
absence of AidB protein confirmed 
these data. Autoregulation of the aidB 
gene might play an important 
physiological role, because to some 
extent mitigates the energetic burden 
of bacterial cell not exposed to 
alkylating agents. In contrast, we were  
not able to assign any role to AidB in 
transcription regulation of ada, alkB 
and alkA genes.  
Another goal of this study was to 
identify and characterize the functional 
domains of AidB. The N-terminal 
region consisting of the first 439 
residues was shown to exhibit the 
same levels of isovaleryl-CoA 
dehydrogenase (IVD) activity as the full 
length protein. The level of IVD activity 
observed in AidB is quite low (Table 2) 
compared to other acyl-CoA 
dehydrogenases: for comparison, 
human isovaleryl-CoA dehydrogenase 
exhibits specific activity of 8.2 to 11.7 
µmol min-1 (mg protein)-1 (Battaile, K.P. 
et al., 1998; Mohsen, A. W. et al., 
1998). Recent structural studies 
revealed several unique features that 
distinguish AidB’s FAD cavity from the 
ACAD active sites despite the 
conservation of their general properties 
(Bowles, T. et al., 2008). These 
observations provided a rationale for 
AidB’s limited acyl-CoA 
dehydrogenase activity, suggesting 
that fatty acyl-CoA are not substrates 
for the enzyme (Rohankhedkar, M.S. 
et al., 2006). The crystal structural of 
AidB has also identified a putative DNA 
binding site located in its C-terminal 
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region. In this work, we verified that the 
C-terminal residues 440-541 comprise 
a domain that is responsible for the 
DNA binding activity. Interestingly, this 
short region was also shown to 
function as a transcriptional repressor 
in vivo. Thus, the results reported here 
showed that the AidB protein is a 
modular transcription factor which 
requires its C-terminal region for 
regulatory function. The identification 
of two structurally and functionally 
independent domains suggests that 
AidB protein might possess 
multifunctional properties. 
Our finding that AidB has 
transcriptional activity does not provide 
any precise information on the possible 
role of the protein in the defence 
against alkylation. AidB has been 
hypothesized to detoxify certain 
alkylating reagents or to repair 
alkylated DNA (Landini, P. et al., 1994; 
Rohankhedkar, M.S. et al., 2006). 
However, numerous and similar 
examples of proteins which have more 
than a biological function have already 
been reported in the literature, i.e. 
Meddows et al., 2005 demonstrated 
that the transcription factor DksA is 
also involved in repair of DNA double-
strand breaks.  
Another intriguing possibility is that 
AidB may stimulate the transcription of 
genes whose products are directly 
responsible for alkylation resistance. 
Therefore, it would be useful to 
perform microarray experiments to 
identify potential novel E. coli genes 
that are regulated by AidB protein in 
response to alkylation damage. 
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ABSTRACT   
Exposure of Escherichia coli to 
alkylating agents activates expression 
of aidB along with three genes (ada, 
alkA, and alkB) that encode DNA 
repair proteins. Despite extensive 
efforts, the molecular function of AidB 
in the response to alkylation damage 
remains uncharacterized. AidB was 
recently shown to be a flavoprotein 
that binds to dsDNA, implicating it as a 
flavin-dependent DNA repair enzyme. 
Subsequent structural studies 
suggested that AidB might protect 
DNA from attack by alkylating agents. 
In this study, we demonstrate that 
AidB prevents DNA damage and that 
it does so in a preferential manner, 
protecting genes adjacent to 
promoters carrying an upstream 
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element, an AT rich transcriptional 
enhancer region. These include many 
of the housekeeping genes required 
for basic metabolic processes, such 
as the rrn operons, suggesting that E. 
coli and possibly other organisms 
preferentially protect subsets of genes 
from DNA damage. 
 
Keywords: AidB protein, alkylating 
agents, DNA protection, UP element. 
 
Running title: Protective role of AidB in 
Escherichia coli. 
 
INTRODUCTION 
Alkylating agents present in the cell 
and in the environment chemically 
modify DNA to produce cytotoxic and 
mutagenic lesions. Alkylation damage 
to DNA therefore poses a severe threat 
to the stability of the genome and, in 
mammals, can lead to genetic 
diseases and cancer. As a safeguard 
against DNA alkylation damage, all 
organisms have evolved multiple DNA 
repair mechanisms to remove these 
modifications and restore DNA to an 
undamaged state. In addition, bacteria 
employ an inducible response that 
serves to protect cells from changing 
levels of mutagens. In Escherichia coli, 
exposure to sublethal doses of 
alkylating agents such as methyl 
methanesulfonate (MMS), N-
methylnitrosourea (MNU), N-methyl-N′-
nitro-N-nitrosoguanidine (MNNG) and 
N-ethyl-N′-nitro-N-nitrosoguanidine 
(ENNG) stimulates the expression of 
four genes, ada, alkB, alkA, and aidB. 
The activation of these genes confers 
increased cellular resistance to the 
mutagenic and cytotoxic effects of 
alkylating agents and is known as the 
adaptive response (Kataoka, H. et 
al.,1983; Nakabeppu, Y. et al., 1984; 
Volkert, M.R. and Nguyen, D.C. 1984). 
The Ada protein is the key enzyme of 
this process; Ada acts both as a 
methyltransferase able to remove 
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methyl groups from damaged DNA and 
as a transcriptional activator for the 
adaptive response genes (Teo, I. et al., 
1986; Nakabeppu, Y. et al., 1984; 
Landini, P. and Volkert, M.R. 1995). 
AlkA is a double-stranded DNA 
glycosylase that catalyzes the base 
excision repair of a wide variety of 
alkylated bases (Nakabeppu, Y. et al., 
1984); AlkB is an α-ketoglutarate-
Fe(II)-dependent DNA dioxygenase 
that repairs 1-methyladenine and 3-
methylcytosine lesions by oxidative 
demethylation (Trewick, S.C. et al., 
2002). Despite detailed understanding 
of Ada, AlkA, and AlkB, the mechanism 
by which AidB protects against DNA 
damage in the adaptive response 
remains elusive. AidB is related in 
sequence to acyl-CoA 
dehydrogenases (ACADs), which use 
a flavin adenine dinucleotide (FAD) to 
catalyze the α,β,-dehydrogenation of 
acyl-CoA conjugates (Landini, P. et al., 
1994) and it was predicted to function 
in detoxification of alkylating agents. 
AidB was shown to be a flavoprotein 
and to bind to dsDNA implicating it as 
a flavin-dependent DNA repair enzyme 
(Rohankhedkar, M.S., et al., 2006). 
Recently, the crystal structure of AidB 
revealed that its DNA binding site lies 
within an interior channel, while its 
flavin binding site is accessible only 
from the exterior of the protein and is 
spatially distant from the DNA binding 
region (Bowles, T. et al., 2008). Based 
on these observations, it was 
suggested that AidB might bind to DNA 
and protect it by inactivating alkylators 
before they are able to react with their 
DNA target.  
The goal of this study was to determine 
if AidB does in fact protect E. coli cells 
from DNA damage by alkylating 
agents. Here we demonstrate that 
AidB prevents DNA damage and that it 
does so in a preferential manner, 
protecting genes transcribed from 
promoters carrying an upstream 
element, an AT rich transcriptional 
enhancer region. These include many 
of the housekeeping genes required for 
basic metabolic processes, such as the 
rrn operons, suggesting that E. coli and 
possibly other organisms preferentially 
protect subsets of genes from DNA 
damage. 
 
MATERIALS E METHODS 
Bacterial strains and plasmids. 
The bacterial strains, the plasmids and 
the oligonucleotides used in this work 
are listed in Table 1. MG1655 and 
MV5924 E. coli strains were a kind gift 
from M. Volkert (University of 
Massachusetts, Worcester, MA). 
 
Media and chemicals. 
Luria-Bertani or nutrient broths (for 
bacterial cultures and plating) and 
suspension medium (for bacterial 
dilutions) were used as described by 
Miller (Miller, J.H. 1972). Ampicillin 
(Sigma) was used at 100 µg/ml. 
 
Construction of the fusion plasmids for 
transcription assays. 
The rrnB promoter P1 with and without 
its UP element, the leuA and the ompF 
promoter were amplified from DNA 
genomic of E. coli by PCR using the 
primers listed in Table 1. The 
amplification products were digested 
with SphI and HindIII and cloned into 
the reporter pET22b-lacZ plasmid. To 
obtain pET22b-lacZ, the lacZ gene was 
inserted into the pET22b (+) 
expression plasmid (Novagen) 
linearized with HindIII and XhoI. The 
resulting plasmids, designated as listed 
in Table 1, were verified by automated 
DNA sequencing. 
 
In vivo transcription assays. 
MG1655 and MV5924 E. coli strains 
were individually transformed with 
pET22b-lacZ, pET22b-PrrnB(+UP)-
lacZ, pET22b-PrrnB(-UP)-lacZ, 
pET22b-PleuA-lacZ and pET22b-
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Table 1: Bacterial strains, plasmids and oligonucleotides. 
 
Strains/plasmids 
 
 
Description 
 
Reference or
source 
E. coli strains 
C41 (DE3)     
 
Strain that derives from BL21 [F-ompT hsdSB (rB- 
mB-) gal dcm (DE3)]. This strain has at least one 
uncharacterized mutation that prevents cell death 
associated with expression of many toxic 
recombinant proteins     
 
Miroux et al. 
(1996) 
MG1655 F- wild-type K-12 strain Volkert 
MV5924 Strain derivative of MG1655 in which the aidB 
gene had been inactivated by a tetracycline 
resistance cassette 
Volkert  
   
Plasmids   
pET22b(+)  carries an N-terminal pelB signal sequence for 
potential periplasmic localization, plus an optional 
C-terminal His-tag sequence 
Novagen 
pET22b-lacZ  pET22b∆(HindIII-XhoI)Ω(lacZ gene)   This work 
pET22b-PrrnB(+UP)-lacZ pET22b-lacZ∆(SphI-HindIII)ΩPrrnB(+UP) This work 
pET22b-PrrnB(-UP)-lacZ pET22b-lacZ∆(SphI-HindIII)ΩPrrnB(-UP) This work 
pET22b-PleuA-lacZ pET22b-lacZ∆(SphI-HindIII)ΩPleuA This work 
pET22b-PompF-lacZ pET22b-lacZ∆(SphI-HindIII)ΩPompF This work 
   
Oligonucleotides  
lacZ Fw 5'-TGTAAGCTTATAACAATTTCACACAGGAA-3' 
lacZ Rv 5'-CGGCTCGAGTTATTTTTGACACCAGAC-3' 
PrrnB(+UP) Fw 5'-TAAAGCATGCATGTTGCGCGGTCAG-3' 
PrrnB(-UP) Fw 5'-ATTTGCATGCCCTCTTGTCAGGCC-3' 
PrrnB Rv 5'-ATTAAGCTTAGGAGAACCCCGCTGA-3' 
PleuA Fw 5'-ATAAGCATGCGGGTTGACATCCGTT-3' 
PleuA Rv 5’-AAGAAGCTTGATAAAGCGAACGATGTG-3’ 
PompF Fw 5’-ATTTGCATGCACAAAGTTCCTTAAATTTTA-3’ 
PompF Rv 5'-TAAAAGCTTAATAAAAATTTACGGAACTATTG-3' 
PompF-lacZ plasmids. These bacterial 
cultures grown overnight in LB medium 
at 30°C, were diluted 1:100 in fresh 
medium. At an A600 nm of 0.4, the 
cultures were divided in five aliquots: 
one was not supplemented and the 
other four aliquots were supplemented 
with MNNG (5µg/ml), ENNG (5µg/ml), 
MMS 0.04%, and MNU 0.04%, 
respectively. Cellular pellets were 
collected during the exponential growth 
phase. β-galactosidase activity from 
the promoters-lacZ fusions was 
determined by measuring ONPG-
hydrolysis, as described by Miller 
(Miller, J.H. 1972) and was comparable 
with the activity obtained by a 
promoterless lacZ gene. 
 
Production and purification of  AidB 
protein. 
The construct pET28a-aidB 
(Amoresano et al., submitted for 
publication) was transformed into the 
E. coli strain C41 (DE3). The 
recombinant cells were grown at 25°C 
to an optical density at 600 nm of ~ 
0.5, at which time 0.05 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG) 
was added and the culture was 
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allowed to grow until the OD600 
reached 3.0. Cells were harvested by 
centrifugation at 5000 x g for 15 min at 
4°C, resuspended in buffer A (50 mM 
Na2HPO4, pH 7.4, 0.3 M NaCl, 10 mM 
imidazole, 1 mM PMSF), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C. The recombinant protein was 
purified by affinity chromatography on 
His-Select Nickel Affinity Gel (Sigma). 
The lysate was loaded onto His-Select 
Nickel Affinity Gel equilibrated with 
equilibration buffer (50 mM Na2HPO4, 
pH 7.4, 0.3 M NaCl, 10 mM imidazole). 
After 1 min of incubation at 4°C, the 
matrix was collected by centrifugation 
at 11000 x g for 1 min and washed 3 
times with same equilibration buffer. 
The recombinant protein was eluted 
with buffer containing 250 mM 
imidazole in 50 mM Na2HPO4, pH 7.4, 
0.3 M NaCl. Protein concentration was 
estimated with Bradford reagent (Bio-
Rad protein assay) and protein content 
was checked by SDS-polyacrilamide 
gel electrophoresis (SDS-PAGE).  
 
Isolation of plasmid DNA and damage 
assay. 
The MG1655 and MV5924 E. coli 
strains bearing pET22b-lacZ were 
grown overnight in LB medium at 30°C; 
these bacterial cultures were then 
diluted 1:100 in fresh medium. At an 
A600 nm of 0.4, the cultures were divided 
in five aliquots: one was not 
supplemented and the other four 
aliquots were supplemented with 
MNNG (5µg/ml), ENNG (5µg/ml), MMS 
0.04%, MNU 0.04%, respectively. After 
addition of alkylating agent, the 
bacterial cells were allowed to grow for 
3 h; the plasmid DNA was isolated and 
served as a probe for the estimation of 
alkylated bases. The plasmids were 
divided into 2 aliquots, one of which 
was treated with the E. coli AlkA (a 
kind gift from Patrick J. O’Brien) and 
endonuclease IV (NEB); the other 
aliquot did not receive further treatment 
(control). Treatment with AlkA was 
performed in 70 mM MOPS, pH 7.5,    
1 mM EDTA, 1mM DTT, 5% glycerol 
for 30 min at 37°C, followed by 
treatment with Endo IV for 1 h at 37°C. 
Then the samples were subjected to 
electrophoresis in 0.8% agarose gel for 
∼1 h at 80 V using 40 mM Tris, pH 7.8, 
1 mM EDTA buffer. 
 
In vitro DNA binding and damage 
assays. 
An in vitro DNA binding assay was 
conducted incubating pET22b-lacZ 
plasmid (100 ng) with varying 
concentrations of AidB in buffer B (10 
mM Tris, pH 7.8, 1 mM EDTA, 20% 
glycerol), for 1 h at 30°C. Mixtures 
were then analysed by electrophoresis 
in a 0.8% agarose gel using 40 mM 
Tris, pH 7.8, 1 mM EDTA buffer. AidB 
and DNA were mixed at the following 
ratios (w/w): 3:1, 15:1, 30:1. In DNA 
damage assay, AidB (3 µg) was 
incubated with pET22b-lacZ (100 ng) 
for 1 h at 30°C, either before or after 
the addition of 300 mM MMS to the 
reaction mixture. The samples  were 
then treated with AlkA and Endo IV 
and subjected to electrophoresis in 
0.8% agarose gel for ∼1 h at 80 V 
using 40 mM Tris, pH 7.8, 1 mM EDTA 
buffer. 
 
Determination of DNA damage on lacZ 
gene. 
MG1655 and MV5924 E. coli strains 
were individually transformed with 
pET22b-lacZ, pET22b-PrrnB(+UP)-
lacZ, pET22b-PrrnB(-UP)-lacZ. These 
bacterial cultures grown overnight in 
LB medium at 30°C, were diluted 1:100 
in fresh medium. At an A600 nm of 0.4, 
the cultures were supplemented with 
0.04% MMS to activate the adaptive 
response and the bacterial cells were 
allowed to grow for 3h. Then, the 
plasmids under study were isolated 
from these bacterial cells and were 
63 
 
digested with HindIII and XhoI to 
release the lacZ fragment. To estimate 
the presence of alkyl lesions, the DNA 
fragments were treated and not with 
the AlkA and Endo IV proteins. The 
samples were then subjected to 
electrophoresis on alkaline agarose gel 
in 30 mM NaOH, 1 mM EDTA, pH 8 
buffer, at 60 V for 3 hours at 25°C. The 
gel was neutralized by soaking in a 
solution containing 1.5 M NaCl and     
1 M Tris-HCl, pH 7.6 for 1 h. Finally, 
the gel was stained in TE buffer (10 
mM Tris-HCl, 1 mM EDTA, pH 7.4) 
containing SYBR® Gold for 30 min at 
25°C and the samples were then 
analysed for single-strand DNA breaks.  
 
RESULTS 
Functional analysis of AidB during 
transcription. 
Recently, using the UP element and 
the -35 sequence from the rrnB P1 
promoter as bait and a sequence 
C D 
MG1655
MV5924 
rrnBP1(+UP)   rrnBP1(-UP)    PleuA           PompF rrnBP1(+UP)    rrnBP1(-UP)    PleuA            PompF 
 
5,6
2,2                2,1      
 MG1655
 MV5924 
9,6 
A B
 
5,72,1             2,3
9,4 
rrnBP1(+UP)  rrnBP1(-UP)     PleuA          PompF 
MG1655 
MV5924
rrnBP1(+UP)  rrnBP1(-UP)     PleuA            PompF 
MG1655
MV5924
6,5
1,6  1         ,5 3,8
64 
 
lacking the UP element for 
comparison, we isolated proteins on 
the basis of their preferential affinity for 
the UP region. Curiously, AidB was 
found as one of several proteins that 
preferentially bind to the UP element 
containing DNA (Amoresano et al., 
submitted for publication). In order to 
determine whether the presence of 
AidB at the rrnB P1 promoter might be 
of biological significance, we tested its 
effect on transcription from this 
promoter by in vivo transcription 
assays. As a control, we also 
investigated the putative AidB activity 
on other several promoter fragments: 
the ribosomal promoter rrnB P1 without 
its UP sequence, the promoter from an 
unrelated gene which lacks an UP 
element (PleuA), and the promoter 
from an unrelated gene which contains 
an UP region (ompF). The DNA 
fragments under study were 
individually fused to a promoterless 
lacZ gene contained in the reporter 
plasmid pET22b-lacZ. Both MG1655 
(wild type) and MV5924 (∆aidB) E. coli 
strains were then transformed with the 
fusion plasmids and grown in LB 
medium, either in the absence or in the 
presence of alkylating agents (MMS, 
MNU, MNNG, ENNG) and the β-
galactosidase activity was monitored 
during the exponential growth phase. 
As shown in Fig. 1A, in all cases, wild 
type and mutant cells not exposed to 
alkylators showed identical levels of β-
galactosidase activity indicating that 
the presence of AidB has no effect on 
transcription during normal cell growth. 
In contrast, upon treatment with 
alkylating agents, the transcription 
levels in the ∆aidB strain were lower 
than that observed for the wild type 
strain (Fig. 1B-E), suggesting a 
functional role for AidB on transcription 
during alkylation stress. Interestingly, 
the results from β-galactosidase 
assays showed that AidB strongly 
affects the activity of promoters 
containing an UP element: indeed, the 
mutant cells harbouring rrnB P1 and 
PompF, upon exposure to N-alkyl-
nitrosoguanidines (MNNG, ENNG) 
(Fig. 1B, 1C), exhibited almost a 10-
fold and 6-fold decrease of promoter 
3,6
 
 
Figure 1. In vivo transcription from 
the promoters-lacZ fusions. The 
pET22b-PrrnB(+UP)-lacZ, pET22b-
PrrnB(-UP)-lacZ, pET22b-PleuA-lacZ 
and pET22b-PompF-lacZ plasmids 
were individually introduced into 
MG1655 (wild type) and MV5924 
(∆aidB) E. coli strains and the β-
galactosidase specific activity was 
determined in the absence (A) and in 
the presence of MNNG (5µg/ml) (B), 
ENNG (5µg/ml) (C), MMS 0.04% (D), 
MNU 0.04% (E) as alkylating agents. 
The activities of promoters are 
reported in Miller units; the activity 
obtained by a promoterless lacZ 
gene was subtracted. Numbers 
above bars refer to the ratio of the β-
galactosidase activity of the promoter 
measured in the wild type cells to the 
activity of that same promoter in the 
aidB mutant strain. Means and 
standard deviations have been 
calculated from four independent 
assays. 
MG1655 
MV5924 
E
rrnBP1(+UP)   rrnBP1(-UP)      PleuA            PompF 
6,6 
1,7 1,4 3,6
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activity, respectively. When the 
promoter regions without UP sequence 
were analyzed, we find that the mutant 
cells exhibit transcription levels slightly 
lower (approximately 2-fold) than that 
observed for the wild type cells. We 
also observed that AidB allows more 
efficient transcription in E. coli cells 
exposed to MNNG and ENNG (Fig. 1B, 
1C) rather than to other alkylators such 
as MMS or MNU (Fig. 1D, 1E), 
supporting the hypothesis that AidB 
might be involved in deactivation of 
nitrosoguanidines. 
Taken together, these data strongly 
demonstrated that AidB affects 
transcription during alkylation stress 
and that it has more pronounced effect 
on the activity of promoters containing 
an upstream element. These results 
raise the possibility that AidB may 
prevent alkyl damage, thereby allowing 
more efficient transcription. 
AidB reduces the level of alkylation 
damage in DNA. 
The aim of our study was to determine 
whether AidB might be able of 
preventing DNA alkylation damage. 
This issue was investigated by a 
plasmid damage assay: the plasmid 
DNA (pET22b-lacZ) was isolated from 
wild type and aidB mutant cells grown 
both in the absence and in the 
presence of alkylators (MMS, MNU, 
MNNG, ENNG) and served as a probe 
for the estimation of alkylated bases on 
DNA. The plasmids were divided into 2 
aliquots, one of which was treated with 
the E. coli AlkA (a kind gift from Patrick 
J. O’Brien) and endonuclease IV (Endo 
IV) proteins; the other aliquot did not 
receive further treatment and served 
as a control. AlkA glycosylase 
recognizes and removes a wide variety 
of alkylated bases (O'Brien, P. J. and 
Ellenberger, T., 2004); Endo IV is an 
 
Figure 2. Plamid damage assay. The pET22b-lacZ DNA was isolated from wild type (Lanes 1-2) 
and ∆aidB (Lanes 3-4) E. coli strains grown in the absence (A) or in the presence of MNNG (5 
µg/ml) (B), ENNG (5 µg/ml) (C), MMS 0.04% (D), MNU 0.04% (E), digested (lanes 2, 4) or not 
(lanes 1, 3) with AlkA and Endo IV and subjected to agarose gel electrophoresis. Lane 5, 1 Kb DNA 
marker (NEB). OC: open circular; L: linear; SC: supercoiled. 
 wt    wt    ∆    ∆
- + - +
wt  wt  ∆   ∆
-   +    -   +
wt   wt  ∆    ∆ 
- + - +
 wt    wt   ∆     ∆ 
- + - +
wt    wt     ∆    ∆ 
- + - +
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Figure 3. AidB protects DNA from alkylation 
damage in vitro. Lane 1-2: pET22b-lacZ 
plasmid not digested or digested with AlkA and 
Endo IV, respectively. Lanes 3-4: The pET22b-
lacZ plasmid was incubated with AidB  for 1 h 
at 37°C; the complex AidB-DNA was treated 
with MMS and not digested (Lane 3) or 
digested (Lane 4) with AlkA and Endo IV. 
Lanes 5-6: The pET22b-lacZ was treated with 
MMS; the DNA methylated was not digested or 
digested with AlkA and Endo IV, respectively. 
Lanes 7-8: The pET22b-lacZ was treated with 
MMS; the DNA methylated was incubated with 
AidB and this sample was not digested or 
digested with AlkA and Edo IV, respectively. 
Lane 9, 1 kb DNA marker (NEB). 
 
apurinic/apyrimidinic (AP) 
endonuclease that converts abasic 
sites produced by AlkA to nicks 
(Ljungquist, S. 1977); therefore, the 
combined action of these two enzymes 
on a damaged plasmid results in the 
conversion of the covalently closed 
circular (supercoiled) form to the open 
circular form. AlkA treated and 
untreated plasmids were then 
subjected to electrophoresis on 
agarose gels and tested to look for loss 
of the supercoiled form. As shown in 
Fig. 2A, alkyl lesions were not detected 
in plasmids isolated from bacteria 
grown in LB medium; when plasmid 
DNA from cells exposed to alkylating 
agents was analyzed (Fig. 2B-E), we 
find that treatment with AlkA and Endo 
IV had no effect on DNA isolated from 
wild type cells (Lanes 2), but resulted 
in a complete loss of supercoiled 
plasmid from the aidB mutant (Lanes 
4). These results strongly indicated 
that the presence of AidB reduces the 
level of alkylation damage in plasmid 
DNA. While the damage assay results 
are consistent with a role for AidB in 
predicted protection of DNA, its 
function in repair of alkyl lesions is not 
ruled out.  
 
AidB binds and protects plasmid DNA.  
In vitro experiments were performed to 
demonstrate conclusively that AidB 
binds DNA to protect it from alkylation 
damage. To this aim, the recombinant 
AidB protein bearing a His tag was 
produced, purified by affinity 
chromatography on Ni2+-agarose 
beads and used in a plasmid damage 
assay. First, gel mobility shift assays 
were performed to determine the 
amount of AidB required to completely 
bind the plasmid DNA. The saturation 
of binding was achieved at a ratio 
protein:DNA of 30:1 (w/w) (data not 
shown). Using this ratio, AidB was then 
incubated with plasmid DNA either 
before or after the addition of MMS to 
the reaction mixture. MMS was used 
for this assay because it does not 
require metabolic conversion to 
alkylate DNA (Adler, I. D. 1980). To 
detect the presence of alkyl lesions, 
the purified plasmid DNA was cleaved 
with AlkA and Endo IV. Figure 3 shows 
that plasmid remains in the supercoiled 
form when AidB is added prior to MMS 
treatment (Lane 4), indicating that AidB 
protein functions in vitro and that the 
His-tagged form is fully active. 
However, when the sequence is 
reversed and AidB is added after MMS 
treatment, no effect of AidB presence 
is detected (Lane 8). An identical 
experiment using BSA protein served 
as a control (data not shown).  
Since the order of addition should not 
affect an AidB repair function, but 
protection should require the presence 
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of AidB prior to damaging treatments, 
we conclude that AidB protein acts by 
preventing damage from occurring. 
AidB preferentially protects DNA 
regions containing an UP element. 
Since AidB specifically binds to UP 
sequence containing promoters, and it 
affects strongly transcription at these 
promoters during exposure to 
alkylating agents, we supposed that 
AidB protection might be preferentially 
targeted to genes with an UP element. 
To address this question, we analyzed 
the effect exhibited by AidB in vivo on 
a portion of plasmid DNA: the lacZ 
fragment. In this experiment, we used 
plasmids carrying a lacZ gene that 
lacks a promoter, lacZ fused to the 
rrnB P1 promoter containing its UP 
element and lacZ fused to rrnB P1 in 
which UP sequence was deleted. We 
investigated whether the presence of 
AidB might affect the content of alkyl 
lesions within the lacZ sequences. To 
this aim, the plasmids under study 
were isolated from wild type and aidB 
mutant cells treated with MMS and 
were digested with restriction enzymes 
to release the lacZ fragment. To 
estimate the presence of alkyl lesions, 
the lacZ DNA fragments were gel 
purified, extracted and treated or not 
with the AlkA and Endo IV proteins. 
The samples were then subjected to 
electrophoresis on alkaline agarose 
gels to denature DNA and separate 
nicked from full-length ssDNA 
fragments. The lacZ integrity was then 
determined by the relative abundance 
of full length lacZ restriction fragments 
and nicked forms. Figure 4 shows that 
the mutant cells are not able to protect 
the lacZ gene (Lanes 8, 10, 12), since 
no full length lacZ fragments were 
detected. This confirms that the 
presence of AidB is required for the 
protection against alkyl damage. 
Analysis of the DNA isolated from wild 
type cells revealed several interesting 
features of AidB specificity. The lacZ 
sequence fused to the UP element 
containing rrnB P1 was fully protected 
since all DNA exposed to AlkA remains 
as full length (Fig. 4, comparison 
between Lanes 3 and 4). When lacZ 
fused to the UP-less ribosomal 
promoter was tested, we find that the 
sample treated with AlkA (Lane 6) 
shows a decrease in the amount of full 
length fragment, as compared with the 
untreated control DNA (Lane 5). 
Interestingly, the treatment of 
promoterless lacZ with AlkA caused an 
almost complete loss of full length 
fragment (Lane 2). 
These results demonstrate that AidB 
preferentially protects the DNA of 
genes transcribed from an UP element 
containing promoter. However, it also 
protects DNA in general, since it does 
provide some protection to the non-
 
Figure 4. AidB preferentially protects DNA 
regions containing an UP element. The 
pET22b-lacZ, pET22b-PrrnB(+UP)-lacZ and 
pET22b-PrrnB(-UP)-lacZ plasmids were 
isolated from wild type (Lanes 1-6) and ∆aidB 
(Lanes 7-12) E. coli strains grown in the 
presence of MMS 0.04% and digested to 
release the lacZ fragment. The digested DNA 
samples were untreated (Lanes 1,3,5,7,9,11) 
or treated (Lanes 2,4,6,8,10,12) with AlkA and 
Endo IV and subjected to electrophoresis on 
alkaline agarose gels. Lanes 1,2,7,8: lacZ 
lacking a promoter (-P); Lanes 3,4,9,10: lacZ 
fused to the rrnB P1 promoter with its UP 
element (+UP); Lanes 5,6,11,12: lacZ fused to 
the rrnB P1 promoter without its UP element   
(-UP); Lane 13: 1Kb DNA marker (NEB). 
-P  -P  +UP+UP-UP-UP  -P    -P +UP +UP-UP -UP 
wt wt   wt wt  wt  wt   ∆    ∆  ∆     ∆    ∆     ∆ 
-    +     -   +     -    +     -    +   -     +     -    +
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transcribing lacZ restriction fragment 
and the lacZ gene fused to the rrnB P1 
promoter lacking the UP element. 
Moreover, the result that AidB protects 
different sequences to varying degrees 
is consistent with the initial observation 
(Fig. 2) that AidB protects whole 
plasmids from alkylation. The 
observation that the entire lacZ 
sequence adjacent to UP element 
containing promoters is protected in a 
better manner suggests that the 
promoter may function to nucleate 
AidB protein binding which may then 
polymerise along the DNA molecule. 
The structural studies of Bowles et al., 
2008, suggest that a single AidB 
protein molecule can bind from 25-30 
base pairs of dsDNA. Thus to protect 
the genome, a minimum of 160,000 
AidB molecules would be required. 
Since AidB has a relatively weak 
promoter, it is unlikely that such a level 
would ever be achieved. Thus we 
suspect that the preferential binding to 
genes such as rrnB, and potentially to 
other UP element containing DNA 
sequences such as aidB itself and its 
regulatory gene ada (Landini, P. et al., 
1998), recA, polA and other highly 
transcribed genes (Estrem, S.T. et al., 
1999) may preferentially protect these 
DNA sequences from alkylation 
damage. 
 
DISCUSSION 
In a previous study, we found the AidB 
protein to be part of the protein 
complex that binds to the -35 and the 
UP elements of the rrnB P1 promoter, 
but not to a sequence lacking the UP 
element. In this work, we investigated 
whether the presence of AidB at the 
rrnB P1 promoter might be of biological 
significance; to this aim, we evaluated 
its possible role in rRNA expression by 
β-galactosidase reporter assays. In 
addition, we also tested the effect of 
AidB on transcription from other 
promoters fused to the lacZ reporter 
gene. As appropriate controls, the 
following promoters were chosen: the 
ribosomal promoter rrnB P1 without its 
UP sequence, the promoter from an 
unrelated gene which lacks an UP 
element (PleuA) and the promoter from 
an unrelated gene which contains an 
UP region (PompF). The fusion 
plasmids were individually introduced 
into both wild type and ∆aidB E. coli 
strains which were then treated and 
not with alkylating agents. Upon 
alkylation stress, a decrease in the 
lacZ expression was observed in the E. 
coli cells lacking AidB as compared to 
the wild type control. Interestingly, 
AidB was found to have a more 
pronounced effect on the activity of 
promoters containing an upstream 
element. Our results clearly 
demonstrated that a functional aidB 
allele is necessary for efficient 
transcription during exposure to 
alkylating agents. These data lead us 
to a line of inquiry concerning the 
possible role of AidB in the 
transcription initiation. Its function 
might be related to repair of alkylated 
DNA given that, during transcription, 
the transcriptional fork generates 
single stranded DNA molecules that 
have been demonstrated to undergo 
alkylation processes much quicker 
than double stranded molecules. 
Another possibility is that AidB might 
prevent alkyl damage by protecting 
DNA, thereby allowing more efficient 
transcription. In this respect, a recent 
report on the three dimensional 
structure of AidB bound to double 
strand DNA provided a rationale for its 
possible role in damage prevention 
(Bowles, T. et al., 2008). 
The goal of our study was thus to 
determine the mechanism by which 
AidB protects against alkylating 
agents. First, through a plasmid 
damage assay we demonstrated that 
AidB in vivo reduces the level of 
alkylation damage in DNA: indeed, 
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upon exposure to alkylators, the DNA 
plasmid isolated from wild type cells 
was shown to be undamaged while 
alkyl lesions were detected in plasmid 
DNA extracted from mutant cells. 
While these results are consistent with 
a role for AidB in predicted protection 
of DNA, we could not rule out its 
possible function in repair of alkyl 
lesions. To unravel this issue, in vitro 
studies were performed incubating 
AidB with plasmid DNA either before or 
after the addition of MMS; an effect of 
AidB presence was detected only in 
the former case. Therefore, as 
predicted by structural analysis, we 
have demonstrated conclusively that 
AidB binds DNA to protect it from 
alkylation damage rather than repair it. 
A similar role has been observed for 
the Dps protein, which protects DNA in 
starved E. coli against oxidative 
damage (Almiron, M. et al., 1992; 
Martinez, A. and Kolter, R. 1997). Both 
AidB and Dps are up-regulated during 
stationary phase and are rpoS-
dependent (Volkert, M.R. et al., 1994; 
Altuvia, S. et al., 1994). Interestingly, 
endogenous methylating agents such 
as nitrosamines are formed as by-
products of stationary-phase 
metabolism (Taverna, P. and 
Sedgwick, B, 1996), leading to an 
accumulation of alkyl lesions on DNA. 
Induction of AidB expression, 
therefore, could serve to prevent 
endogenous stationary-phase 
alkylation damage in a manner similar 
to Dps protection of oxidative damage. 
Finally, since AidB was shown to 
specifically bind to UP sequence 
containing promoters and to affect 
strongly transcription at these 
promoters upon exposure to alkylating 
agents, we asked if AidB protection 
might be preferentially targeted to 
genes with an UP element. To address 
this question, we investigated whether 
the presence of AidB might affect the 
content of alkyl lesions within lacZ 
sequences fused to the rrnB P1 
promoter containing and not its UP 
element and judged by comparison 
with the lacZ fragment lacking a 
promoter. Our experiments 
demonstrated that AidB preferentially 
protects DNA sequences transcribed 
from promoters carrying an UP 
element. 
In conclusion, in this work we 
characterized the role of AidB in the E. 
coli adaptive response to alkylating 
agents: AidB functions to protect DNA 
from alkylation damage, by binding it 
and, presumably, by inactivating 
alkylators before they are able to react 
with their DNA target. In addition, we 
demonstrated that AidB preferentially 
protects DNA sequences adjacent to 
UP element-containing promoters, 
which include many of the 
housekeeping genes required for basic 
metabolic processes, such as the 
sequences encoding the ribosomal 
rRNA or the DNA polymerase I that is 
involved in DNA replication and repair. 
Further experiments are required to 
address the question whether the 
preferential protection exhibited by 
AidB is limited to transcriptionally 
active DNA. It would also be useful to 
examine if a similar protective 
mechanism is conserved and active in 
other organisms. 
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Potential role for the Escherichia coli AidB and the Pseudomonas putida 
PP4780 as detoxification enzymes. 
 
INTRODUCTION 
Alkylating agents comprise a broad class of highly reactive chemical compounds that 
introduce alkyl groups into biologically active molecules and prevent normal 
functioning. These compounds mostly react with DNA molecule to produce cytotoxic 
and mutagenic lesions. Alkylation damage to DNA therefore poses a severe threat to 
the stability of the genome and, in mammals, can lead to genetic diseases and 
cancer. Living organisms are continuously exposed to alkylating agents that are 
among the most abundant environmental pollutants influencing health of the persons 
exposed: these molecules that include nitrosamines and nitrosoureas, are released 
into the ecosystem at high concentrations, as a consequence of human activities 
(Vaughan, P., et al., 1991; Taverna, P. and Sedgwick, B. 1996). Since alkylating 
molecules are ubiquitous and hence unavoidable, all organisms (eubacteria, 
archaebacteria, and eukaryotes) have evolved multiple DNA repair strategies as a 
safeguard against alkylation damage. In addition, many bacteria, to defend against 
fluctuating levels of environmental alkylators, mount an inducible response that 
enhances cellular resistance to alkylation damage and is known as the adaptive 
response. In Escherichia coli, exposure to sublethal doses of alkylating agents such 
as methyl methanesulfonate (MMS), N-methylnitrosourea (MNU), N-methyl-N′-nitro-
N-nitrosoguanidine (MNNG), and N-ethyl-N′-nitro-N-nitrosoguanidine (ENNG) 
increases the expression of aidB along with three genes (ada, alkA, alkB) that 
encode DNA repair proteins (Kataoka, H. et al., 1983; Nakabeppu, Y. et al., 1984; 
Volkert, M.R. and Nguyen, D.C. 1984). The role of AidB in the response to alkylating 
agents was elusive for many years. AidB was shown to be a flavoprotein that has 
weak isovaleryl-CoA dehydrogenase activity and that binds to double strand DNA 
(Landini, P. et al., 1994; Rohankhedkar, M.S. et al., 2006). Our recent work 
demonstrated that AidB prevents alkylation damage by protecting DNA and, 
presumably, by inactivating alkylators before they are able to react with their target. 
Interestingly, a recent report on the three dimensional structure of AidB bound to 
dsDNA (Bowles, T. et al., 2008) supported this model, revealing that the protein is 
well equipped to sterically occlude DNA from attack by damaging agents. 
Importantly, the unique chemical environment of FAD active site provided a rationale 
for a possible role of AidB in deactivation of nitrosoguanidines or their reactive 
intermediates. In this respect, AidB’s FAD cavity was shown to be rich in thiol and 
methylsulfide groups and since MNNG, unlike MMS or MNU, is activated by thiols to 
produce highly reactive methylation agents (e.g., methyldiazonium ion) (Lawley, P. D. 
1974), it is intriguing to speculate that flavin binding channel may act as a sink for 
reactive MNNG derivatives. Coupled with structural analysis, our recent results help 
to support the hypothesis that AidB may act as a detoxification enzyme: indeed, we 
demonstrated that AidB allows more efficient transcription during stress alkylation 
and that it has a more pronounced effect in E. coli cells exposed to nitrosoguanidines 
(MNNG, ENNG) rather than to other alkylators such as MMS or MNU. Taking into 
account these observations, AidB represents a promising tool for the treatment of 
sites contaminated by alkylating agents. Since, ideally, the design of successful 
strategies for the bioremediation would require the knowledge of the microorganisms 
present in the polluted environments, their metabolic abilities, and how they respond 
to changes in environmental conditions, the challenge of this experimental work was 
to identify E. coli AidB homologues in bacteria used for bioremediation applications 
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and to investigate the possible involvement of these gene products in the protection 
against alkylating agents. Particularly, the our attention has been focused on the 
search for AidB homologues in pseudomonads that are among extensively studied 
workhorses of environmental bioremediation owing to their ability to degrade 
numerous different contaminants (Wackett, L.P. 2003). The huge potential of the 
pseudomonads does not solely depend on a high proportion of genes responsible for 
the metabolism, transport and efflux of organic compounds, but also on broad 
capability of metabolic regulation (Nelson, K.E. et al ., 2002): indeed, the control of 
gene expression is the key determinant of their flexibility and, in this respect, a variety 
of highly integrated regulatory mechanisms have been identified. Hence, on the basis 
of the potential degradative capability offered by AidB and the great versatility of 
Pseudomonas species, the aim of this work was to identify new potential candidates 
for the bio-treatment of wastes and environments contaminated by alkylating 
compounds. 
 
MATERIALS AND METHODS 
Bacterial strains and plasmids. 
The bacterial strains, the plasmids and the oligonucleotides used in this work are 
listed in Table 1. MG1655 and MV5924 E. coli strains were a kind gift from M. Volkert 
(University of Massachusetts, Worcester, MA). 
 
Media and chemicals. 
Luria-Bertani or nutrient broths (for bacterial cultures and plating) and suspension 
medium (for bacterial dilutions) were used as described by Miller (Miller, J.H. 1972). 
Kanamycin and tetracycline (Sigma) were used at 50 and 5 µg/ml, respectively. 
 
Construction of the expression plasmids. 
The PP4780 gene was amplified from DNA genomic of P. putida KT2440 by 
polymerase chain reaction (PCR) using the forward and reverse primers listed in 
Table 1. The amplified fragment was digested with the restriction enzymes 
underlined in Table 1 and cloned into the expression vector pET28a (Novagen) which 
was linearized with the same restriction enzymes. The resulting plasmid, pET28a-
PP4780, was verified by automated DNA sequencing. For the complementation 
experiments, the PP4780 gene was positioned downstream of the lac promoter into 
the expression vector pET28a-Plac, generating pET28a-Plac-PP4780.  
 
Production and purification of  recombinant proteins. 
The constructs pET28a-aidB (Amoresano et al., submitted for publication) and 
pET28a-PP4780 (Table 1) were individually transformed into the E. coli strain C41 
(DE3). The recombinant cells were grown at 25°C to an optical density at 600 nm of 
~0.5, at which time 0.05 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) was 
added and the cultures were allowed to grow until the OD600 reached 3.0. Cells were 
harvested by centrifugation at 5000 x g for 15 min at 4°C, resuspended in buffer A 
(50 mM Na2HPO4, pH 7.4, 0.3 M NaCl, 10 mM imidazole, 1 mM PMSF), disrupted by 
passage through a French Press and centrifuged at 14000 x g for 30 min at 4°C. The 
recombinant proteins were purified by affinity chromatography on His-Select Nickel 
Affinity Gel (Sigma). The lysate was loaded onto His-Select Nickel Affinity Gel 
equilibrated with equilibration buffer (50 mM Na2HPO4, pH 7.4, 0.3 M NaCl, 10 mM 
imidazole). After 1 min of incubation at 4°C, the matrix was collected by 
centrifugation at 11000 x g for 1 min and washed 3 times with same equilibration 
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Table 1: Bacterial strains, plasmids and oligonucleotides. 
Strains/plasmids 
 
Description 
 
Reference or
source 
E. coli strains 
C41 (DE3)     
 
Strain that derives from BL21 [F-ompT hsdSB (rB- mB-) 
gal dcm (DE3)]. This strain has at least one 
uncharacterized mutation that prevents cell death 
associated with expression of many toxic recombinant 
proteins     
 
Miroux et al. 
(1996) 
MG1655 F- wild-type K-12 strain Volkert 
MV5924 Strain derivative of MG1655 in which the aidB gene 
had been inactivated by a tetracycline resistance 
cassette 
Volkert  
Plasmids   
pET28a(+) Plasmid carrying an N-terminal 
His•Tag®/thrombin/T7•Tag® configuration plus 
an optional C-terminal His•Tag sequence.  
Novagen 
pET28a-Plac-aidB pET28a-Plac∆(BamHI-HindIII)Ω(aidB gene) Previous work
pET28a-Plac-PP4780 pET28a-Plac∆(BamHI-HindIII)Ω(PP4780 gene)             This work 
pET28a-aidB pET28a∆(BamHI-HindIII)Ω(aidB gene) 
 
Amoresano 
et al., 2009 
pET28a-PP4780  pET28a(BamHI-XhoI)Ω(PP4780 gene) This work 
Oligonucleotides  
PP4780 Fw 5'-ATAGGATCCATGAGCCTGCACCAG-3' 
PP4780 Rv 5'-TTACTCGAGCAACAGGGGCCAGG-3' 
PP4780-compl Rv 5'-TTAAAGCTTCAACAGGGGCCAGG-3' 
 
buffer. The recombinant proteins were eluted with buffer containing 250 mM 
imidazole in 50 mM Na2HPO4, pH 7.4, 0.3 M NaCl. Protein concentration was 
estimated with Bradford reagent (Bio-Rad protein assay) and protein content was 
checked by SDS-polyacrilamide gel electrophoresis (SDS-PAGE).  
 
Growth profiles.  
MV1161 (wild type) and MV5924 (∆aidB) E. coli strains were not transformed or 
transformed, individually, with pET28a-Plac-PP4780 and pET28a-Plac-aidB. These 
bacterial cultures grown overnight in LB medium at 37°C, were diluted 1:100 in fresh 
medium. At an A600 nm of 0.2, the cultures were divided in four aliquots supplemented 
with MMS 0.04%, MNU 0.04%, MNNG (5µg/ml) and ENNG (5µg/ml), respectively. 
After addition of alkylating agent, the bacterial cells were allowed to grow overnight. 
For all experiments, each growth profile was reproduced three times.  
 
Isovaleryl-CoA dehydrogenase activity assay.
Isovaleryl-CoA dehydrogenase activity assays were carried out at room temperature 
in 200 mM phosphate buffer, pH 8.0, and using purified recombinant proteins that 
had been dialyzed to remove imidazole. For routine assays, 2 mM isovaleryl-CoA 
(Sigma) was used as the substrate and 0.1 mM 2,6-dichlorophenolindophenol 
(DCPIP) was used as the terminal electron acceptor in a final volume of 300 µl. The 
change in absorbance at 600 nm was monitored by using a Beckman DU 7500 
spectrophotometer, and the enzyme activity was calculated by assuming an 
extinction coefficient of 20.6 mM−1 cm−1 for DCPIP. 
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RESULTS 
AidB increases cell survival after exposure to nitrosoguanidines. 
Inducible resistance of E. coli to the cytotoxic and mutagenic effects of alkylating 
agents involves the increased expression of the ada-alkB operon, alkA and aidB 
genes (Lindahl, T. et al., 1988). The DNA repair mechanisms of Ada, AlkA, and AlkB 
have been structurally and functionally characterized (Landini, P. and Volkert, M.R. 
1995; Nakabeppu, Y. et al., 1984; Trewick, S. C. et al., 2002); recently, we 
demonstrated that AidB prevents alkylation damage rather than repair it. In order, to 
completely define the role of AidB in preventing alkylators-induced toxicity, the effect 
of its deletion on sensitivity to different alkylating compounds was tested. Specifically, 
we investigated the AidB response to four different mutagens; these include alkyl 
sulfonates (MMS), nitrosoureas (MNU), and nitrosoguanidines (MNNG or ENNG). To 
this aim, both MG1655 (wild type) and MV5924 (∆aidB) E. coli strains were grown in 
LB medium, in the presence of sub-inhibitory concentrations of the mutagens 
described above and their growth behaviour was analyzed and compared. As shown 
in Figs. 1A and 1B, the aidB mutant cells don’t display any change in sensitivity to 
MMS or MNU as compared with the wild type cells; in contrast, the inactivation of 
aidB gene was shown to decrease resistance to lethal and mutagenic effects of 
MNNG and ENNG (Figs. 1C and 1D). Interestingly, the complementation of the 
∆aidB mutation by pET28a-Plac-aidB plasmid restored the cellular resistance to 
nitrosoguanidines; in fact, the complementated strain was shown to have a growth 
profile identical to wild type cells (Figs. 1C and 1D). Taken together, these results 
suggested that AidB plays a critical role in preventing toxicity induced by MNNG and 
ENNG. Since sensitivity to only nitrosoguanidines was affected in MV5924 strain, we 
hypothesized that AidB may be involved, by a dehydrogenase mechanism, in a 
detoxification pathway of this class of alkylators that constitute one of the most 
important environmental contaminants influencing health of the persons exposed. 
This result is consistent with previous structural studies performed by Bowles et al., 
2008. Hence, on the basis of these observations, AidB was shown to represent a 
promising tool for the bio-treatment of sites contaminated by alkylating agents. 
 
AidB homologues in Pseudomonas species.  
Since, ideally, developing successful strategies for the bioremediation requires the 
knowledge of the microorganisms present in the polluted environments, their 
metabolic abilities, and how they respond to changes in environmental conditions, 
this experimental work was targeted at identify as well as at characterize E. coli AidB 
homologues in bacteria used for bioremediation applications. To this aim, the 
deduced amino sequence of the 60.5 kDa AidB was submitted to Swiss Protein and 
GenBank-EMBL databases. Interestingly, we found that AidB homologues are not 
present in many bacteria closely related to E. coli (Klebsiella, Vibrio, Shewanella, and 
Photorhabdus), but the closest hits are from some γ-proteobacteria (Pseudomonas, 
Azotobacter, and Acinetobacter), β-proteobacteria (Burkholderia, Ralstonia, 
Bordetella), and even gram-positive bacteria (Mycobacterium, Nocardia). This 
observation was intriguing because Pseudomonas species and closely related 
organisms are the most extensively studied and the most frequently used for 
bioremediation applications (Wackett, L.P. 2003), owing to their ability to degrade 
many several organic pollutants. Particularly, the homology search revealed that 
AidB shows 46% identity with the putative acyl-CoA dehydrogenase coded by the 
PP4780 gene from Pseudomonas putida KT2440.  
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Interestingly, the conservation of Glu425, that corresponds to the catalytic residue in 
most of the short- and medium- chain acyl-CoA dehydrogenases, suggested that a 
dehydrogenase or oxidase activity is essential to the physiological function of the P. 
putida protein. Strain KT2440, whose genome has recently been sequenced (Nelson, 
K.E. et al., 2002), is one of the best characterized pseudomonads; its broad 
metabolic versatility, genetic plasticity, and ability to colonize many different 
environments such as bulk soil and the rhizosphere make this bacterium an ideal 
candidate for bioremediation applications (Clarke, P. 1982; Molina, L. et al., 1998; 
Espinosa-Urgel, M. et al., 2002; Timmis, K. N. 2002; Jiménez, J. I. et al., 2002; 
Canovas, D. et al., 2003; Santos, P. M. et al., 2004; Ramos-Gonzalez, M. I. et al., 
2005; Kurbatov, L. et al., 2006; Nogales, J. et al., 2008). P. putida was shown to 
adapt to a variety of stress conditions and interestingly, the changes that may occur 
in soil include the fluctuation in levels of alkylating agents. This bacterium has also 
been certified as a biosafety system, which means that it can be used as a host for 
containment systems (Molin, S. et al., 1993) both for applications in biotechnological 
production and release into the environment. On the basis of these observations, it 
was intriguing to investigate the possible involvement of the acyl-CoA 
dehydrogenase from P. putida in the response to alkylation stress. 
 
Cloning and over-expression of the PP4780 gene in E. coli. 
To characterize the putative acyl-CoA dehydrogenase from P. putida, the first  step of 
our work was to clone the PP4780 gene into a commercial expression vector of the 
pET series and to over-express the recombinant product in E. coli cells; the protein 
bearing a 6 His tag at the C-terminus was purified by affinity chromatography on Ni2+-
agarose beads and its homogeneity was tested by SDS-PAGE and mass 
fingerprinting analyses. Successively, a preliminary characterization of the purified 
protein was performed examining its potential enzymatic properties. To this aim, the 
isovaleryl-CoA dehydrogenase (IVD) activity of the P. putida protein was examined 
and compared with that of EcAidB. The product coded by the PP4780 gene 
displayed low levels of isovaleryl-CoA catalytic activity that are identical to that 
exhibited by AidB protein (Table 2). It is intriguing to speculate that, such for AidB, 
fatty acyl-coA are not substrates for the P. putida enzyme but that its active site may 
act as a sink for certain alkylating compounds or their reactive intermediates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Isovaleryl-CoA dehydrogenase activity of the P. putida protein 
coded by the PP4780 gene and the E. coli AidB was assayed as described 
in Materials and Methods following the isovaleryl following the isovaleryl-
CoA-dependent reduction of the electron acceptor DCPIP. The data shown 
are averages of 10 measurements.  
 
Protein Isovaleryl-CoA dehydrogenase activity 
 µmol min-1 [mg protein]-1
AidB 0.12 ± 0 
PP4780 0.13 ± 0 
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PP4780 protects the bacterial cell from alkylation damage. 
The putative involvement of PP4780 in cellular protection against alkylating agents 
was investigated by transforming MV5924 (∆aidB) E. coli strain with a plasmid 
carrying the PP4780 gene and by analyzing the effect of this gene product on 
sensitivity of aidB mutant cells to nitrosoguanidines. To this aim, the strain 
complementated was exposed to sub-inhibitory concentrations of MNNG or ENNG 
and its growth profile was compared with that determined for the wild type MG1655 
and ∆aidB MV5924 strains treated with nitrosoguanidines. As shown in Figs. 2A and 
2B, the PP4780 gene suppressed the increased nitrosoguanidines-sensitivity caused 
by aidB mutation; in fact the complementated strain was shown to have a growth 
profile identical to wild type cells. 
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Figure 2: Growth profiles of MG1655 (wild type), MV5924 (∆aidB) and MV5924 
transformed with pET28a-Plac-PP4780 plasmid, grown in the presence of MNNG 5 µg/ml 
(A) and ENNG 5 µg/ml (B), respectively.  
 
This finding clearly demonstrated that PP4780 expression produced a functional 
protein that is involved in the resistance against alkylation damage, presumably by 
acting as a detoxification enzyme which inactivates nitrosoguanidines.  
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In order, to further define the P. putida protein role in preventing toxicity after 
nitrosoguanidines challenge, we also tested whether PP4780 over-expression might 
confer increased resistance to E. coli cells treated with both MNNG and  ENNG. 
Interestingly, recombinant cells that over-express PP4780 exhibited to be more 
resistant to nitrosoguanidines as compared with wild type and aidB-overexpressing 
cells (Figs. 3A and 3B).  
Taken together these results, we clearly demonstrated that the P. putida protein 
plays a critical role in defending the bacterial cell against alkylation stress; the 
putative involvement of this protein in detoxification of nitrosoguanidines was 
considered as a possible explanation for the phenotypes observed. 
Clearly, further studies will be required to elucidate whether E. coli AidB and P. 
putida protein effectively act as detoxification enzymes to destroy nitrosoguanidines 
that are recognised as one of the most abundant environmental pollutants. However, 
the data obtained in this research project strongly support the possibility of 
developing new successful strategies for the bioremediation of environments and 
industrial effluents contaminated by alkylating compounds. 
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Figure 3: Growth profiles of MG1655 (wild type), MG1655 over-expressing AidB and 
MG1655 over-expressing PP4780, grown in the presence of MNNG 5 µg/ml (A) and ENNG 5 
µg/ml (B), respectively. 
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CONCLUSIONS 
The strategy of using and manipulating detoxification abilities of microorganisms to 
reduce environmental contamination, such as in soils and waste waters, appears to 
be feasible alternative to physicochemical methods. This work has been aimed at 
exploring new potential candidates for the bio-treatment of wastes and environments 
contaminated by alkylating compounds that are among abundant pollutants present 
in the ecosystem. The study has been specifically focused on the AidB protein, a 
component of the adaptive response to alkylating agents in bacterium Escherichia 
coli.  
Initially, the role of AidB in the bacterial cell was investigated through structural and 
functional characterization of its protein domains. Successively, the mechanism by 
which AidB directly protects against alkylation stress has been determined: AidB 
prevents DNA damage, presumably by inactivating certain alkylators before they are 
able to react with their DNA target. 
Finally, taking into account its potential role in the detoxification of alkyl-
nitrosoguanidines, this experimental work was targeted at identify as well as at 
characterize E. coli AidB homologues in bacteria used for bioremediation 
applications. Specifically, the study has been focused on the acyl-CoA 
dehydrogenase coded by the PP4780 gene from Pseudomonas putida KT2440. The 
involvement of this protein in preventing toxicity induced by nitrosoguanidines has 
been demonstrated: the complementation of the aidB mutation by PP4780 gene was 
shown to decrease the cellular sensitivity to nitrosoguanidines and the over-
expression of PP4780 was shown to confer increased resistance to lethal and 
mutagenic effects of these damaging agents. The potential role for the P. putida 
protein in detoxification of nitrosoguanidines was considered as a possible 
explanation for the phenotypes observed. Clearly, characterizing the degradative 
properties of the acyl-CoA dehydrogenase from E. coli and P. putida KT2440 will be 
required to allow their potential application in bioremediation field. Besides, further 
work should be done aimed at exploring the entire metabolic pathways necessary for 
the complete degradation of alkylating compounds. In light of these observations, the 
current research should be focused on both identification of enzymatic activities 
involved in the catabolic pathway of alkylators degradation, as well as on testing their 
catalytic performances.  
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Abstract 
Identification of interacting proteins in 
stable complexes is essential to 
understand the mechanisms that 
regulate cellular processes at the 
molecular level. Transcription initiation 
in prokaryotes requires coordinated 
protein-protein and protein-DNA 
interactions often involving one or 
more transcription factors in addition to 
RNA polymerase (RNAP) subunits. 
The RNAPα subunit is a key regulatory 
element in gene transcription which 
functions through direct interaction with 
other proteins to control all stages of 
the process. A clear description of the 
RNAPα protein partners will greatly 
benefit the understanding of 
transcription modulation. 
A functional proteomic approach was 
employed to investigate protein 
components specifically interacting 
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with RNAPα. A tagged form of the 
Escherichia coli RNAPα was used as a 
bait to fish its molecular partners out 
from the entire cellular extract. Among 
other interactors, the 50S ribosomal 
protein L2 (RPL2) was clearly identified 
by mass spectrometry. The direct 
interaction between RNAPα and RPL2 
was further confirmed both in vivo and 
in vitro by co-immunoprecipitation and 
bacterial two-hybrid experiments. The 
functional role of this interaction was 
also investigated in the presence of a 
ribosomal promoter by using a β-
galactosidase gene reporter assay. 
The results clearly demonstrated that 
RPL2 was able to increase β-
galactosidase expression only in the 
presence of a specific ribosomal 
promoter whereas it was inactive when 
assayed with an unrelated promoter. 
Interestingly, other ribosomal proteins 
(L1, L3, L20, L27) did not show any 
influence on rRNA expression. 
Findings reported here strongly 
suggest that besides ribosome 
assembly the highly conserved RPL2 
protein plays also a specific and direct 
role in transcription regulation. 
 
Keywords: L2 ribosomal protein, RNA 
polymerase, transcription regulation,  
functional proteomics,  mass 
spectrometric procedures. 
 
Running title: Transcriptional role of 
ribosomal protein L2 in Escherichia 
coli. 
 
Introduction 
Understanding the mechanism and 
regulation of transcription in bacteria 
requires dissection of the specific roles 
of the individual components of the 
multi-protein transcription complex 
including the multi-subunit enzyme 
RNA polymerase (RNAP). It is well 
known, in fact, that one of the major 
factors ensuring correct gene 
expression in microorganisms is the 
 
 efficiency with which RNAP recognises 
the specific promoters of different 
genes. The single form of RNAP in 
Escherichia coli consists of a 
tetrameric core enzyme (ββ’α2) 
capable of RNA synthesis and factor-
independent termination, and the σ 
subunit responsible for recognition of 
specific transcription initiation sites. 
However, although RNAP σ constitutes 
the main determinant for promoter 
recognition, α subunit also plays a key 
role in the stability of the transcription 
complex (3,10). The E. coli RNAP α 
subunit consists of two domains, the 
amino terminal domain (NTD) and the 
carboxy terminal domain (CTD) 
connected by a flexible linker that 
allows the CTD domain to interact with 
promoter elements located at different 
distances from the RNAP binding site 
(2). The α subunit fulfils at least two 
functions during genes transcription: it 
is involved in both the assembly of the 
core enzyme and the regulation of 
transcription initiation. The role of the 
two domains is clear: NTD is needed 
for dimerization and interaction with the 
β and β’ subunits whereas CTD is 
important for both DNA binding and 
protein-protein interactions. 
Transcription initiation requires 
coordinated protein-protein and 
protein-DNA interactions often 
involving one or more transcription 
factors in addition to RNAP subunits 
(19). Transcription factors can interact 
with nearly all RNAP components, 
although αCTD constitutes the most 
frequent target. Class I activators bind 
to an upstream site and contact the 
αCTD thereby recruiting RNAP to the 
promoter (6, 20). The α subunit is then 
a key regulatory element in gene 
transcription which functions through 
direct interaction with other proteins to 
control all stages of the process. A 
clear description of the α subunit 
protein partners will greatly benefit the 
understanding of transcription 
modulation. Recently functional 
proteomics approaches essentially 
based on pull-down or 
immunoprecipitation experiments (17) 
have been introduced to investigate 
protein-protein interactions both in vitro 
and in vivo. The association of a 
specific protein with molecular partners 
belonging to protein complexes 
involved in particular mechanisms can 
greatly contribute to the description of 
the cellular processes at the molecular 
level (9, 12).                     
In this work, a 6-His tagged 
recombinant form of the α subunit from 
E. coli RNAP (RNAPα) was used as a 
bait to fish its molecular partners out 
from the entire cellular extract. Among 
other interactors, the 50S ribosomal 
protein L2 (RPL2) was clearly identified 
by mass spectrometric procedures. 
The direct interaction between RNAPα 
and RPL2 was further confirmed both 
in vivo and in vitro by co-
immunoprecipitation experiments and 
two hybrid technique. The functional 
role of this interaction was investigated 
by in vivo transcription assays using 
lacZ as reporter gene. RPL2 was 
shown to increase β-galactosidase 
expression only when a specific 
ribosomal promoter was used in the 
assay, whereas it was inactive in the 
presence of an unrelated promoter. 
Interestingly, other ribosomal proteins 
(L1, L3, L20, L27) did not show any 
effect on rRNA expression. Findings 
reported here strongly suggest that 
besides ribosome assembly the highly 
conserved RPL2 protein plays also a 
specific and direct role in transcription 
regulation. 
Material and methods                    
Bacterial strains and plasmids. 
The bacterial strains and the plasmids 
used in this work are listed in Table 1.  
 
Media and chemicals. 
Luria-Bertani or nutrient broths (for
 
 Table 1: Bacterial strains and plasmids. 
Strains/plasmids Description Reference or Source 
Strains   
E. coli K12  wild type  DSMZ 
C41 (DE3)     Strain that derives from BL21 [F-ompT hsdSB (rB- 
mB-) gal dcm (DE3)]. This strain has at least one 
uncharacterized mutation that prevents cell death 
associated with expression of many toxic 
recombinant proteins     
ref. 15 
R721 71/18 glp O-P434/p22lacZ ref. 5 
Plasmids   
pET22b(+)  carries an N-terminal pelB signal sequence, plus 
an optional C-terminal His-tag sequence; ampicillin 
resistance 
Novagen 
pET28a(+)  carries an N-terminal His•Tag®/thrombin/T7•Tag® 
configuration, plus an optional C-terminal His•Tag 
sequence; kanamycin resistance 
Novagen 
pET22b-αpol pET22b(+)∆(NdeI-XhoI)Ω(rpoA gene)   This work 
pET22b-c-Myc pET22b(+)∆(NdeI-BamHI)Ω(c-myc tag)     This work 
pET22b-c-Myc-L2    pET22b-c-Myc∆(BamHI-XhoI)Ω(rplB gene)     This work 
pET22b-c-Myc-
Thioredoxin    
pET22 b-c-Myc∆(BamHI-XhoI)Ω(trxC gene) This work 
pET28a-αpol pET28a∆(BamHI- XhoI)Ω(rpoA gene)   This work 
pcIP22 pC132 derivative carrying N-terminal end of p22 
repressor; ampicillin resistance 
ref. 5 
pcI434 pACYC177 derivative carrying N-terminal end of 
434 repressor; chloramphenicol resistance 
ref. 5 
pcIP22-RNAPα pcI P22∆(SalI- BamHI)Ω(rpoA gene)    This work 
pcI434-RNAPα pcI434∆(SalI- BamHI)Ω(rpoA gene)    This work 
pcI434-RPL2 pcI434∆(SalI- BamHI)Ω(rplB gene)    This work 
pcI434-L2 pcI434∆(NdelI- BamHI)Ω(rplB gene)    This work 
pcI434-L1 pcI434∆(NdelI- BamHI)Ω(rplA gene)    This work 
pcI434-L3 pcI434∆(NdelI- BamHI)Ω(rplC gene)    This work 
pcI434-L20 pcI434∆(NdelI- BamHI)Ω(rplT gene)    This work 
pcI434-L27 pcI434∆(NdelI- BamHI)Ω(rpmA gene)    This work 
pET22b-PrrnD pET22b∆(SphI-HindIII)Ω(rrsD promoter)   This work 
pET22b-PaidB pET22b∆(SphI-HindIII)Ω(aidB promoter)   This work 
pET22b-PrrnD-lacZ pET22b-PrrnD∆(HindIII-XhoI)Ω(lacZ gene)   This work 
pET22b-PaidB-lacZ pET22b-PaidB∆(HindIII-XhoI)Ω(lacZ gene)   This work 
  
bacterial cultures and plating) and 
suspension medium (for bacterial 
dilutions) were used as described by 
Miller (14). Ampicillin, kanamycin and 
chloramphenicol (Sigma) were used at 
100, 50 and 34 µg/ml, respectively. 
 
Construction of the expression 
plasmids. 
The rpoA, rplA, rplB, rplC, rplT, rpmA 
and trxC genes were amplified from 
DNA genomic of E. coli by PCR using 
the specific primers listed in Table 2. 
The amplified fragments were digested 
with the restriction enzymes underlined 
in Table 1 and cloned into the 
commercial expression vectors which 
were linearized with the same 
restriction enzymes. To obtain 
pET22b-c-Myc, a NdeI/BamHI digested 
fragment corresponding to the c-Myc 
epitope was inserted into the 
 
 pET22b(+) expression plasmid 
(Novagen) linearized with NdeI and 
BamHI. 
The resulting plasmids, designated as 
listed in Table 1, were verified by 
automated DNA sequencing. 
 
Production and purification of  
recombinant proteins. 
The constructs pET22b-αpol, pET22b-
c-Myc-L2, pET22b-c-Myc-Thioredoxin 
and pET28a-αpol (Table 1) were 
individually transformed into the E. coli 
strain C41 (DE3). For αRNAP and 
Thioredoxin production, the 
recombinant cells were grown in LB at 
37°C without induction until the OD600 
reached 3.0. The rplB gene was 
expressed as follows: recombinant 
cells were grown at 37°C to an optical 
density at 600 nm of ~ 0.9, at which 
time 0.05 mM isopropyl-beta-D-
thiogalactopyranoside (IPTG) was 
added and the cultures were allowed to 
grow until the OD600 reached 3.0. Cells 
were harvested by centrifugation at 
5000 x g for 15 min at 4°C, 
resuspended in buffer A (50 mM 
Na2HPO4, pH 7.4, 0.3 M NaCl, 10 mM 
imidazole, 1 mM PMSF), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C. The recombinant proteins were 
purified by affinity chromatography on 
His-Select Nickel Affinity Gel (Sigma) 
according to slightly modified 
manufacturer’s instructions. The lysate 
was loaded onto His-Select Nickel 
Affinity Gel equilibrated with 
equilibration buffer (50 mM Na2HPO4, 
pH 7.4, 0.3 M NaCl, 10 mM imidazole). 
After 1 min of incubation at 4°C, the 
matrix was collected by centrifugation 
at 11000 x g for 1 min and washed 3 
times with washing buffer (50 mM 
Na2HPO4, pH 7.4, 0.8 M NaCl, 10 mM 
imidazole). The recombinant proteins 
were eluted with buffer containing 250 
mM imidazole in 50 mM Na2HPO4, pH 
7.4, 0.3 M NaCl. Protein concentration 
was estimated with Bradford assay (1) 
and protein content was checked by 
SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). 
 
Fishing for partners. 
100 µl of His-Select Nickel Affinity Gel 
(Sigma) were incubated twice with 10 
mg of bacterial protein extract for 2 
hours at 4°C as preclearing step. The 
unbound protein extract was then 
incubated with 6HisRNAPα linked onto 
agarose beads by His-Ni(2+) 
interactions for 2 hours at 4°C. The 
matrix was collected by centrifugation 
at 5000 x g for 10 min and washed 4 
times with washing buffer. The retained 
proteins were eluted with 100µl of 
Laemmli buffer (62.5 mM Tris-HCl, pH 
6.8, 10% glycerol, 2% sodium dodecyl 
sulfate (SDS), and 0.1% bromophenol 
blue) containing 0.1 M DTT (4). The 
eluate was fractionated by 10 % 
monodimensional SDS-PAGE and 
stained with Brilliant Blue G-colloidal 
Coomassie (Sigma). 
 
In situ digestion.  
Coomassie blue-stained protein bands 
were excised from SDS-PAGE gels 
and washed in deionised MilliQ grade 
water (three times, 10 min). The 
excised spots were then washed first 
with acetonitrile and then with 0.1 M 
ammonium bicarbonate (three times, 
15 min). Protein bands were then in gel 
digested as previously described (16).  
 
MALDI MS analyses. 
MALDI-TOF mass spectra were 
recorded using an Applied Biosystem 
Voyager DE STR instrument. A mixture 
of analyte and matrix solution (alfa-
cyano-hydroxycinnamic acid 10 mg/ml 
in 66% ACN, 10 mM citric acid, in 
MilliQ water) was applied to the 
metallic sample plate and dried down 
at room temperature. Mass calibration 
was performed using external peptide 
standards.
 
  
 
Raw data were analysed using the 
computer software provided by the 
manufacturer and reported as 
monoisotopic masses. Peptide masses 
of tryptic fragments from each digested 
protein were used to search for protein 
databases using an in-house version of 
the Mascot software (Matrix Science). 
 
Nano-Liquid Chromatography-ESI 
Tandem Mass Spectrometry 
(LC/MS/MS).                                
Tryptic peptide mixtures obtained as 
previously described were also 
analysed by nano-LC/ES/MS/MS on-
line using a linear ion trap instrument 
(4000Q-trap Applied Biosystems). The 
proteolytic digest was fractionated on a 
HP 1100 nano HPLC apparatus 
(Hewlett-Packard, Palo Alto, CA) using 
a capillary C18 column (75 µm x 150 
mm, 300 Å) (Torrance, CA) with 0.1% 
(v/v) formic acid, 2% (v/v) ACN in H2O 
(solvent A) and 0.1% (v/v) formic acid, 
2% (v/v) H2O in ACN (solvent B) by 
means of a linear gradient from 5 to 
Table 2: Oligonucleotides.  
rpoA-pET22b Fw        5’ ATACATATGATGCAGGGTTCTGTGACAG 3’  
rpoA-pET22b Rv 5’ TAACCTGTGCTCGAGTAACTCGTCAGCG 3’  
c-myc Fw 5'ATTCATATGGAACAAAAACTCATCTCAGAAGAGGATCTGAAT
GGGGCCGCAGGATCCTAT3’ 
 
c-myc Rv 5'ATAGGATCCTGCGGCCCCATTCAGATCCTCTTCTGAGATGA
GTTTTTGTTCCATATGAAT3’ 
 
rplB-pET22b Fw 5’ TATGGATCCATGGCAGTTGTTAAATG 3’  
rplB-pET22b Rv          5’ ATACTCGAGTAATTTGCTACGGCGAC 3’  
trxC-pET22b Fw          5’ CCGGATCCATGAATACCGTTTGTACCCATTG 3’  
trxC-pET22b Rv 5’ CCCTCGAGTAAAAGAGATTCGTTCAGCCAG 3’  
rpoA-pET28a Fw         5’ GAGGGATCCATGCAGGGTTCTGTGACAG 3’  
rpoA-pET28a Rv         5’ GTGCTCGAGTTACTCGTCAGCGATGC 3’  
rpoA-pcI Fw 5' TATCTAGAGCGTCGACCATGCAGGGTTCTGTGACAG 3’  
rpoA-pcI Rv                5' ATACTCGAGCGGGATCCTTACTCGTCAGCGATGCTT 3’  
rplB-pcI434 Fw 5' TATCTAGAGCGTCGACCATGGCAGTTGTTAAATGTA 3’  
rplB-pcI434 Rv             5’ ATACTCGAGCGGGATCCTTATTTGCTACGGCGACG  3’  
L2-pcI434 Fw   5’ TAACATATGATGGCAGTTGTTAAATGTAA 3’  
L2-pcI434 Rv  5’ TTAGGATCCTTATTTGCTACGGCGACG 3’  
rplA-pcI434 Fw 5’ GAGCCATATGCATGGCTAAACTGACCAAGCG 3’  
rplA-pcI434 Rv             5’ GCGGGATCCTTAGTTTACAGAAGCGCTCAGG 3’  
rplC-pcI434 Fw 5’ GAGCCATATGCATGATTGGTTTAGTCGGTAAA 3’  
rplC-pcI434 Rv             5’ GCGGGATCCTTACGCCTTCACAGCTGGTTT 3’  
rplT-pcI434 Fw 5’ GAGCCATATGCATGGCTCGCGTAAAACGTGG 3’  
rplT-pcI434 Rv             5’ GCGGGATCCTTATGCCAGAGCTGCTTTCGC 3’  
rpmA-pcI434 Fw 5’ GAGCCATATGCATGGCACATAAAAAGGCTGG 3’  
rpmA-pcI434 Rv             5’ GCGGGATCCTTATTCAGCTTCGATGCTGATAAA 3’  
PrrnD-pET22b Fw        5’ GTGCGCATGCACAGAAAAAAAGATC 3’  
PrrnD-pET22b Rv        5 ’TCGAAGCTTCGGAGGCGCATTATAG 3’  
PaidB-pET22b Fw    5’ GTGCGCATGCATAAGAATGTTTTAGC 3’  
PaidB-pET22b Rv 5’ TCGAAGCTTCACCATTAGTATGGTC 3’  
lacZ-pET22b Fw          5’ TGTAAGCTTATAACAATTTCACACAGGAA 3’  
lacZ-pET22b Rv           5’ CGGCTCGAGTTATTTTTGACACCAGAC 3’  
 
 70% solvent B for 60 min at a flow rate 
of 0.2 µl/min. The column was directly 
connected to the ion source through 
the nanospray probe and both ES/MS 
and ES/MS/MS spectra were acquired 
throughout the entire analysis by 
dependent data scanning, monitoring 
the five most intense ions. 
Co-immunoprecipitation and Western 
blotting analysis. 
For co-immunoprecipitations, E. coli 
strain C41 (DE3) was co-transformed 
with pET22b-c-Myc-L2/pET28a-αpol 
and with pET22b-c-Myc-
Thioredoxin/pET28a-αpol as control of 
the experiment. 2 ml of cultures grown 
overnight were inoculated into 200 ml 
of LB medium containing 100 µg/ml 
ampicillin and 50 µg/ml kanamicin. 
After expression of the recombinant 
genes without induction, cells were 
harvested by centrifugation at 5000 x g 
for 15 min at 4°C, resuspended in 50 
mM Na2HPO4 (pH 7.4), 1mM PMSF, 
disrupted by passage through a French 
Press and centrifuged at 14000 x g for 
30 min at 4°C. The protein contents 
were checked by Western blot 
analysis. The supernatants were then 
used for the co-immunoprecipitation 
experiments. Cell lysates were 
incubated with agarose-linked T7 
antibody (Bethyl) and with agarose 
beads alone (control of the experiment) 
at 4°C overnight. The beads were then 
collected by centrifugation and 
washed; the bound proteins were 
eluted with 1×SDS–PAGE sample 
buffer (2% SDS, 10% glycerol, 62.5 
mM Tris-HCl [pH 6.8], 100 mM 
dithiothreitol, 0.01% bromophenol blue) 
and subjected to SDS-PAGE followed 
by Western blot analysis that was 
performed by using anti-T7 mouse 
antibody (Novagen) and anti-c-Myc 
mouse antibody (Calbiochem) as first 
antibodies and anti-mouse IgG 
conjugated to peroxidase as a 
secondary antibody (Calbiochem).  
 
The two-hybrid system: growth 
conditions and dimerization assay. 
The plasmids pcIP22, pcI434 and their 
derivates needed for the two hybrid 
experiment (Table 1) were introduced 
into R721 competent cells. The 
recombinant cells were inoculated into 
0.5 ml LB medium, diluted 1:1000 in 10 
ml LB supplemented with 1x10-4 M 
IPTG and grown with aeration at 34 °C 
for about 5h. At this time the OD600 
should range between 0.3 and 0.4 (5). 
Assay of β-galactosidase activity was 
performed as described by Miller (14). 
The activity was represented in Miller 
units and was calculated as follows: 
activity (Miller units) = 1,000 × 
A420/(time [min] × volume [culture] × 
optical density at 600 nm). 
 
Construction of pET22b-PrrnD-lacZ 
and pET22b-PaidB-lacZ for 
transcription assays. 
The rrnD P1 and the aidB promoter 
were amplified from DNA genomic of 
E. coli by PCR using the primers listed 
in Table 2. The amplified products 
were digested with SphI and HindIII 
and cloned into the pET22b(+) vector 
which was linearized with the same 
restriction enzymes. Then the lacZ 
gene was positioned downstream the 
rrnD P1 and the aidB promoter using 
HindIII and XhoI. Plasmid 
constructions were verified by 
automated DNA sequencing. 
 
In vivo transcription assays.  
The C41 cells transformed with 
pET22b-PrrnD-lacZ and the C41 cells 
co-transformed with pET22b-PrrnD-
lacZ/pcI434-L2 were grown overnight in 
LB medium at 37°C and then were 
diluted 1:100 in fresh medium and 
selective antibiotics were added. As 
control of the experiment, the C41 cells 
transformed with pET22b-PaidB-lacZ 
and the C41 cells co-transformed with 
pET22b-PaidB-lacZ/pcI434-L2 were 
used. At an optical density at 600 nm 
 
 of 0.9, IPTG was added (final 
concentration 0.05 mM) and cellular 
pellets were collected during the 
growth. The cells were resuspended in 
50 mM Na2HPO4 (pH 7.4), disrupted by 
passage through a French Press and 
centrifuged at 14000 x g for 30 min at 
4°C. The supernatant was collected 
and protein concentration was 
determined with the Bio-Rad protein 
assay (1), using bovine serum 
albumine as standard. β-galactosidase 
activity was determined by measuring 
ONPG-hydrolysis, as described by 
Miller (14). The putative effect of other 
ribosomal proteins (L1, L3, L20, L27) 
on rRNA transcription was also tested 
by in vivo transcription assays. To this 
aim, the C41 cells were co-transformed 
with the following constructs: pET22b-
PrrnD-lacZ/pcI434-L1, pET22b-PrrnD-
lacZ/pcI434-L3, pET22b-PrrnD-
lacZ/pcI434-L20, pET22b-PrrnD-
lacZ/pcI434-L27 and the β-
galactosidase activity was monitored 
during the exponential growth phase. 
As control of the experiment, the C41 
cells co-transformed with pET22b-
PaidB-lacZ and pcI434-L1/L3/L20/L27 
were used. 
 
Results and discussion  
Identification of novel proteins 
associated with the RNAP alpha 
subunit.  
Understanding protein functions as 
well as unravelling cellular 
mechanisms at the molecular level 
constitutes a major challenge in 
modern biology. Both targets can be 
addressed through the identification of 
interacting protein partners in vivo. The 
association of an unknown protein with 
components belonging to a specific 
protein complex involved in a particular 
mechanism would in fact be strongly 
suggestive of its biological function (11, 
13, 17). Furthermore, a detailed 
description of the cellular signalling 
pathways might greatly benefit from 
the elucidation of protein-protein 
interactions in the cell (7, 8). 
Identification of interacting proteins in 
stable complexes in a cellular system 
by functional proteomic approach is 
essentially accomplished by affinity-
based procedures. The basic idea is to 
express the protein of interest with a 
suitable tag to be used as a bait to fish 
its specific partners out from the entire 
cellular extract. Individual components 
within the multi-protein complex are 
then fractionated by SDS-PAGE and 
identified by mass spectrometric 
methodologies. Investigation of the 
regulatory transcriptional network in E. 
coli was carried out by identifying 
transcriptional modulators interacting 
with the RNAP α subunit employing a 
"fishing for partners" strategy 
combined with mass spectrometric 
procedures. The recombinant plasmid 
pET22b-αpol was introduced into the 
E. coli cells and the resulting 
expressed 6x-His tagged RNAP α 
subunit (6HisRNAPα) was purified by 
affinity chromatography on a His-
Select Nickel Affinity Gel. From 1 liter 
of bacterial growth about 20 mg of 
6HisRNAPα pure protein was obtained. 
In a classical pull down experiment, the 
6HisRNAPα was linked to agarose 
beads by His-Ni(2+) interactions and 
the clear bacterial extract was 
incubated with the bait. The 
immobilized protein formed stable non-
covalent interactions with specific 
partners occurring in the E. coli extract 
that were retained on the insoluble 
matrix, while the unbound proteins 
were eluted by repetitive washings. 
After mild washes to eliminate non-
specific interactions, the protein 
components specifically recognised by 
the bait were eluted in Laemli buffer 
and fractionated onto a 10% mono-
dimensional SDS PAGE. An equal 
amount of bacterial extract was 
incubated with His-Select Nickel 
Affinity Gel beads lacking RNAPα  
 
 under the same 
experimental conditions as 
negative control. Figure 1 
shows the resulting SDS-
PAGE gel following colloidal 
Coomassie staining where 
lane 4 and lane 5 
correspond to the negative 
control and the sample, 
respectively. Due to the 
complexity of the gel 
patterns and the low 
resolution of 1D 
electrophoresis, several 
proteins can occur in the 
same gel band.  
Therefore, protein bands 
specifically present in the 
sample lane and absent in 
the control lane cannot be 
identified  by simply 
comparing the two gel 
profiles. The entire lines from 
the sample and the control 
were then cut in slices (38 
slices each) and each gel 
slice was submitted to the 
identification procedure. 
Proteins contained in the 
slices were reduced, 
alkylated and in situ digested 
with trypsin.  
The resulting peptide 
mixtures were directly 
analysed by mass 
spectrometry methodologies 
using both the peptide mass 
fingerprinting procedure and 
LC-MS/MS analyses (12, 17
comparison between the sam
the control was then performed
basis of the proteins ef
identified in each gel slice. C
proteins identified in both the
and the sample slices were di
and only those proteins 
identified in the sample slic
absent in the control were sele
putative RNAPα interactors. F
this procedure, the bait protein 
  
Figure 1. Fractionation of RNAPα interactors by mono-
dimensional SDS PAGE. 
After a preclearing step, the bacterial extract was incubated 
with the 6HisRNAPα linked to agarose beads and the protein 
components specifically recognised by the bait were eluted in 
Laemli buffer. Lane 1, molecular markers; lane 2, total bacterial 
extract; lane 3, unbound proteins not retained by the bait; lane 
4, protein extract retained by His-Select Nickel Affinity Gel 
alone and eluted with Laemli buffer (control); lane 5, proteins 
specifically retained by the bait. ). The 
ple and 
 on the 
fectively 
ommon 
 control 
scarded 
solely 
es and 
cted as 
ollowing 
RNAPα 
was only identified in the sample slice 
C19 with an apparent molecular mass 
of about 40 kDa, whereas it was 
absent in the  corresponding control 
slice 19 and it was not detected in any 
gel slice from the control lane.  
Among many others, we focused our 
attention on the protein occurring in 
band C25 at about 30 kDa (Figure 1, 
lane 5). The MALDI-MS spectrum 
obtained from an aliquot of the tryptic 
digest of band C25  is shown in Figure 
  
Figure 2. MALDI MS analysis of the tryptic digest of band C25. 
Band C25 was in situ digested with trypsin and the resulting peptide mixture extracted from the gel 
and directly analysed by MALDI MS. Peaks labelled with an asterisk were used to search for a non 
redundant sequence database using the MASCOT software, leading to the identification of RPL2. 
2. Peaks labelled with an asterisk were 
used to search for a non redundant 
sequence database using a in-house 
version of the MASCOT software. The 
query returned a highly significant 
match (score 160) with ribosomal 
protein L2, whose predicted molecular 
mass of 30 kDa corresponded to the 
observed electrophoretic mobility of 
band C25. The mass spectral analyses 
led to a sequence coverage greater 
than 50% of RPL2.           
The remaining portion of the tryptic 
digest was analysed by LC/MS/MS. 
Peptides were fractionated by nano-
HPLC directly inserted into the 
nanoelectrospray source and their 
mass values accurately determined. 
Peptide ions were simultaneously 
isolated and fragmented into the mass 
spectrometer producing daughter ion 
spectra from which sequence 
information could be inferred. Several 
sequence stretches were obtained that 
matched peptide fragments occurring 
within RPL2 sequence thus confirming 
previous MALDI data and indicating 
RPL2 as a putative RNAPα interactor. 
No trace of RPL2 could be observed in 
any gel slice from the control lane. 
                The interaction between RNAPα 
subunit and RPL2 proposed by the 
functional proteomic approach had to 
be confirmed by both in vitro and in 
vivo investigations. First, this 
interaction was verified by a totally 
independent approach based on co-
immunoprecipitation experiments. 
Both T7-tagged RNAPα and c-Myc 
labelled RPL2 were co-expressed in 
E. coli C41 cells under the control of 
 
Verification of RNAPα–RPL2 
interaction by co-immunoprecipitation. 
 
 an IPTG inducible promoter. However, 
since it is well known that pET vectors 
always express a small amount of the 
recombinant protein even in the 
absence of induction, stimulation of 
the recombinant cells with IPTG was 
omitted to avoid unnecessary 
overproduction of the two proteins. 
The protein extract from recombinant 
cells was fractionated by SDS-PAGE 
and stained by colloidal Coomassie as 
control. The protein bands 
corresponding to RNAPα and RPL2 
could not be detected, thus ruling out 
overexpression of the two proteins. 
The total protein extract was 
immunoprecipitated by anti-T7 
antibody linked to agarose beads and 
underivatised agarose beads as 
control. Figure 3A shows the Western 
blot of the T7-RNAPα 
immunoprecipitate developed with anti 
c-Myc antibodies to highlight the 
presence of RPL2. A protein band 
 
 
Figure 3. Co-immunoprecipitation experiments. 
Total protein extracts from E. coli strain C41 co-transformed with pET28a-αpol/pET22b-c-Myc-L2 
and with pET28a-αpol/pET22b-c-Myc-Tioredoxin were subjected to immunoprecipitation with 
agarose-linked T7 antibody and with agarose beads alone as control, followed by immunoblotting 
with anti-c-Myc antibody (left panel) and with anti-T7antibody (right panel). In this experiment the 
recombinant RNAPα contains a T7 tag. In all the experiments (A-D), lanes 1-3 corresponding to 
the unbound, the wash and the elution fraction when anti-T7 antibody beads were used while lane 
4 corresponds to the fraction eluted from agarose beads alone. The panels A and B represent the 
T7-RNAPα:c-Myc-L2 coimmunoprecipitation. In A and B, lane 5 contains the purified T7-tagged 
form of RNAPα and lane 6 contains the purified c-Myc tagged form of RPL2. The panels C and D 
represent the absence of T7-RNAPα:c-Myc-Tioredoxin coimmunoprecipitation. In C, lane 5 
contains the purified c-Myc tagged form of Thioredoxin and lane 6 contains the purified T7-tagged 
form of RNAPα. In D, lane 5 contains the purified T7-tagged form of RNAPα and lane 6 contains 
the purified c-Myc tagged form of Thioredoxin.
 
 positive to anti c-Myc antibody was 
clearly detected in lane 3 
corresponding to the anti T7 
immunoprecipitate. A pure c-Myc 
tagged RPL2 sample was loaded in 
lane 6 as control and it was positively 
stained by the antibody whereas pure 
T7-RNAPα was not recognised as 
expected (lane 5).  
The presence of T7-RNAPα in the 
immunoprecipitate was verified by 
developing the Western blot with anti-
T7 antibodies (Figure 3B). A protein 
band of about 40 KDa was clearly 
detected by the antibody in lane 3, that 
perfectly corresponded to pure T7-
RNAPα loaded in lane 5 as control. As 
expected, pure c-Myc RPL2 was not 
recognised by the anti T7 antibody 
(lane 6) thus ruling out any cross 
reactivity in the experiment. No signal 
was generated in the fraction eluted 
from agarose beads alone (lanes 4, 
Figure 3A-B).  
A co-immunoprecipitation experiment 
using T7-tagged RNAPα and an 
unrelated protein, a c-Myc labelled 
Thioredoxin was performed as control 
to rule out any possible artefact in the 
co-IP between RNAPα and RPL2 and 
to confirm the physiological relevance 
of this interaction. Thioredoxin is a 
cytosolic oxidoreductase involved in 
the reduction of other proteins by 
cysteine thiol-disulfide exchange and 
then it is completely unrelated with the 
transcriptional mechanism. The 
recombinant proteins were produced 
in E. coli C41 cells using the same 
experimental conditions described 
above and the total protein extract 
was immunoprecipitated by anti-T7 
agarose-conjugated antibody and 
underivatised agarose beads as 
control. As shown in Figure 3D, when 
the Western blot was developed with 
anti-T7 antibodies, a protein band 
corresponding to pure T7-RNAPα 
loaded in lane 5 as control was clearly 
visible in the lane 3 corresponding to 
fraction eluted from anti-T7 antibody 
beads. On the contrary, Figure 3C 
shows that, when the anti-c-Myc 
antibody was used, a protein band 
corresponding to pure thioredoxin 
(loaded in lane 5 as control) was only 
detected in lane 1 containing the 
unbound material. No trace of this 
band could be observed in the IP lane 
(Fig. 3C, lane 3). These results 
demonstrated that thioredoxin did not 
interact with RNAPα, indicating that, at 
least in the conditions used, no 
aspecific aggregation of the expressed 
proteins had occurred and ruling out 
any possible artefact in the co-IP 
experiments. A biologically 
significative interaction seems to take 
place between RNAPα and RPL2 
confirming previous proteomic data. 
 
Investigation of RNAPα-RPL2 
interaction.  
A further question to be addressed was 
whether RNAPα and RPL2 proteins 
gave origin to a direct interaction or 
they just belong to the same multi-
protein complex. To address this point, 
we designed a biochemical experiment 
based on the bacterial two hybrid 
system (5). 
The genes coding for RNAPα and 
RPL2 were cloned in the two plasmid 
vectors pcIP22 and pcI434 which 
contained the N-terminal domain of 
phage 434 and P22 repressor, 
respectively. The recombinant 
plasmids obtained were used to 
transform the E. coli strain R721 that 
harbours the 434-P22 chimeric 
operator located upstream the lacZ 
gene. If RNAPα and RPL2 had given 
origin to a direct interaction, a 
functional repressor would be 
produced and the β-galactosidase 
activity expressed by lacZ gene would 
be decreased. 
The ability of the reconstituted 
repressor to bind to the chimeric 
operator and to affect enzymatic 
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 Table 3. Two-hybrid assay. 
(a) The pcI plasmids were inserted into E. coli strain R721 by transformation and the ability of the 
reconstituted repressors to bind to the chimeric operator was then tested by measuring the 
residual β-galactosidase activity. (b) Two-hybrid assay to investigate the interaction between 
RNAPα and RPL2. The plasmids pcIP22-RNAPα and pcI434-L2 were both expressed in E. coli 
R721 cells and the residual β-galactosidase activity was recorded. In the absence of any pcI 
plasmid, strain R721 produced 2500 Miller units of β-galactosidase activity (mean of 5 
independent experiments). Other values are the mean of 9 independent experiments. 
pcI plasmids β-galactosidase       proportion of residual         
    (Miller units)             β-galactosidase activity (%) 
(a) 
pcI434 2350±2.5    95% 
pcIP22 2517±3.4 100% 
pcIP22+pcI434 2373±1.5   94.1% 
pcI434-434 1886±2.6   75% 
pcIP22-434 2113±3.1   86% 
pcI434-434+pcIP22-434   351±2.7   14% 
 
(b) 
pcIP22-RNAPα 1915±1.8   76.2% 
pcI434-RPL2 1829±2.5   72.7% 
pcI434-RNAPα 2200±3.4   88% 
pcIP22-RNAPα+pcI434-RPL2   880±2.9   35% 
pcIP22-RNAPα+pcI434-RNAPα    401±3.2   16%  
 
ctivity was tested by measuring the 
esidual β-galactosidase activity 
ollowing induction of the bacterial cells 
ith 0.1 mM IPTG. The results are 
eported in Table 3. When the 
lasmids pcIP22-RNAPα and pcI434-
PL2 were both expressed in E. coli 
721 cells, a considerable decrease in 
he β-galactosidase activity was 
ecorded with the residual enzymatic 
ctivity dropping down to 35%. 
ince RNAPα is known to form a 
unctional dimer, the plasmids pcIP22-
NAPα and pcI434-RNAPα were also 
o-expressed in R721 cells as control. 
s expected, when RNAPα gave 
rigin to the dimeric structure, a 
unctional repressor was produced 
nd the β-galactosidase activity 
ecreased to 16% of the initial value. 
he results of the bacterial two hybrid 
ssay demonstrated that a direct 
nteraction occurs between RNAPα 
nd RPL2 within the multi-protein 
complex. 
 
RPL2 is a transcriptional modulator.  
Finally we addressed the point whether 
the binding of RPL2 to RNAPα might 
have a functional role in modulating the 
transcription mechanism in E. coli. 
Since RPL2 is essential for growth and 
survival of E. coli, we could not design 
a knock-out gene experiment. The 
putative transcriptional role of the 
interaction between RNAPα and RPL2 
was then investigated by in vivo 
transcription experiments using a 
classic gene reporter assay. 
The lacZ gene coding for E. coli β-
galactosidase was cloned into the 
pET22b(+) expression vector, under 
the control of the ribosomal promoter 
rrnD P1, originating the recombinant 
expression vector pET22b-PrrnD-lacZ. 
The rrnD promoter P1 used contains 
the DNA sequence extending from -61 
to +1 including the core promoter plus 
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ure 4. In vivo transcription assays. 
 E. coli C41 cells were transformed with pET22b-PrrnD-lacZ or with pET22b-PaidB-lacZ vector 
 the β-galactosidase specific activity was monitored in the absence and in the presence of the 
ombinant proteins L1, L2, L3, L20 and L27. The β-galactosidase activity was evaluated at log 
se. White bars represent the β-galactosidase activity in the absence of recombinant production; 
y bars represent the β-galactosidase activity when recombinant L2 is overproduced; black bars 
resent the β-galactosidase activity measured in the presence of L1/L3/L20 or L27. Means and 
dard deviations have been calculated from three independent assays.  upstream element (Table 2). The 
e coding for RPL2 was cloned into 
 pcI434 plasmid, generating the 
ombinant expression vector pcI434-
 The two compatible expression 
tors were then used to co-transform 
oli C41 cells. The same cells were 
sformed with pET22b-PrrnD-lacZ 
tor alone as control. E. coli cells 
e allowed to grow and the β-
ctosidase activity was monitored in 
h cell cultures. Figure 4 shows the 
ults obtained. A large increase in 
 β-galactosidase activity could 
rly be observed in the E. coli cells 
ducing recombinant RPL2 as 
compared to the control. These finding 
suggested that the ribosomal protein 
might act as a transcriptional activator 
of the ribosomal operon rrnD. 
The specificity of RPL2 toward the rrnD 
promoter P1 was tested by an in vivo 
transcription assay using β-
galactosidase as reporter gene under 
the control of an unrelated promoter, 
the aidB promoter. The PaidB used 
contains the DNA sequence extending 
from -61 to +1 including the core 
promoter plus the upstream element 
(Table 2). As shown in Fig 4, 
recombinant RPL2 did not affect β-
galactosidase expression when the 
 aidB promoter was used in the assay, 
as the enzymatic activity in cell 
cultures transformed with the 
constructs pET22b-PaidB-lacZ and 
pcI434-L2 remains unchanged. These 
data confirmed previous results, that 
RPL2 is a transcriptional regulator 
specific for the ribosomal promoter 
rrnD P1. 
In addition, to ensure that the effect on 
rrnD P1 could be specifically attributed 
to RPL2, the putative role of other 
ribosomal proteins on rRNA 
transcription was tested. As 
appropriate controls, four proteins of 
the bacterial ribosome were chosen: 
L1 and L3 that are relatively large 
ribosomal proteins such as L2; L20, a 
ribosomal protein that participates in 
the early assembly steps of the 50 S 
ribosomal subunit (18) and L27 that is 
a relatively late assembly protein (22). 
As clearly shown in Fig. 4, L1, L3, L20 
and L27 were unable to affect lacZ 
expression driven by both rrnD P1 and 
PaidB, thus demonstrating the specific 
and direct role of RPL2 on rRNA 
expression. 
Besides their role in ribosome 
assembling, several ribosome proteins 
have been shown to fulfil other 
biological functions in the cell. One of 
the best characterised functions is the 
ability of some E. coli ribosomal 
proteins to regulate the translation of 
their own multicistronic mRNAs (23). 
Other E. coli ribosomal proteins have 
been demonstrated to play roles in 
transcriptional antitermination (S4 and 
S10) or to be involved in DNA repair 
and replication (S9 and L14) (21). Data 
reported in this paper showed that the 
highly conserved RPL2 protein is 
involved in transcription regulation by 
acting as an activator of the ribosomal 
operon transcription. Moreover, the 
functional proteomic approach 
indicated that RPL2 belongs to a large 
multi-protein transcription complex that 
gathers at the RNAPα subunit. Finally, 
we demonstrated that the 
transcriptional activator function 
exerted by RPL2 is carried out through 
the direct and specific binding of the 
ribosomal protein to the α subunit of 
the RNA polymerase. 
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bstract
A regulative two-component system previously identified in Pseudoalteromonas haloplanktis TAC125 was used to construct a
old inducible expression system that is under the control of l-malate. Performances of the inducible system were tested for both
sychrophilic and mesophilic protein production using two “difficult” proteins as control. The results obtained demonstrated that
oth psychrophilic -galactosidase and yeast -glucosidase are produced in a fully soluble and catalytically competent form.
ptimal conditions for protein production, including growth temperature, growth medium and l-malate concentration were
lso investigated. Under optimized conditions yields of 620 and 27 mg/l were obtained for -galactosidase and -glucosidase,
espectively.
2006 Elsevier B.V. All rights reserved.
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. Introduction
Incorrect folding of the nascent polypeptide chains
s one of the main problems occurring during heterol-
gous protein production in bacteria. A key role in this
rocess is played by intermolecular hydrophobic inter-
∗ Corresponding author at: Dipartimento di Chimica Organica e
iochimica, Complesso Universitario di Monte Sant’Angelo, Via
inthia, 80126 Napoli, Italy. Tel.: +39 081674314;
ax: +39 081674313.
E-mail address: anduilio@unina.it (A. Duilio).
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doi:10.1016/j.jbiotec.2006.07.003lactosidase; -Glucosidase
ctions taking place among partly folded intermediates
hat cause protein molecules to stick together thus driv-
ng them away from the productive folding pathway
Georgiou and Valax, 1996). Since formation of inclu-
ion bodies often impairs the recombinant production
f valuable proteins, many experimental approaches
ave been explored to minimize this undesirable effect,
ncluding expression of chimerical proteins (Mitra et
l., 2005) and co-expression with chaperonines (Luo
nd Hua, 1998). Expression of “difficult” proteins has
lso been carried out by lowering the temperature
t the physiological limit allowed for the growth of
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esophilic host organisms (between 15 and 18 ◦C for
scherichia coli). Lowering the temperature, in fact,
as a pleiotropic effect on the folding process, desta-
ilising the hydrophobic interactions needed for inter-
ediates aggregation (Jeon et al., 1995). Although in
ome cases this approach has been reported to increase
ields of soluble and active recombinant protein prod-
cts, the exploitation of an industrial process performed
t suboptimal growth condition of the expression host
ight hardly be considered.
A rational alternative to mesophilic organisms is
he use of naturally cold-adapted bacteria as hosts for
rotein production at low temperature (even at around
◦C). The development of a shuttle genetic system for
he transformation of the cold adapted Gram-negative
acterium Pseudoalteromonas haloplanktis TAC125
PhTAC125) (Birolo et al., 2000; Tutino et al., 2001)
as already been reported. This system has made it
ossible the isolation of constitutive psychrophilic pro-
oters and the construction of cold expression sys-
ems for the homologous/heterologous protein pro-
uction at low temperatures (Duilio et al., 2004a,b).
he described expression system represented the first
xample of heterologous protein production based on a
rue cold-adapted replicon (Duilio et al., 2003). How-
ver, the development of an effective cold expression
ystem needs to be finely tuned possibly using ad
oc promoters. Physical separation between bacterial
rowth phase and expression of the desired proteins,
n fact, cannot only improve the productivity of the
ntire system but can also play an important role in
he production of proteins toxic for the host cells.
hese goals can only be achieved by using regulated
romoters and efficient induction strategies. Recently,
sing a proteomic approach and taking advantage
rom the genome sequence of PhTAC125 (Medigue
t al., 2005) we isolated and characterized a func-
ionally active two-component system. The regulatory
ystem (PSHAb0361–PSHAb0362) is involved in the
ranscriptional regulation of the gene coding for an
uter membrane porin (PSHAb0363), and it is strongly
nduced by the presence of l-malate in the medium
Papa et al., in press).
In this paper we used the regulative region com-
rising the two-component system located upstream
he PSHAb0363 gene to construct an inducible expres-
ion vector, named pUCRP that is under the control
f l-malate. Performances of the inducible system
e
f
Pology 127 (2007) 199–210
ere tested for both psychrophilic and mesophilic
rotein production using two “difficult” proteins as
odel systems. Moreover, an evaluation of optimal
nduction conditions for protein production was also
arried out. Data presented in this paper demon-
trated that both psychrophilic -galactosidase from
hTAE19 (Hoyoux et al., 2001) and mesophilic -
lucosidase from Saccharomyces cerevisiae (Kopetzki
t al., 1989a,b) are produced in PhTAC125 in good
ields and in a completely soluble and catalytically
ompetent form.
. Materials and methods
.1. Bacterial strains, DNA constructs and media
Pseudoalteromonas haloplanktis TAC125
PhTAC125) (Birolo et al., 2000), a Gram-negative
acterium was grown in aerobic conditions at 4
nd 15 ◦C in minimal medium (1 g/l KH2PO4, 1 g/l
H4NO3, 10 g/l NaCl, 0.2 g/l MgSO4 × 7H2O,
0 mg/l FeSO4, 10 mg/l CaCl2 × 2H2O, supplemented
ith casamino acid 0.5% w/v and different con-
entration of l-malate when requested) and in TYP
roth (16 g/l yeast extract, 16 g/l bacto tryptone,
0 g/l marine mix) at pH 7.5, supplemented with
00g/ml ampicillin if transformed. The plasmids
ere mobilized into P. haloplanktis TAC125 by
nterspecific conjugation using the transformed E.
oli S17-1 (λpir) cells as donor (Tascon et al., 1993).
liquots (100l) of logarithmic cultures of the donor
nd the recipient strains were mixed and spotted
s a drop onto TYP plate. After 16 h of mating at
5 ◦C, the cells were resuspended in 200l of TYP
edium. Psychrophilic transconjugants were selected
y plating serial dilutions at 4 ◦C on TYP plates
ontaining 100g/ml ampicillin (Tutino et al., 2001).
.2. Construction of the expression vectors
Plasmids are all reported in Table 1.
Genomic DNA preparation from PhTAC125 was
arried out as previously described (Tosco et al., 2003).
The pUCRP inducible cold-adapted gene-
xpression vector was constructed by cloning DNA
ragment corresponding to the cold-active promoter of
(PSHAb0363) vector (Papa et al., in press; http://
R. Papa et al. / Journal of Biotechnology 127 (2007) 199–210 201
Table 1
Plasmids and oligonucleotides
Plasmid Description References
P(PSHAb0363) pPLB containing the PSHAb0363 promoter region (PhTAC125
genome chromosome II from 423068 to 419631 bp)
Papa et al. (in press)
pPLB Promoter-trap cold-adapted vector containing the promoter-less
PhTAE79 lacZ gene
Duilio et al. (2004a,b)
pUCLT/Rterm Vector deriving from the pUC18 plasmid, containing the T/R box
and the transcription termination signal from PhTAC125 aspC gene
Tutino et al. (2002)
pUCRP pUCLT/Rterm containing PSHAb0363 promoter region This work
pPM4 pUCLT/Rterm containing P4 PhTAC125 promoter region (422 bp,
GenBank accession number AJ557253)
Duilio et al. (2004a,b), Siani et al. (in press)
pPM4GLUCPl Expression vector containing ScGLUCPl gene Duilio et al. (2003)
pKK-177GLUCPl Recombinant vector for the cytoplasmic, IPTG-inducible
production of ScGLUCPl in Escherichia coli
Kopetzki et al. (1989a)
pUCRPGLUCPl pUCRP containing ScGLUCPl gene This work
Oligonucleotide
PSHAb0363a Fw 5′-CAAAGCTAGGCAAAGCTTAATTATAC-3′
PSHAb0363a Rv 5′-CCTGGATCCAATATCGATAGTTTTACG-3′
PSHAb0363b Fw 5′-GATGGACGTCTAGAACTATCGATATTAG-3′
PSHAb0363b Rv 5′-CCTTCAATCTAGATATCTGCAGGAGTATC-3′
PSHAb0363c Fw 5′-GATACTCCTGCAGATATATTAATTG-3′
PSHAb0363c Rv 5′-GTTTAACGTGTCTGCAGTTTATCATATGGTGTCC-3′
ATATG
TTTCG
w
p
T
p
d
d
(
F
g
f
P
d
r
fi
p
w
b
n
o
w
t
o
2
i
a
p
t
1
a
p
t
2
p
α
B
g
t
d
uAG1 5′-CAAGCTTACACAGGAAGAGAAATC
AG2 5′-GGGGAATCTGGTAAACCAGGACG
ww.bioinfo.hku.hk/GenoList/index.pl?database=
sychrolist) into pUCLT/Rterm vector (Fig. 1,
able 1).
P(PSHAb0363) promoter region was inserted into
UCLT/Rterm vector by a three steps procedure as
escribed in Fig. 1. The first step consisted in the
ouble HindIII/ClaI digestion of a 1700 bp fragment
PCR amplified by using the primers PSHAb0363a
w and PSHAb0363a Rv and the PhTAC125 DNA
enomic as template). In the second step a 750 bp
ragment was amplified using PSHAb0363bFw and
SHAb0363b Rv as primers and double ClaI/PstI
igested. Finally, the third fragment containing the 3′
egion of P(PSHAb0363) promoter region was ampli-
ed using PSHAb0363c Fw and PSHAb0363c Rv as
rimers and PstI digested. The amplified fragments
ere cloned into pUCLT/Rterm corresponding sites
y using two consecutive ligation reactions, and their
ucleotide sequence checked to rule out the occurrence
f any mutation during synthesis. The resulting vector
as called pUCRP (Table 1).
The amplifications were performed using in a mix-
ure containing 60 ng of template, 50 pmol of each
ligonucleotide primer, 1.8 mM, MgCl2, 50 mM KCl,
2
(
aACTATTTC-3′
AATAC-3′
0 mM Tris–HCl pH 8.3, 0.1% gelatine, 200M dNTP
n a final volume of 50l. The mixtures were incubate
t 95 ◦C for 10 min, after which 1.25 U of Taq DNA
olymerase were added. Twenty cycles of amplifica-
ion (consisting of 1 min at 95 ◦C, 1.5 min at 58 ◦C and
min at 72 ◦C) were carried out and were followed by
cycle in which the extension reaction at 72 ◦C was
rolonged for 10 min in order to complete DNA syn-
hesis.
.3. Construction of expression vectors for the
roduction of Saccharomyces cerevisiae
-glucosidase in PhTAC125
The S. cerevisiae MAL12 gene (ScMAL12, Gen-
ank accession no. E.C.3.2.1.20), encoding the -
lucosidase (Kopetzki et al., 1989a) was inserted into
he pUCRP expression vector by a single step proce-
ure, consisting in the double NdeI/BamHI digestion
sing pPM4GLUCPl plasmid as template (Duilio et al.,
003). The resulting vector was called pUCRPGLUCPl
Table 1).
pPM4GLUCPl expression vector was generated by
two-step procedure, the first one consisting in the
202 R. Papa et al. / Journal of Biotechnology 127 (2007) 199–210
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Pig. 1. Construction of pUCRP expression vector. (A) PhTAC125
(PSHAb0363) vector (Papa et al., in press). (B) pUCLT/Rterm pro
ouble NdeI/PstI digestion of a 580 bp fragment (PCR
mplified by using the AG1 and AG2 primers and
he expression vector pKK-177GLUCPl as template).
n the second step, a 1180 bp fragment, containing
he 3′ region of MAL12 gene, was recovered from
KK-177GLUCPl (Kopetzki et al., 1989a) by a double
stI/BamHI digestion. Finally, the two fragments were
igated into the pPM4 vector (Siani et al., in press),
reviously digested with NdeI and BamHI, generating
he plasmid pPM4GLUCPl (Table 1). A DNA sequenc-
ng reaction was performed on the ScMAL12 amplified
egion to rule out the occurrence of mutations intro-
uced by the PCR synthesis.
.4. Enzymatic assays and analytical procedures
Duplicate cultures of recombinant PhTAC125 cells
ere aerobically grown in liquid culture and cellu-
ar pellets (corresponding to 25 OD600 nm) were col-
ected during the growth. The cells were resuspended in
ml of lysis buffer (100 mM sodium phosphate, 5 mM
m
p
6
εgenomic fragment corresponding to the cold-active promoter of
ss vector. (C) pUCRP expression vector.
DTA, 2% Triton X-100, 1 mM PMSF, 1 mM DTT, and
mg/ml lisozyme, pH 7.8), and incubated for 20 min
t 15 ◦C. After a centrifugation step of 20 min at 4 ◦C
500 × g, the supernatant was collected.
Protein concentration was determined with the Bio-
ad protein assay (Bradford, 1976), using bovine
erum albumine as standard.
Recombinant cold-active -galactosidase was
ssayed spectrophotometrically at 25 ◦C as previously
eported (Hoyoux et al., 2001), and calculation were
erformed on the basis of an extinction coefficient
or o-nitrophenol of 3.5 mM−1 cm−1 at 410 nm and
pecific activity of 138.2 U/mg purified enzyme
Hoyoux et al., 2001). Catalytic parameters were
etermined as reported in Hoyoux et al., 2001.
-Glucosidase production was assayed using 5 mM
NPG (p-nitrophenyl--d-glucopyranoside) as chro-
ogenic substrate at 25 ◦C in 100 mM potassium phos-
hate, 1 mM MgCl2, 100 mM 2-mercaptoethanol, pH
.8, and calculated on the basis of the p-nitrophenol
410 nm = 1.8 mM−1 cm−1 and specific activity of
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30 U/mg purified enzyme (Kopetzki et al., 1989a).
atalytic parameters were determined as reported in
opetzki et al. (1989a,b).
.5. In situ digestion
The protein bands stained by Colloidal Comassie
Pierce) and containing the proteins to be identified
ere excised, cut in small pieces and washed in 50 mM
mmonium bicarbonate pH 8.0 in 50% acetonitrile to a
omplete destaining. The gel pieces were re-suspended
n 50 mM ammonium bicarbonate pH 8.0, reduced with
0 mM DTT at 56 ◦C for 45 min and alkylated with a
5 mM solution of iodoacetamide in the same buffer for
0 min at room temperature in the dark. The excess of
eagent was descarded and the gel pieces were washed
everal times with the buffer, resuspended in 50 mM
mmonium bicarbonate and incubated with 100 ng of
rypsin for 2 h at 4 ◦C and overnight at 37 ◦C. The
upernatant containing peptides was removed and the
emaining gel pieces were washed with acetonitrile in
rder to extract the peptides still present in the gel.
hese two fractions were then collected and freeze-
ried.
.6. MALDI MS analysis and protein identiﬁcation
MALDI mass spectra were recorded on an
pplied Biosystem Voyager DE-PRO mass spectrom-
ter equipped with a reflectron analyser and used
n delayed extraction mode. A 1l of peptide sam-
le was mixed with an equal volume of -cyano-4-
ydroxycynnamic acid as matrix (10 mg/ml in 0.2%
FA in 70% acetonitrile), applied to the metallic sam-
le plate and air dried. Mass calibration was performed
y using the standard mixture provided by manufac-
urer. Raw data, reported as monoisotopic masses, were
hen introduced into MASCOT peptide fingerprinting
earch program (by Matrix Science, Boston, USA)
vailable on the net and used for protein identification.
. Results and discussionThe isolation and the structural and functional char-
cterization of a l-malate inducible promoter from
hTAC125 has already been reported (Papa et al., in
ress). This promoter, named P(PSHAb0363), is able to
p
t
wology 127 (2007) 199–210 203
irect the expression of a promoter-less psychrophilic
acZ gene, exhibiting a 13-fold increase in the -
alactosidase activity when l-malate was added to the
edium (Papa et al., in press). Performances of this
nducible system were tested both for psychrophilic and
esophilic protein production using the psychrophilic
-galactosidase from P. haloplanktis TAE79 and the S.
erevisiae -glucosidase. These proteins were chosen
ecause they can hardly be expressed in recombinant
orm in mesophilic hosts even at sub-optimal temper-
ture conditions. When the -galactosidase was pro-
uced in E. coli cells at 18 ◦C, 20 mg of catalytically
ctive enzyme was produced per liter of culture (Feller,
ersonal communication). Analogously, recombinant
east -glucosidase produced in E. coli aggregates in
nsoluble form, the active soluble amount of protein
eing less than 1% of the total production (Le Thanh
nd Hoffmann, 2005).
.1. Psychrophilic protein production in
hTAC125
The cold-active promoter P(PSHAb0363) was used
o construct an inducible cold-adapted gene-expression
ector named pUCRP containing the gene coding
or the -galactosidase from P. haloplanktis TAE79.
hTAC125 cells harbouring -galactosidase were
rown in liquid culture in minimal medium in the pres-
nce and in the absence of l-malate at 15 ◦C up to
he stationary phase. An aliquot of each culture was
ollected and the soluble protein content was ana-
yzed by SDS gel electrophoresis. Fig. 2A shows the
oomassie blue-stained gels corresponding to the pro-
ein extracts from PhTAC125 recombinant cells grown
n the absence and in the presence of l-malate. The
resence of a strong 118 kDa extra-band could clearly
e detected in the cellular extract grown in the presence
f the inducer (panel A, lane 3). In the absence of l-
alate, only a tiny band with the same electrophoretic
obility was observed (panel A, lane 2). These data
uggest that under the control of the inducible expres-
ion system -galactosidase is produced in PhTAC125
nly in the presence of l-malate, indicating an unde-
ectable basal activity of the inducible P(PSHAb0363)
romoter.
The unambiguous identification and a detailed struc-
ure characterization of the expressed -galactosidase
ere obtained by mass spectrometric analysis of the
204 R. Papa et al. / Journal of Biotechnology 127 (2007) 199–210
Fig. 2. Recombinant production of the thermally labile -galactosidase from PhTAE19 in PhTAC125 cells. Panel A: 7.5% SDS PAGE gel
electrophoresis of protein extracts from PhTAC125 cells harboring P(PSHAb0363) and grown in minimal medium in the absence (lane 2) and
in the presence (lane 3) of l-malate, in comparison with -galactosidase from PhTAE79 used as control (lane 1); molecular weight marker (lane
4). The recombinant protein is indicated by an open box. Panel B: MALDI-TOF analysis of the -galactosidase peptides generated by tryptic
digestion. Panel C: Mascot Search Results.
iotechnology 127 (2007) 199–210 205
c
(
t
a
r
t
t
o
t
M
t
b
u
t
g
g
g
a
t
a
b
T
a
t
T
t
d
r
u
r
4
t
d
s
p
Table 2
Catalytic parameters of psychrophilic -galactosidase and meso-
philic -glucosidase produced in PhTAC125 in comparison with
those determined for the purified enzymes
Proteins KM (mM)
-Galactosidase produced in PhTAC125 0.25 ± 0.04
Purified -galactosidase (Feller, personal
communication)
0.21
-Glucosidase produced in PhTAC125 0.18 ± 0.02
Purified -glucosidase (Kopetzki et al., 1989a) 0.2
KM value for -galactosidase was determined according to the assay
conditions reported in Hoyoux et al. (2001) using -oNPG as sub-
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orresponding Coomassie blue stained protein band
Fig. 2A, lane 3) following in situ digestion with
rypsin. The resulting peptide mixture was directly
nalysed by MALDI mass spectrometry and the accu-
ate mass values recorded in the spectra were used
o search for the entire NCBI protein databank using
he MASCOT software. Fig. 2C shows the outcome
f the search procedure that unambiguously identified
he protein band as the P. haloplanktis -galactosidase.
ass spectral data allowed us to verify a large por-
ion of the -galactosidase (Fig. 2B), ruling out possi-
le modification and/or mutation of the protein prod-
ct. This structural characterization demonstrated that
he recombinant product was indeed the expected -
alactosidase from PhTAE79.
To test the catalytic activity of recombinant -
alactosidase, PhTAC125 recombinant cells were
rown in liquid culture at 4 and 15 ◦C both in the
bsence and in the presence of l-malate up to the sta-
ionary phase. -Galactosidase catalytic activity was
ssayed in the cell lysates as previously described
y Hoyoux et al. (2001) using -ONPG as substrate.
he KM for the synthetic substrate was determined
nd found to be almost identical to that obtained for
he purified enzyme (Feller, personal communication;
able 2), thus indicating that the protein had assumed
he correct native conformation.
Since wild type PhTAC125 does not show any
etectable -galactosidase activity, the lysate from
ecombinant cells harbouring the void vector was
sed as negative control. The specific activity of the
ecombinant enzyme is reported in Table 3. Both at
and 15 ◦C enzymatic activity greatly increases in
he presence of l-malate, being the largest increase
etected at 15 ◦C. These data demonstrated that a
oluble psychrophilic -galactosidase is efficiently
roduced in PhTAC125 in a catalytically competent
c
t
i
able 3
-Galactosidase and -glucosidase specific activities (U/mg) from PhTAC
5 ◦C grown in minimal medium (MM) in the presence and in the absence o
Specific activity (U/mg) ± S.D.
-Galactosidase
4 ◦C 15 ◦C
M 0.21 ± 0.05 0.86 ± 0
M + l-malate 2.12 ± 0.05 11.42 ± 1
ata shown are the average of 12 measurements. S.D.: standard deviation.trate. KM value for -glucosidase was determined according to the
ssay conditions reported in Kopetzki et al. (1989a) using -pNPG
s substrate.
orm. The transcriptional activity of the inducible
ystem was further investigated by monitoring -
alactosidase activity during the exponential and
he late-stationary growth phase. These experiments
emonstrated that -galactosidase activity remained
nchanged during cellular growth from the exponential
o the late stationary phase (data not shown).
.2. Induction conditions
Once the production of a recombinant biologically
ctive -galactosidase in PhTAC125 was defined, dif-
erent induction conditions were tested to optimize the
roductivity of the P(PSHAb0363) inducible system.
his procedure consisted in two consecutive steps: (i)
efinition of the optimal cellular growth phase in which
xpression of the heterologous gene has to be induced
definition of t0); (ii) definition of the optimal inducer
oncentration to obtain higher levels of expression of
he psychrophilic gene (definition of C0).
PhTAC125 recombinant cells were grown in min-
mal medium in the absence of l-malate at 15 ◦C.
125 cells harbouring P(PSHA0363) and pUCRPGLUCPl at 4 and
f l-malate, respectively
-Glucosidase
4 ◦C 15 ◦C
.02 0.03 ± 0.00 0.03 ± 0.00
.05 0.31 ± 0.03 0.75 ± 0.05
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Fig. 3. Optimal conditions of induction for the -galactosidase
production. (A) Time of induction (t0). -Galactosidase produc-
tion yield in PhTAC125 cells harbouring P(PSHAb0363) grown
in minimal medium (MM) obtained by adding l-malate 0.2% at
different time (t0) during cellular growth curve. The correspond-
ing optical density before l-malate addiction were: early expo-
nential phase t0 = 5 h (OD 600 nm = 0.32 ± 0.03); mid exponential
phase t0 = 7 h (OD 600 nm = 0.53 ± 0.04); early stationary phase
t0 = 10 h (OD 600 nm = 1.31 ± 0.08); mid stationary phase t0 = 23 h
(OD 600 nm = 1.92 ± 0.10). (B) Concentration of inductor (C0).
-Galactosidase production yield in PhTAC125 cells harbouring
P(PSHAb0363) grown in minimal medium (MM) obtained by adding
l-malate at mid-exponential phase at four different concentrations
(C0). -Galactosidase activity was monitored before the addition
of inducer (as negative control of the experiment), and 2–8–24 h
a
(
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c
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nduction of psychrophilic gene expression was tested
y adding l-malate 0.2% at four different phases
uring cellular growth, i.e. early (t0 = 5 h; OD
00 nm = 0.32 ± 0.03) and mid (7 h; OD 600 nm = 0.53
0.04) exponential phase, early (10 h; OD 600 nm =
.31 ± 0.08) and mid (t0 = 23 h; OD 600 nm = 1.92 ±
.10) stationary phase. Recombinant -galactosidase
ctivity was monitored before the addition of the
nducer and 2, 8 and 24 h after the induction (t1).
ig. 3A shows the yield of -galactosidase, expressed
s mg of protein/l (Hoyoux et al., 2001), and the induc-
ion ratios (IR) obtained at the four different phases cal-
ulated as a ratio of -galactosidase yield at a specific
ime after the induction (t1) with respect to that before
nduction (t0). The best induction ratios (t1/t0) were
bserved when l-malate was added during the expo-
ential phase, with the highest ratio detected in the mid-
xponential phase. High levels of recombinant enzyme
an be already detected on cell lysates after 8 h from
nduction, but maximal -galactosidase production
as recorded at t1 = 24 h from induction (716 mg/l).
The second step in the optimization procedure con-
isted in the definition of the optimal concentration
f inductor (C0). Four different concentrations of l-
alate 0.2%, 0.4%, 1% and 5%, were added to recom-
inant PhTAC125 cells, at mid-exponential phase. Cell
ysates were collected at 2, 8 and 24 h from induc-
ion and -galactosidase activity was assayed. Yield
f -galactosidase and calculated induction ratios are
eported in Fig. 3B. Lower concentrations of inducer
ielded the highest IR values with the maximum effect
btained using 0.4% l-malate. In these experiments,
he results obtained at 0.2% l-malate, were slightly dif-
erent from those reported in Fig. 3A possibly due to a
lightly higher basal -galactosidase activity, although
he final enzyme production at 24 h was very similar
561 mg/l). Higher concentration of l-malate resulted
n a strong reduction in the IR value, probably due to
n effect of the dicarboxylic acid on the osmotic equi-
ibrium of the cell; in particular when 5% l-malate
as added to recombinant cells, a decrease of cellu-
ar growth was observed (data not shown). Also in
his case, the highest production was obtained when
ell lysates were collected 24 h after the induction
620 mg/l).
Finally, effect of the growth medium on produc-
ion of the recombinant enzyme was investigated.
hTAC125 recombinant cells were grown at 15 ◦C
f
s
i
cfter the induction (t1). Numbers above bars refer to induction ratios
t1/t0). Means and standard deviations have been calculated from
our independent assays.
n both minimal (MM) and complex medium (Typ).
ccording to the conditions previously determined,
ells were induced with 0.4% l-malate at mid expo-
ential phase and cell lysates were collected after 24 h
rom the induction. Table 4 summarises the results
howing that recombinant -galactosidase production
n induced cells is always higher than that observed for
ells not treated with l-malate. The inducer has a much
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Table 4
-Galactosidase and -glucosidase production yields from
PhTAC125 cells harbouring P(PSHA0363) and pUCRPGLUCPl
grown at 15 ◦C in minimal medium (MM) and in rich medium
(Typ) in the presence and in the absence of l-malate, calculated
accordingly to Hoyoux et al. (2001) and Kopetzki et al. (1989a),
respectively
Production yield (mg/1) ± S.D.
-Galactosidase -Glucosidase
MM 12.8 ± 0.3 0.64 ± 0.00
MM + l-malate 620 ± 24 26.7 ± 1.8
TYP 5.6 ± 1.0 0.43 ± 0.04
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iYP + l-malate 25.0 ± 0.9 9.22 ± 0.04
he data shown are the average of 12 measurements. S.D.: standard
eviation.
igher effect (almost one order of magnitude) in min-
mal than in rich medium, showing a 48-fold increase
n -galactosidase production in MM compared to the
.5-fold observed in Typ medium. Many reasons can
ccount for this observation including competition for
ntry and interference with regulation networks due to
he presence of many related metabolites in the rich
edium.
.3. Production of a mesophilic protein in
hTAC125
For the expression of the S. cerevisiae -
lucosidase, the ScMAL12 gene encoding the yeast
nzyme was inserted into the inducible expression vec-
or pUCRP, as described in Section 2. The recombinant
ector was mobilized into PhTAC125 cells and the
sychrophilic transconjugants were grown in minimal
edium both in the absence and in the presence of l-
alate at 15 ◦C up to the late exponential phase. Cell
ellets were collected, disrupted and the soluble protein
ractions were analysed by SDS gel electrophoresis.
s shown in Fig. 4A, the presence of a protein band
howing an electrophoretic mobility similar to that of
ommercial yeast -glucosidase (lane 1) was clearly
etectable (lane 3). This band is not present in the
xtract from recombinant PhTAC125 cells grown in
he absence of l-malate (lane 2), suggesting that a sol-
ble -glucosidase is produced by the psychrophilic
nducible system only upon treatment with l-malate.
Cellular insoluble fractions were also analysed to
etect any recombinant -glucosidase aggregated in
nclusion bodies. However, the SDS-PAGE analysis
m
a
l
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uled out the occurrence of any protein band cor-
esponding to the yeast enzyme (data not shown)
hus demonstrating that the recombinant-glucosidase
s only produced in soluble form in the psy-
hrophilic system. The unambiguous identification and
detailed structure characterization of the expressed
-glucosidase were obtained by mass spectrometric
nalysis as described above. The results are shown
n Fig. 4B and C. Mass spectral data were used by
he MASCOT software to search for the NCBI pro-
ein databank leading to a clear identification of the
east enzyme (Fig. 4B). The peptide mass fingerprint-
ng procedure showed that the identified peptides were
cattered along the entire -glucosidase sequence, rul-
ng out the possible occurrence of genetic rearrange-
ent. This structure characterization demonstrated that
he recombinant product was indeed the expected -
lucosidase from Saccharomyces cerevisiae.
The biological activity of the recombinant enzyme
as tested by enzymatic assay following the
elease of p-nitrophenol from p-nitrophenyl--d-
lucopyranoside (PNPG) at 410 nm (Kopetzki et al.,
989a). As for -galactosidase, the calculated KM
or the synthetic substrate was nearly identical to the
eported by Kopetzki et al. (1989a) for the purified
nzyme, indicating a correct folding process of the
ecombinant protein (Table 2).
PhTAC125 recombinant cells were grown in liquid
ulture at 4 and 15 ◦C up to the mid exponential phase
nd then treated or not treated with 0.4% l-malate. Cel-
ular lysates were collected 24 h after induction and the
mount of recombinant -glucosidase assessed by its
atalytic activity as reported in Kopetzki et al. (1989a).
Table 3 reports the specific activity of recombinant
-glucosidase obtained. The highest -glucosidase
roduction was observed in lysates from induced cells
rown at 15 ◦C (0.75 U/mg), demonstrating that the
east -glucosidase is efficiently expressed in the
nducible psychrophilic host system in a totally soluble
nd catalytically competent form.
Effect of the growth medium in the production of
he recombinant -glucosidase was also investigated.
hTAC125 recombinant cells were grown in duplicate
n liquid culture at 15 ◦C in minimal and in complex
edium; induction was performed with 0.4% l-malate
t the mid exponential phase and cell lysates were col-
ected 24 h after induction. Recombinant-glucosidase
as produced in induced PhTAC125 cells in a totally
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Fig. 4. Recombinant production of the mesophilic -glucosidase from Saccharomyces cerevisiae in PhTAC125 cells. Panel A: 7.5% SDS PAGE
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he presence (lane 3) of l-malate, in comparison with commercial 
lane 4). The recombinant protein is indicated by an open box. Panel
igestion. Panel C: Mascot Search Results.
oluble and active form in both growth media. Accord-
ng to previous results, the effect of l-malate induction
s observed in both conditions (Table 4) but is much
igher in minimal than in rich medium (induction ratio
1 versus 21, total yield 26.7 mg/l).
. ConclusionsAn inducible cold expression system, which is
ffective in the production of both psychrophilic and
esophilic proteins, was developed in the Antarctic
a
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h
sPGLUCPl grown in minimal medium in the absence (lane 2) and in
idase from yeast used as control (lane 1); molecular weight marker
DI-TOF analysis of the -glucosidase peptides generated by tryptic
sychrophilic bacterium PhTAC125. Performances of
his inducible system were tested using two “ardu-
us” proteins. Both recombinant psychrophilic -
alactosidase and yeast -glucosidase were produced
n PhTAC125 as soluble and catalytically active
nzymes. Structural and kinetic analyses of the recom-
inant proteins showed that both enzymes were nearly
dentical to their native counterparts. The absence of
ggregated protein material might certainly be due
o the lower expression temperature that destabilises
ydrophobic interactions (Jeon et al., 1995). However,
ince the optimal expression temperature determined
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or PhTAC125 is only marginally lower than that used
or proteins production in E. coli (15 ◦C compared to
8 ◦C), other factors must play an effect in preventing
ggregation.
Experimental conditions for optimal protein pro-
uction in the cold inducible expression system were
lso defined. Low concentrations of l-malate and long
nduction time are effective for maximal protein pro-
uction. Higher l-malate concentration was shown
ither to be less effective or to impair cellular growth.
he unusually long time of induction might possibly
e ascribed to the long time of duplication displayed
y PhTAC125 when grown in minimal medium. The
nducible system exhibits better performances in min-
mal medium when compared with rich medium.
At optimal expression conditions, recombinant
-galactosidase is produced in an high yields
620–720 mg/l), indicating that the inducible system
an be very effective in the expression of psychrophilic
roteins that are usually poorly produced in mesophilic
osts. A significant lower production yield is observed
or yeast -glucosidase putatively due to the differ-
nt codon usage between the eukaryotic and bacterial
rganisms. Nevertheless, the cold expression system
ielded a satisfactory amount of this protein in a solu-
le and active form.
Both recombinant proteins were structurally charac-
erized in details by mass spectrometric analyses and
heir KM values were determined showing to be almost
oincident with those defined for the native enzymes.
The cold inducible expression system described in
his paper has a number of interesting features, includ-
ng the natural low temperature of cell growth and
he possibility of fine tuning the recombinant expres-
ion via the inducible promoter. These aspects might
e useful for biotechnological applications, although
o attempts were performed to define how the expres-
ion system works upon up-scaling which really is the
rucial step to disclose industrial perspectives. In this
espect, the better performances of the system in min-
mal medium must be underlined both for economical
easons and for the utilization in bioreactors.cknowledgments
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Abstract
Two-component systems are widespread in nature and constitute the most
common mechanism of transmembrane signal transduction in bacteria. Recently,
a functionally active two-component system consisting of malS and malR genes
possibly involved in the expression of a C4-dicarboxylate transporter system
(dctAB operon) was identified in the marine Antarctic bacterium Pseudoalteromo-
nas haloplanktis TAC125. In this paper, we performed a functional analysis of the
two-component system and demonstrated its involvement in the regulation of the
expression of C4-dicarboxylate transporter genes. The expression of the C4-
dicarboxylate transporter genes was induced by L-malate with the promoter
element located upstream of the dctA gene being active only in the presence of
the inducer. A s54 promoter responsible for the L-malate dependent transcription
regulation was identified and functionally characterized. The molecular mechan-
ism involves an inverted repeat sequence located upstream the s54 promoter that
was shown to bind regulatory proteins only in the presence of L-malate. The
protein factor responsible for the induction of the dctAB operon expression was
eventually identified as the transcriptional regulatory protein MalR. MalR is the
first transcriptional factor identified in P. haloplanktis TAC125 and one of the few
transcriptional modulators reported so far in cold adapted bacteria.
Introduction
Two-component regulatory systems are widespread in nat-
ure and exist not only in nearly all prokaryotes and many
Archaea but also in eukaryotes such as plants, fungi and
yeasts (West & Stock, 2001). A typical two-component
regulatory system consists of a signalling histidine kinase
(sensor kinase) and a cytoplasmic response regulator, usual-
ly a transcription factor acting as activator or repressor.
Binding of an environmental signal ligand to the sensory
domain of the histidine kinase induces autophosphorylation
of the transmitter domain that in turn serves as phospho-
donor for its cognate response regulator, thus activating the
control protein and leading to transcriptional regulation
(Wolanin et al., 2002). In bacteria, these regulatory systems
are involved in many signal-processing mechanisms, from
chemotaxis and flagellar movement to internal nitrogen
availability or pathogenicity, from the control of gene
expression for nutrient acquisition and virulence to antibio-
tic resistance (Galperin, 2004). Two-component regulatory
systems are often used by free-living bacteria that have to
adapt to frequent changes in nutritional availability and,
more generally, in environmental conditions in which they
need to finely tune gene expression. By contrast, bacteria that
live in stable niches (e.g. symbionts of aphids, rickettsias,
extremophiles or some marine hydrocarbon-degrading bac-
teria) seem to have less-regulated promoters and less regula-
tory factors (Cases et al., 2003; Cases & de Lorenzo, 2005).
The Antarctic Pseudoalteromonas haloplanktis TAC125 is
the cold-adapted bacterium, so far characterized, endowed
with the highest specific growth rate at low temperature. It
was considered a likely candidate to study the molecular
basis of physiological adaptation with the added value of
having interesting biotechnological features. This microor-
ganism was, in fact, suggested as a promising novel host
system for the recombinant protein production at low
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temperatures (Duilio et al., 2004a, b). Using genome se-
quencing, corroborated by in silico and in vivo analyses,
exceptional genomic and metabolic features have been
uncovered (Medigue et al., 2005). Annotation of the genome
highlighted the presence of a large number of regulatory
mechanisms including typical two-component systems,
although P. haloplanktis TAC125 usually lives in stable
environmental niches. Using a proteomic approach, we
identified a functionally active two-component system con-
sisting of two Coding DNA Sequences (CDSs) PSHAb0361
and PSHAb0362 (Papa et al., 2006). This regulatory ele-
ment was suggested to be involved in the expression of a
C4-dicarboxylate transporter system comprising CDSs
PSHAb0363 and PSHAb0364, coding for an outer membrane
porin and a putative periplasmic transporter of dicarboxylic
acids, respectively (Papa et al., 2006). Pseudoalteromonas
haloplanktis TAC125 metabolizes L-malate very efficiently.
In silico analyses, revealed the presence of a gene presumably
coding for malic enzyme (PSHAa2725, EC No. 1.1.1.40).
These enzymes play a key role in allowing cellular growth on
L-malate, a key intermediate of Kreb’s cycle (Iwakura et al.,
1979). In this paper, we performed a functional analysis of
the two-component system with the aim to investigate its
involvement in the regulation of the expression of C4-
dicarboxylate transporter.
Materials and methods
Methods
Bacterial strains, DNA constructs and media
Pseudoalteromonas haloplanktis TAC125 (Birolo et al., 2000)
was collected in 1992 from seawater near the French
Antarctic Station Dumont d’Urville (601400; 401010E).
It was routinely grown in aerobic conditions at 150 r.p.m.
at 15 1C in minimal medium, containing 1 g L1 KH2PO4,
1 g L1 NH4NO3, 10 g L
1 NaCl, 0.2 g L1 MgSO4 7H2O,
10mg L1 FeSO4, 10mg L
1 CaCl2 2H2O, supplemented
with 0.5% casamino acid and 0.2% L-malate as carbon
source (Papa et al., 2006) and 100mgmL1 ampicillin when
transformed.
Reverse transcriptase (RT)-PCR
Total RNA was extracted from P. haloplanktis TAC125
cells grown up to 3 OD600 nm as described previously (Tosco
et al., 2003) in minimal medium in the presence and in the
absence of 0.2% L-malate. RNA was reverse transcribed
using SuperScript II RNAse H Reverse Transcriptase
(Invitrogen) according to the manufacturer’s instructions.
cDNAwas amplified using specific oligonucleotides designed
on malRS and dctAB respectively as primers (Table 1), and
Taq polymerase (Promega, Madison, WI) according to the
manufacturer’s instructions. The reaction mixture was am-
plified (95 1C for 4500; 58 1C for 4500; 72 1C for 6000, 35 cycles),
and the products were detected by gel electrophoresis. As a
control of the experiment, PCR amplifications on genomic
DNAwith the same oligonucleotide pairs used for RT-PCR,
were performed. Densitometric analysis of the bands for the
quantification of transcription levels in the presence and in
the absence of L-malate was performed using QUANTITY ONE
Biorad software.
Primer extension analysis
Total RNA for primer extension analysis was extracted from
recombinant P(PSHA0363) P. haloplanktis TAC125 cells
(Papa et al., 2006) grown in minimal medium in the
presence of L-malate. Primer extension experiments were
performed as described previously (Tosco et al., 2003), using
the specific PSHAb0363PE Rev oligonucleotide as primer
(Table 1).
Preparation of protein extracts
Protein extracts were performed as described previously
(Papa et al., 2006).
Construction of promoter and UP (upstream)
deletion mutants
Two mutants P(PSHAb0363s70) and P(PSHAb0363s54)
were constructed from P(PSHAb0363) vector applying the
one-step overlap extension PCR strategy (Urban et al.,
1997). Either the fw/rev s70 or fw/rev s54 primers were
designed to introduce two single-point mutations, thereby
destroying the respective putative s70  10 box and s54
 24 box (Table 1). Further, a vector containing a mutated
version of the upstream sequence containing only the
proximal portion of the upstream region was generated and
named P(PSHAb0363)UP. The P(PSHAb0363) vector was
hydrolysed with ClaI and EcoRV enzymes. ClaI is located
about 1600 bp upstream of the inverted repeat sequence,
while EcoRV is located within the inverted repeat sequence
(Fig. 2a and c). This enzymatic digestion separates the distal
upstream region from the proximal region. A PCR-ampli-
fied fragment was obtained using an oligonucleotide con-
taining ClaI in its original position and a mutated
oligonucleotide containing EcoRV site immediately up-
stream the inverted repeat sequence (Table 1). This frag-
ment, opportunely controlled by sequencing, was then
inserted into the P(PSHAb0363) hydrolysed vector to gen-
erate the P(PSHAb0363)UP vector.
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Transcriptional fusion assays
Recombinant strains were grown either in the presence or in
the absence of L-malate up to midstationary phase (24 h).
Reporter assays of transcriptional fusions were performed by
measuring b-galactosidase activity as described by Duilio
et al. (2004a, b).
Electromobility shift assay (EMSA)
A 120-bp DNA fragment containing the inverted repeat
sequence located upstream dctA gene (UPdctA) was ob-
tained by PCR amplification using the specific oligonucleo-
tide pairs indicated in Fig. 2a and Table 1. The obtained
fragment was 32P labelled with the random primed DNA
labelling kit (Roche) according to the manufacturer’s in-
structions. EMSAs were performed in 20-mL reaction vo-
lume, in binding buffer (10mM Tris, pH 7.5, 10mM EDTA,
0.1mM PMSF). Total protein extract (10mg) was incubated
with the 32P-labelled DNA (2 ng, 50 000–100 000 c.p.m.) in
binding buffer in the presence of 8 mg of poly(dI–dC) as a
nonspecific competitor for the binding reaction, for 20min
at room temperature. A 120-bp PCR-amplified fragment of
the intragenic region of dctA was used as control (for
oligonucleotide pairs, see Table 1). Mixtures were then
analysed by electrophoresis on 6% native polyacrylamide
gel (29 : 1 cross-linking ratio) in TBE buffer (45mM
Tris-HCl, pH 8.0, 45mM boric acid, 1mM EDTA). Electro-
phoreses were performed at room temperature at 200V. The
gels were dried and analysed by autoradiography. In compe-
tition experiments, incubations were performed after the
addition of five- to 50-fold molar excesses of unlabelled
competitor DNA to the reaction mixture, containing pro-
teins and poly(dI-dC).
Western blot analysis
An antiserum against MalR was raised in rabbit (Primm,
Milan, Italy), using the synthetic peptide comprising the
region 122–136 of the protein (NH2-CDKRSLVMENRALKR-
COOH) as antigen. Protein extracted from P. haloplanktis
TAC125 cells grown both in the presence and in the absence
of L-malate, were resolved by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) under re-
ducing conditions using standard procedures (Sambrook &
Russell, 2001). The proteins were transferred on to a
polyvinylidene difluoride (PVDF) membrane using an elec-
troblotting transfer apparatus (Trans-Blot Semi-Dry Trans-
fer Cell, Bio-Rad). MalR protein was detected using the
Table 1. Plasmids and oligonucleotides
Description References
Plasmids
P(PSHAb0363) pPLB containing the PSHAb0363 promoter region (3600 bp) Papa et al. (2006)
Oligonucleotides
PSHAbMalS RT-PCR Fw 50-GGTTTGGTCGAATACATGACTTAGAGC-30 This work
PSHAbMalS RT-PCR Rv 50-CATCAACCATAACAACCGAGGTAACTGC-3 0 This work
PSHAbMalR RT-PCR Fw 50-GATGAGGCGATGATCCGCGATTCG-30 This work
PSHAbMalR RT-PCR Fw 50-CTAAACCCACCTTCATTCACCAATGCC-30 This work
PSHAbdctA RT-PCR Fw 50-CCGATACAGGCGTTATGCGCTACGC-30 This work
PSHAbdctA RT-PCR Rv 50-CACTCTGAGTGTTGATACAAAGCACC-30 This work
PSHAbdctB RT-PCR Fw 50-GTAGCCGCGCCTTATGCTCATCC-3 0 This work
PSHAbdctB RT-PCR Rv 50-CCACTAAACTCGCCTAGCAAAGGT-30 This work
PSHAbMalSR RT-PCR Fw 50-CTAAGGCCGCACCCTTTGTCGGC-30 This work
PSHAbMalSR RT-PCR Rv 50-GTAACGTGCAACCAGCTCTTTGC-30 This work
P(PSHAb0363) PE Rev 50-CGTTAAGTGGGCTATGTGC-30 This work
PSHAbdctA bandshift Fw 50-GGGCATGTAGTAGTGTGCG-30 This work
PSHAbdctA bandshift Rv 50-GATGGCCAACTACTAAATAAAC-3 0 This work
dctA bandshift control Fw 50-CTTACCTAATATGGTATTAGC-30 This work
dctA bandshift control Rv 50-GGCGCTTCTATTTGTGTGCCTTC-30 This work
PSHAb0363s70 Fw 50-GGGTGTACAACAAAGAGTAGATTC-30 This work
PSHAb0363s70 Rv 50-GAATCTACTCTTTGTTGTACACCC-3 0 This work
PSHAb0363s54 Fw 50-GTAGTTAACCATCATTTTGCTTAATGG-30 This work
PSHAb0363s54 Rev 50-CCATTAAGCAAAATGATGGTTAACTAC-30 This work
PSHAb0363UP Fw 50-CGTAAAACTATCGATATTAGATACAGG-30 This work
PSHAb0363UP Rv 50-CACTTTTATTTAAAGATATCACCTTTATCG-30 This work
PSHAb0363C Fw 50-GATACTTCCTGCAGATATATTAATTG-30 Papa et al. (2006)
PSHAb0363C Rev 50-CCTGTGTCCCGGGTATCATCATGTGTCC-30 Papa et al. (2006)
PSHAb0363 PE Rv 50-GCTCTAAGTCATGTATTCGACC-3 0 This work
Underlined sequences represent restriction sites inserted.
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anti-rabbit polyclonal antibody produced on the 122–136
target peptide of the protein (1 : 500) and peroxidase-con-
jugated anti-rabbit secondary antisera (1 : 20 000) (A9169,
Sigma). The membrane was developed using SuperSignal
West Femto Maximum Sensitivity Substrate detection kit
(Pierce) according to the manufacturer’s instructions.
Southwestern blot and cross-interaction analyses
Proteins extracted from P. haloplanktis TAC125 cells grown
both in the presence and in the absence of L-malate, were
resolved by SDS-PAGE and transferred on to a PVDF
membrane as described previously. The UPdctA 32P-labelled
fragment used for EMSAwas also used for the Southwestern
experiment. The PVDF membrane was first washed three
times in 10mM Tris-HCl, pH 7.5, containing 5% nonfat dry
skimmed milk, 10% glycerol, 2.5% Triton X-100, 0.1mM
dithiothreitol and 150mM NaCl at 25 1C. The membrane
was then soaked in binding buffer (10mM Tris-HCl, pH 7.5,
0.125%milk, 8% glycerol, 1mMdithiothreitol, 1mM EDTA
and 40mM NaCl). Incubation with UPdctA fragment
(500 000 c.p.m.mL1) was performed in 3mL of binding
buffer containing 5mM MgCl2 at 25 1C for 16 h with gentle
agitation. The membrane was then washed three times in
10mM Tris-HCl, pH 7.5, and 50mM NaCl for 15min. The
membrane was then exposed for autoradiography. The
PVDF membrane preincubated with the anti-MalR sera
was then incubated in the presence of the radiolabelled
UPdctA fragment in binding buffer for 16 h with gentle
agitation at 25 1C. The membrane was then washed three
times in 10mM Tris-HCl, pH 7.5, and 50mM NaCl for
15min and exposed for autoradiography.
Results
Functional analysis of the two-component
regulatory system
We identified four genes possibly involved in the uptake of
C4-dicarboxylic acids (Papa et al., 2006). These genes,
schematically shown in Fig. 1c, are located on P. haloplanktis
TAC125 chromosome II. malS and malR encode for a
putative C4-dicarboxylate sensor kinase and a putative C4-
dicarboxylate response regulator, respectively. Downstream
the malR gene, dctA and dctB are coding for an outer
membrane porin and a putative transporter of tri-dicarb-
oxylic acids, respectively. The transcriptional regulation
of malRS and dctAB loci under different conditions was
300 bp 
malS fw
149 bp 185 bp–77 bp 
malR malS 
malR fw malR rv malS rv dctA fw dtcA rv dctB fw dtcBrv 
dctA fw dtcB rv malRS  fw malRS rv 
(c)
(a) malS
      +      PC 
malR 
        +    PC 
dctA
+     PC 
dctB
       +     PC 
23S rRNA gene
16S rRNA gene
5S rRNA gene
(b)
malRS
      +      PC 
     dctAB 
                       +    PC 
23S rRNA gene
16S rRNA gene
5S rRNA gene
–
–
–
– –
–
I IIII III IVI 
dctA dctB
179 bp12 bp
Fig. 1. Schematic organization and transcriptional analysis ofmalRS two-component regulatory system. (a) L-Malate-dependent transcriptional induction of
the malRS and dctAB genes, monitored by RT-PCR (top panels) and visualization of the same samples in an agarose–formaldehyde gel
of total RNA (bottom panels). Total RNA samples were extracted from cells grown in minimal medium in the presence (1) and in the absence ( ) of
L-malate. Pseudoalteromonas haloplanktis TAC125 genomic DNA was used as positive control (PC). (b)Transcriptional analysis of malRS and dctAB loci both
in the presence and in the absence of L-malate (top panels) and visualization of the same samples in an agarose–formaldehyde gel of total RNA (bottom
panels). Pseudoalteromonas haloplanktis TAC125 genomic DNA was used as positive control (PC). (c) A schematic representation of the malRS and dctAB
locus and their transcriptional organization. The position of the oligonucleotides used for the amplifications (’) and the corresponding transcripts are also
indicated. , putative promoter element; , transcript detected in the absence of L-malate; , transcript detected in the presence of L-malate.
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investigated by RT-PCR. RT-PCR analyses were performed
on the RNA extracted from P. haloplanktis TAC125 cultured
in minimal medium both in the presence and in the absence
of L-malate. The results are shown in Fig. 1a. malS was not
detected in the absence of L-malate, whereas a transcription
product was weakly detected in the presence of the inducer
(Fig. 1a). The light bands in panel II seem to show that
transcription of the malR gene occurred essentially at the
same level under both conditions. Analogously, a dctA
transcription product was detectable in both conditions
although it appeared strongly induced by the presence of
L-malate (Fig. 1a). By contrast, transcription of the dctB gene
did not seem to be strongly affected by the presence of L-
malate, showing a band under both conditions (Fig. 1a).
However, in the absence of malate, the band in panel IV of
Fig. 1a appeared weaker than the band detected when malate
was added. A densitometric analysis of the transcripts was
then performed using the QUANTITY ONE Biorad software and
the data are reported in Table 2. A slight but clear increase in
the intensity of the transcript band was observed following
malate addition.
We also analysed the possible presence of bicistronic
transcripts for both malRS and dctAB loci (Fig. 1b, Table 1).
A cotranscriptional regulation for malS and malR genes
could not be detected, although previous sequence analysis
had revealed that these two genes are partially overlapped
(7 bp). This result could be probably due to the very low
expression level of this locus. As shown in Fig. 1b, a very
small amount of the bicistronic transcription product
encompassing the dctAB locus could only be detected when
L-malate was added to the minimal medium. A schematic
view of the transcriptional regulation of malRS and dctAB
loci is reported in Fig. 1c.
The occurrence of both the single dctA and the dctA-dctB
bicistronic messengers was further investigated by primer
extension experiments. Figure 2b shows the occurrence of
(b) (c)
(a)
GGGCATGTAGTAGTGTGCGATAAAGGTGATGTTTTTAAATAAAAGTGTGCGGATATCCGCACACTTTTTTGCT
TTAAAAACAGTGTTAATCATTTAACTAGCTGAAATTTATGTTTATTTAGTAGTTGGCCATCATTTTGCTTAAT
GGGTGTACAACAATAAGTAGATTCTAATTTTTAGGACACATG
σ CONSENSUS SITE (    )    Y T G G C A C G N N N N T T G C W
σ CONSENSUS SITE (    )    T R G R T W –- (14-19 bp) -- T A T R A Y
Y: C,T 
W: A,T 
R: A,G
N: A,G,C,T
+1
σ  –24 box σ  –12 box 
σ  –10 box
σ  –35 box
dctA EMSA Fw
dct  EMSA rv
SD+1
T G C A 
P1
P2
Fig. 2. Transcriptional analysis of dctAB operon
by primer extension analysis. (a) The nucleotide
sequence upstream of the dctA gene. The putative
P1 and P2 promoters are underlined and
highlighted in bold. The corresponding –10 and
–35 regions of s70 core promoter (indicated with
broken lines) and the corresponding –12 and –24
regions of s54 core promoter (indicated with
continuous lines) are in bold. The transcriptional
start sites are underlined and highlighted in grey.
The ribosome-binding site (SD) is indicated in italics,
while the dctA start codon is indicated in bold.
Specific oligonucleotide pairs used to PCR amplify
the region are shown. The putative binding site
recognized by MalR is highlighted in black (EcoRV
endonuclease site is shown). (b) Primer extension
analysis of the dctA transcript. A 19-bp
oligonucleotide was annealed to recombinant
P(PSHAb0363) Pseudoalteromonas haloplanktis
TAC125 total RNA and extended using reverse
transcriptase. The nucleotide sequence of the
upstream region was determined using the same
oligonucleotide as primer (lane T, G, C and A).
(c) Putative hairpin structure within the 53-bp-long
inverted repeat sequence (EcoRV endonuclease site
is shown in grey).
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two different transcription initiation sites. A proximal start
site, corresponding to an adenine base, was identified only
13 bp upstream of the dctA start codon (P1), while a distal
start site (adenine) was identified 33 bp upstream of the
translational start site (P2). The nucleotide sequence up-
stream of the dctA gene was then carefully examined. A
putative s70 promoter element was identified upstream of
the proximal start site, according to the P. haloplanktis
TAC125 consensus sequence previously defined (Duilio
et al., 2004a, b). Moreover, a putative s54 promoter element
was detected upstream of the distal transcriptional start
site. The consensus sequence required to define the s54
-dependent core promoter was derived from a collection of
186 promoters from 47 different bacterial species (Barrios
et al., 1999). In contrast to s70, it is well known that s54 can
originate a transcriptionally competent open complex only
in the presence of a transcriptional activator, known as
bacterial enhancer-binding protein (EBP), usually bound at
least 100 bp upstream of the promoter site (Studholme &
Dixon, 2003). The DNA region located upstream of the s54
core promoter was then examined revealing the presence of a
53-bp long sequence corresponding to a perfect inverted
repeat element positioned 71-bp upstream of the P2 tran-
scription initiation site (Fig. 2a–c).
To investigate which promoter is involved in the
L-malate-dependent transcriptional regulation, the  10 box
of the s70 and the  24 box of the s54 core promoters were
individually mutated to destroy the respective promoter con-
sensus sequence. P(PSHAb0363s54) and P(PSHAb0363s70)
were obtained by mutating the nucleotide residues mainly
conserved within the corresponding consensus sequences
(Barrios et al., 1999; Paget & Helmann, 2003). The nucleo-
tide sequences of the two mutated promoters are shown in
Fig. 3a. The activity of the promoters was investigated by
transcriptional fusion experiments. The two mutated DNA
sequences were individually fused to a promoter-less lacZ
gene contained in the pPLB plasmid (Duilio et al., 2004a, b).
Recombinant cells harbouring the mutated and wild-type
promoters were grown in minimal medium either in the
absence or in the presence of L-malate and recombinant cells
were collected in midstationary growth phase, as the max-
imum production of b-galactosidase was observed during
this growth phase (Papa et al., 2007). As expected, mutation
of each core promoter sequence resulted in a clear decrease
of b-galactosidase activity in comparison with the corre-
sponding value obtained with the wild-type promoter
(Fig. 3b). This result very likely indicates a cooperative effect
of two promoters that could be disturbed by the introduc-
tion of a mutation in one of two core promoters. However,
the transcriptional efficiency of the two mutated promoters
was very differently affected by the presence of L-malate. The
b-galactosidase activity remained unchanged when L-malate
was supplied to cells containing the s54-mutated vector
(PSHAb0363s54). On the contrary, cells harbouring the
s70 mutated promoter (PSHAb0363s70) showed an in-
crease in the b-galactosidase activity when L-malate was
added. These findings clearly indicated that only the s54
promoter is involved in the transcriptional regulation
mediated by L-malate. Moreover, a transcriptional lacZ
fusion construct containing a deletion of the distal upstream
region (UP) was also prepared. The deletion destroys the
inverted and repeat sequence, thus preventing the formation
of the hairpin structure (Fig. 2c). Cells harbouring
(PSHAb0363)UP were grown in the presence and in the
absence of L-malate. As shown in Fig. 3b, the b-galactosidase
activity remained unchanged when L-malate was supplied,
suggesting that an intact UP element is needed for transcrip-
tion regulation.
Identification of a cis-regulatory element
Functional analysis of the inverted repeat element located
upstream of the P2 transcriptional start site, was carried out
by EMSA to investigate whether this region might be able to
interact with P. haloplanktis TAC125 proteins. A 120-bp
DNA fragment encompassing the inverted repeat sequence
and the  24 box of the s54 promoter (UPdctA) (Fig. 2a),
was incubated with the entire protein extracts from cells
grown in minimal medium either in the absence or in the
presence of L-malate. A clear gel mobility shift band could
Table 2. Densitometric analysis of malRS and dctAB transcripts and ribosomal RNA, in the presence and in the absence of L-malate, as reported in Fig. 1
malS malR dctA dctB dctAB
 malate 1 malate  malate 1 malate  malate 1 malate  malate 1 malate  malate 1malate
13.45 308.97 141.36 190.12 208.31 2004.22 523.93 888.59 14.23 381.94
23S rRNA gene 16S rRNA gene 5S rRNA gene
 malate 1 malate  malate 1 malate  malate 1malate
1667.66 1735.55 1579.79 1590.87 699.20 673.78
To calculate the intensity of the band, the same area was used for each transcript. The value reported for each condition corresponds to the total
intensity of all the pixels in the volume divided by the area of the volume (density), as reported in user guide of the QUANTITY ONE software. Estimated errors
are c. 5% of the value.
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only be detected when the inverted repeat fragment was
incubated with the protein extract from cells grown in the
presence of L-malate, whereas no binding was observed in
the absence of the inducer. A 120-bp DNA fragment of the
intragenic region of dctA was incubated with the entire
protein extracts from cells grown in minimal medium either
in the absence or in the presence of L-malate, as control. The
free probe is shown for comparison (Fig. 4a). The specificity
of the binding was further demonstrated by competition
EMSA experiments (Fig. 4b). The specific labelled probe was
incubated with total protein extracts in the presence of
increasing amounts (five-, 20- and 50-fold) of unlabelled
specific and nonspecific DNA competitors.
Identification of the transcriptional
regulatory factor
Bacterial EBPs typically consist of three domains, the
N-terminal regulatory domain acts either positively or
negatively on ring formation and ATPase activity while
the central domain with ATPase activity contains the signa-
ture GAFTGA motif, which mediates interactions with s54
(Bose et al., 2008). Finally, the C-terminal DNA-binding
domain enables specific promoter recognition by allowing
EBPs to bind to enhancer-like sequences located c.
100–150 bp upstream of the transcription start site. An in
silico INTERPROSCAN analysis of MalR revealed domain archi-
tecture similar to the nitrogen assimilation regulatory
protein NtrC, with an N-terminal response regulator recei-
ver domain that contains the phosphorylation site, a central
output domain directly responsible for the interaction with
the s54 holoenzyme form of RNAP and a C-terminal DNA-
binding domain. Mal R also presents the motif that mediates
interactions with s54 at residues 223–228, but with a
tyrosine replacing the phenylalanine (GAYTGA). For this
reason, MalR was suggested to be the likely candidate for the
regulation of dctAB via s54 activation.
Southwestern blot analysis was then designed to investi-
gate the ability of MalR to specifically recognize the cis-
regulatory element. The radiolabelled UPdctAwas incubated
with protein extracts from cells grown in the presence and in
the absence of L-malate. Figure 5 shows that a single
hybridized band with an apparent molecular mass of about
50 kDa was clearly detected in the presence of the inducer.
The tiny band observed in the absence of L-malate indicated
that recruitment of the regulatory factor also occurred in the
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Fig. 3. Functional characterization of s54 and s70
core promoters by two single-point mutations.
(a) The two core promoter sequences are
underlined. Single-point mutations for each
promoter are highlighted in grey. (b) Profiles of
b-galactosidase activity of P(PSHAb0363),
P(PSHAb0363s70), P(PSHAb0363s54) and
P(PSHAb0363)UP transcriptional fusion
constructs measured in midstationary phase in
Pseudoalteromonas haloplanktis TAC125 cells
grown in minimal medium in the presence and in
the absence of L-malate.
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absence of the inducer, although it was strongly induced
when L-malate was added to the medium. The identity of the
50-kDa protein involved in the binding to the regulatory
element was univocally assessed by two further experiments.
First, the same membrane was developed with antibodies
raised against the MalR protein. A clear immunostained
band perfectly matching the radiolabelled signal was de-
tected by the anti-MalR antibody when the nucleotide probe
was incubated with the protein extract from cells grown in
the presence of L-malate. According to the transcriptional
data, an identical immunostained band could also be
detected when L-malate was omitted from the medium.
Second, the specificity of the interaction between the MalR
and the DNA cis-regulatory element was confirmed by a
specific cross-competition experiment. The membrane con-
taining the protein extracts from cells grown in the presence
and in the absence of L-malate was first incubated with anti-
MalR serum and then hybridized with the radiolabelled
DNA fragment. No hybridization bands could be detected
following interaction between the radiolabelled DNA frag-
ment and the cell extract, as it was clearly observed in the
previous experiment (Fig. 5), suggesting that anti-MalR
antibodies recruited MalR preventing its interaction with
the DNA fragment. As a whole, these findings demonstrated
that MalR is able to specifically recognize the cis-regulatory
element located upstream of dctA gene and to regulate the
L-malate dependent expression of the downstream genes.
Discussion
A functionally active two-component system was recently
identified in the Antarctic bacterium P. haloplanktis TAC125
by differential proteomic experiments (Papa et al., 2006).
This regulatory element consists of PSHAb0361 and
PSHAb0362 and was suggested to be involved in the expres-
sion of a C4-dicarboxylate transporter system comprising
PSHAb0363 and PSHAb0364 (Papa et al., 2006). The pro-
teins encoded by PSHAb0361 and PSHAb0362, hereby
indicated as malS and malR, exhibited 31.7% and 58.3%
identity with a C4-dicarboxylate transport sensor protein
(Q87R82) and a C4-dicarboxylate transport transcriptional
regulatory protein (Q8ECK1) from Vibrio parahaemolyticus
and Shewanella oneidensis, respectively. PSHAb0363 encoded
a putative protein sharing 33.1% identity with an outer
membrane porin from S. oneidensis (Q8EGP2). PSHAb0364
coding for a putative protein sharing 46.3% identity with a
di-tricarboxylate transporter from Corynebacterium gluta-
micum (Q8NTS7) was found 12 bp downstream of the outer
membrane porin gene, thus suggesting the involvement of
these two CDSs in the transport and the uptake of C4-
dicarboxylic acids. Accordingly, these CDSs were renamed
dctA and dctB (C4-dicarboxylate transport), respectively.
Functional analysis of the malRS and dctAB loci seems to
indicate that each gene is independently transcribed by its
own promoter in both loci. However, functional differences
exist among the various promoters. The promoter elements
located upstream of themalS gene and, particularly, the dctA
gene were strongly affected by L-malate with the former
I
+
50 kDa 
II III
– + – + –
Fig. 5. Southwestern blot analysis of UPdctA region and total protein
extract of Pseudoalteromonas haloplanktis TAC125 cells grown in the
presence and in the absence of L-malate. Panel I, Southwestern assay
showing the interaction between the UPdctA used as probe and a
50-kDa protein in the cellular extract of cells grown both in the presence
(1) and in the absence ( ) of L-malate. Panel II, Western immunoblot
with anti-MalR antibodies showing the presence of MalR protein in the
cellular extract of cells grown both in the presence (1) and in the
absence ( ) of L-malate. Panel III, Cross-competition assay. The PVDF
membrane containing the protein extracts from cells grown in the
presence (1) and in the absence ( ) of L-malate was first incubated
with anti-MalR serum and then hybridized with the radiolabelled UPdctA
fragment.
(a) (b)
1 2 3 4 5 1 2 3 4 5 6
Specific probe Nonspecific probe
Fig. 4. EMSAs performed using UPdctA region and total protein extract
of Pseudoalteromonas haloplanktis TAC125 cells grown in the presence
and in the absence of L-malate. (a) Lane 1, free probe; lane 2, nonspecific
probe incubated with proteins extracted from cells grown in the absence
of L-malate; lane 3, specific probe incubated with proteins extracted
from cells grown in the absence of L-malate; lane 4, nonspecific probe
incubated with proteins extracted from cells grown in the presence of L-
malate; lane 5, specific probe incubated with proteins extracted from
cells grown in the presence of L-malate. (b) Competition assays per-
formed by incubating specific radiolabelled probe with total protein
extract of P. haloplanktis TAC125 grown in the presence of L-malate, and
increasing quantity (five-, 20- and 50-fold) of unlabelled nonspecific and
specific DNA competitors.
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being active only in the presence of the inducer. On the
contrary, the promoter located upstream of the malR and
dctB genes seem to be insensitive or slightly responsive to the
presence of L-malate, as in the case of dctB. The malate
dependence of the promoter located upstream of the dctA
gene confirmed the involvement of the corresponding porin
in the L-malate uptake, as reported previously (Papa et al.,
2006). The occurrence of two different transcription initia-
tion sites upstream of the dctAB locus was demonstrated.
A putative s70 promoter element was identified upstream of
the proximal start site. Moreover, a putative s54 promoter
element was inferred upstream of the distal transcriptional
start site (Barrios et al., 1999). The s54 core promoters seem
to be remarkably highly conserved both in sequence and in
structure as compared with the more variable s70 promo-
ters. This conservation very likely reflects the strict require-
ments for promoter recognition and function needed for a
highly controlled regulation. Functional analysis of the two
promoters demonstrated that only the activity of the s54
promoter was affected by L-malate. However, the dctA gene
was found to be expressed from both promoters, the
constitutive s70 promoter active also in the absence of L-
malate and responsible for the basal level of the dctA
transcript, and the inducible s54 promoter, which assures
high levels of transcript in the presence of the inducer.
In contrast to s70 RNAP bound at its cognate promoter
sites, s54 RNAP is unable to spontaneously isomerize from a
closed complex to a transcriptionally competent open com-
plex (Studholme & Dixon, 2003). To proceed with initiation
of transcription, the closed complex must participate in an
interaction with transcriptional activators known as bacter-
ial EBPs, involving nucleotide hydrolysis. Transcriptional
activators usually bind at least 100 bp upstream of the
promoter site, and DNA looping is required for the activator
to contact the closed complex and catalyse the formation of
the open promoter complex. Accordingly, the molecular
mechanism exerted by L-malate on the expression of the
dctAB operon involves the inverted repeat sequence located
upstream of the s54 promoter. This DNA sequence repre-
sents a cis-acting region able to bind P. haloplanktis TAC125
regulatory proteins only when the cells were grown in the
presence of L-malate. The protein factor responsible for the
L-malate dependent induction was identified as the tran-
scriptional regulatory protein MalR.
In silico analysis revealed a close similarity of MalR
sequence with NtrC, a typical bacterial EBP. Two-compo-
nent systems have evolved to allow bacteria to sense and
respond to a wide range of stresses and environmental cues,
using specialized EBPs. Examples include the nitrogen
assimilation regulatory protein NtrC and the dicarboxylic
acid transport regulator DctD (Studholme & Dixon, 2003).
Bacterial EBPs show a classical architecture consisting of
three domains, the N-terminal regulatory domain acting
either positively or negatively on ring formation and ATPase
activity, the central AAA1domain endowed with ATPase
activity and the C-terminal DNA-binding domain enabling
specific promoter recognition.
Binding of MalR to the inverted repeat sequence pro-
duced a very highly retarded shift band in the EMSA
experiment, suggesting something very large binding to it,
either RNAP or a multimer of MalR. Indeed, upon phos-
phorylation, NtrC forms oligomers (possibly an octamer)
that can hydrolyse ATP and couple the energy available from
ATP hydrolysis to the formation of an open complex with
s54 holoenzyme (Lee et al., 2001). Interaction of MalR with
the DNA inverted repeat sequence very likely stabilizes the
interaction of the RNAP on the s54 core promoter thus
activating the transcription of downstream genes. However,
transcription of malR gene and production of MalR protein
seem to occur at the same level both in the absence and in
the presence of L-malate. A possible explanation for this
apparent discrepancy is that L-malate induces the expression
of the MalS histidine kinase that can act as phospho-donor
for its cognate MalR response regulator increasing the
amount of the active form of the control protein and leading
to transcriptional activation.
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